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Abstract 
Transmembrane proteins traverse the lipid bilayers of cell membranes and play a highly 
important role in many processes in vivo. Malfunctions of membrane proteins have been shown 
to cause a variety of disease states, for example, cystic fibrosis, hereditary hearing loss, and 
hypothyroidism. Furthermore, membrane proteins are targets of over 60% of all drugs available 
on the market. Thus, information on membrane protein function is of immense importance for 
the understanding of processes associated with disease states and for the development of new and 
improved therapeutics. 
 Detailed spatial structures of proteins are typically obtained from crystal X-ray 
diffraction data. Crystallizing membrane proteins, however, is extremely difficult due to their 
amphiphilic properties that affect their stability in aqueous solutions. The trial-and-error nature 
of the crystallization process requires large-scale screening efforts, which is often hampered by 
the limited availability of membrane protein samples. 
 In meso crystallization is a powerful alternative to the traditional crystallization of 
membrane proteins directly from aqueous solutions. The method involves reconstitution of the 
proteins into so-called lipidic mesophases that are comprised of lipid bilayers, providing a 
native-like environment for the proteins. Lipidic mesophases form spontaneously upon mixing of 
the aqueous solution of a protein with a lipid. The microstructural properties of the mesophase 
play a highly important role in crystallogenesis in meso and depend on the composition of the 
overall mixture in a complex manner. Understanding the effect of mesophase microstructure on 
the outcome of crystallization trials is necessary for improving the success rate of the process. 
Mesophases, however, are difficult to handle due to their high viscosity, and require special 
mixing and dispensing tools both for protein crystallization and for microstructural studies. The 
properties of lipidic mesophases also hampered miniaturization using microfluidic technologies, 
commonly used for screening of protein crystallization from solutions. 
 Microfluidic platforms developed in this dissertation are the only examples of 
microfluidic devices that combine mesophase-handling capabilities and X-ray transparency as 
required for in situ analysis of mesophases and of protein crystals. The platforms provide a route 
to reduce the preparative scale, automate sample formulation, and eliminate manual handling in 
two distinct aspects of mesophase-based technologies: (i) screening of the structure/composition 
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relationships of the properties of lipidic mesophases, and (ii) in meso crystallization of 
membrane proteins.  
Macroscale studies of the phase behavior of lipidic mesophases with additives typically 
present in membrane protein crystallization highlight the complexity of structure/composition 
relationships in these systems, as discussed in Chapter 2. These studies are highly laborious and 
require the preparation of a large number of samples with systematically varying compositions. 
Microfluidic platforms developed and validated in Chapters 3 and 4 allow for automated 
simultaneous formulation of multiple samples and scale down the amount of material per sample 
at least 300-fold compared to the standard macroscale method. X-ray transparency of the 
platforms enables small-angle X-ray scattering analysis on-chip, as required to establish the 
microstructure of the mesophases. The platforms address two types of structural studies of 
mesophases. The microfluidic system presented in Chapter 3 is designed for the studies of the 
effect of additives on the microstructure of mesophases in multicomponent crystallization 
mixtures. The chip developed in Chapter 4 is applicable for studies of phase behavior in binary 
lipid/water mixtures, which is necessary for the understanding of fundamental principles of self-
assembly in lipidic systems and for assessing suitability of novel lipids for in meso 
crystallization. 
Chapter 5 describes a microfluidic platform for in meso crystallization of membrane 
proteins. The platform reduces the amount of material per trial 7-fold compared to similar 
macroscale methods. Platform architecture has been validated by crystallizing a membrane 
protein Photosynthetic Reaction Center (RC) from Rhodobacter Sphaeroides. Furthermore, 
crystal structure of RC was solved using X-ray diffraction data collected on-chip. Thus, the 
platform fully eliminates manual crystal harvesting and is a highly promising tool for structural 
biology. The platform is uniquely positioned for the simultaneous analysis of the protein crystals 
and the surrounding mesophase, which is not possible with existing macroscale approaches. This 
information is invaluable for unraveling the factors defining the outcome of crystallization trials 
and for improving the success rate in membrane protein crystallization. 
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Chapter 1. 
Lipidic mesophases and in meso crystallization 
of membrane proteins 
 
1.1  Introduction 
Transmembrane proteins play a pivotal role in many cellular processes, for example, in transport 
of components across cell membranes, signaling between cells and subcellular domains, and 
biochemical pathway regulation. Normal function of membrane proteins is paramount for health, 
and malfunctions have been linked to conditions as diverse as polycystic kidney disease, 
Alzheimer’s disease, and cystic fibrosis.1 Because of their biological importance, membrane 
proteins account for over 60% of drug targets.2 Detailed information on the structure of 
membrane proteins and on the mechanisms of their action is invaluable for the understanding of 
their function, as required for the developments of new and improved treatments. However, high-
resolution structures of membrane proteins are only scarcely available. The bottleneck here is the 
difficulty of obtaining sufficiently large, diffraction-quality membrane protein crystals for X-ray 
diffraction analysis, the primary source of structural information. As of October 2012, only 
~1100 crystal structures of membrane proteins are currently available, of which only 400 are 
unique,3 compared to >80000 structures of soluble proteins.4 
The two most common crystallization methods for membrane proteins are in surfo and in 
meso,5 although crystallization from detergent-stabilized solutions in apolar solvents6 and from 
bicelle-stabilized solutions has also been reported.7 Most approaches for membrane protein 
crystallization require that a protein initially be transferred from the native cell membrane into an 
aqueous solution. The difficulties in the crystallization of membrane proteins are conferred by 
their intrinsically amphiphilic structure, i.e., presence of hydrophilic and hydrophobic domains 
within the protein molecule (Figure 1.1A). To prevent denaturing of hydrophobic domains upon 
exposure to the hostile aqueous environment, membrane proteins are solubilized in detergent 
micelles that form a protective shield around the part of the molecule that originally resided in 
the interior of the cell membrane (Figure 1.1B). In the in surfo method a precipitant is added 
directly to a solution detergent-solubilized protein to induce crystallization and crystals grow 
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from a solution.5 In the in meso method pioneered by Landau and Rosenbusch8 the solution of 
detergent-stabilized protein is mixed with a lipid to form a mesophase (Figure 1.1C), a self-
assembled nanoscale structure composed of lipid bilayers with embedded protein molecules. 
Precipitant is then added to the protein-containing mesophase (Figure 1.1D), with subsequent 
protein crystal growth taking place within the mesophase (Figure 1.1E). The lipid bilayers of the 
mesophase create a membrane-like environment for the protein and are thought to maintain it in 
the native conformation. The in meso method has been credited with a number of breakthroughs 
human membrane protein structures, such as β2 adrenergic receptor9 and κ-opioid receptor,10 
targets of many common drugs. 
 
Figure 1.1. A cartoon representation of the in meso crystallization approach.5,6,7 Red arrows in panel C point at depictions of 
protein molecules embedded in the bilayers of a mesophase of lipid monoolein. Protein purification and concentrating steps in-
between A, B, and C are not shown. (Parts of the figure are reprinted from M. Caffrey, Current Opinion in Structural Biology, 
2000, 10(4), 486-497, with permission from Elsevier, and from P. Nollert, Journal of Applied Crystallography, 2002, 35(5), 637-
640, with permission of the International Union of Crystallography, http://dx.doi.org/10.1107/S0021889802012001.)  
In Chapter 1.2.1 and 1.2.2 we describe the properties of relevant mesophases and the 
current mechanistic understanding of the in crystallogenesis in meso, Chapter 1.2.4 describes 
reported implementations of the in meso method, and Chapter 1.2.5 focuses on the challenges 
associated with the method. Structure and properties of lipidic mesophases are discussed in detail 
in Chapter 1.3.1-1.3.3. Chapter 1.4.1-1.4.3 focus on the challenges associated with in meso 
crystallization of membrane proteins and studies of the phase behavior of lipidic mesophases and 
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with related miniaturization strategies. For brevity, solutions of membrane proteins will be 
referred to as “protein solutions” throughout the dissertation. 
 
1.2  Crystallization of membrane proteins in lipidic mesophases 
1.2.1  Lipidic mesophases for in meso crystallization 
This section briefly summarizes the aspects of structure and properties of lipidic mesophases 
relevant for in meso crystallization. Lipidic mesophases are described in detail Chapter 1.2.1 and 
1.2.2. 
 
Figure 1.2. Cartoon representations of mesophase types. Lipid bilayers are shown in brown and yellow, aqueous compartments 
are shown in blue. As much as possible, the dimensions of lipid monolein (light brown), membrane proteins (grey or purple), 
thicknesses of lipid bilayer and dimensions of aqueous compartments have been drawn to scale. In case of lipid monoolein, lipid 
bilayer thickness in all lipidic phases is approximately 40 Å at room temperature and is indicated with red arrows. (A) Curved 
lipid bilayers of the lipidic cubic mesophase of Pn3m type with reconstituted membrane proteins encircled in blue ovals for 
clarity. (B) Lamellar mesophase. (Reprinted from M. Caffrey, Current Opinion in Structural Biology, 2000, 10(4), 486-497, with 
permission from Elsevier.) (C) Sponge phase with reconstituted membrane proteins (purple). (Reprinted from V. Cherezov, J. 
Clogston, M.Z. Papiz, M. Caffrey, Journal of Molecular Biology, 2006, vol. 357(5), 1605-1618, with permission from Elsevier.) 
Lipidic mesophases consist of highly ordered lipid bilayers interspersed with aqueous 
channels and self-assemble spontaneously when certain lipids are mixed with water or aqueous 
solutions.11 The two classes of mesophases most relevant in the in meso crystallization are 
lamellar and cubic. The lamellar phase is comprised of stacks of flat lipid bilayers, whereas in 
the cubic phase the bilayers are highly curved and are saddle-shaped at every point in the 
mesophase (Figure 1.2).12 The distinguishing property of cubic mesophases is the 3D-continuous 
structure of the bilayers as well as of the aqueous channels. 
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Cubic phases are prerequisite for crystallogenesis in meso,13 presumably due to the 
bicontinuous structure of both lipidic and aqueous compartments that allows for 3D diffusion of 
proteins within the mesophase. On the contrary, in lamellar phases protein molecules are 
constrained to moving along a single lamella. The aqueous channels of cubic mesophases are 
sufficiently large to incorporate hydrophilic domains of membrane protein molecules, whereas 
the size of the aqueous compartments in lamellar phases is likely too small, causing the proteins 
to separate from the mesophase.14 Because the microstructure of lipidic mesophases is sensitive 
to temperature and composition of the crystallization mixture, compatibility of a given set of 
crystallization conditions with cubic phase formation must be assessed experimentally.15-18 
Formation of mesophases has been reported in many synthetic 
and naturally occurring lipids. The lipid most commonly used for in 
meso crystallization is monoolein8,15 (Figure 1.3), a monoacylglycerol 
with 18 atoms in the hydrocarbon chain of the lipid tail. Other 
homologues of monoacylglycerols have also been tested as matrices for 
in meso crystallization,19-22 and in a recent report a new family of 
isoprenoid lipids suitable for in meso crystallization has also been 
demonstrated.23,24 The structure of the lipid molecule defines the 
properties of cubic mesophases, such as the thickness and curvature of 
lipid bilayers, the size of aqueous channels within the mesophase, and stability of cubic phases, 
as discussed in Chapter 1.3. These properties have important implications for protein 
crystallogenesis in meso. 
 
1.2.2  Mechanism of in meso crystallization 
Phase transformations and properties of the mesophase itself have been shown to play a 
highly important role in the outcome of crystallization trials in meso.13,25-28 All membrane protein 
crystals grown in meso are of type 1,29 with protein molecules packed in ordered sheets.30 In the 
case of membrane protein bacteriorhodopsin, crystal formation in meso was observed as long as 
the bilayer curvature in the mesophase was within a certain range.28  Although a bulk cubic phase 
was required for crystal growth,13 atomic force microscopy measurements showed that crystal 
nucleation occurs with a local cubic-to-lamellar rearrangement.31 Existence of a lamellar phase 
surrounding a membrane protein crystals grown in meso was also confirmed optically13 and in 
Figure 1.3 Structure of lipid 
monoolein with the polar 
head group shaded in blue 
and the hydrocarbon tail 
shaded in grey. 
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SAXS studies.26 Based on these findings, mechanistic description of crystallogenesis focused on 
the concepts of bending elasticity and topology of lipid bilayers.13,25-27  
 
Figure 1.4. Hydrophobic matching at the protein–membrane interface in membranous media with diverse curvatures. Membrane 
proteins are shown schematically as cylinders. Lipid bilayers are depicted as planar or curved structures. (A) Schematic depiction 
of hydrophobic (white) and hydrophilic (blue) domains of a membrane protein. (B, C) Protein cylinder interacting with a curved 
bilayer of a cubic lipidic mesophase (B) before and (C) after precipitant addition. Mismatch between the two hydrophobic 
surfaces is shown in red. (D) Two membrane protein in a flattened bilayer of the mesophase; hydrophobic mismatch is relieved. 
(Parts of the figure are reprinted from P. Nollert, H. Qiu, M. Caffrey, J. P. Rosenbusch and E. M. Landau, Federation of Europian 
Biochemical Societies Letters, 2001, 504, 179-186, with permission from Elsevier.) 
The driving force of protein crystal nucleation is believed to be the geometric mismatch 
between the saddle-shaped bilayers of the cubic phase and the hydrophobic domains of proteins 
adapted to planar cell membranes (Figure 1.4).13,27 For the optimal coverage of the hydrophobic 
domains of protein molecules, the lipid bilayers must adopt a strained, locally flattened geometry 
(Figure 1.4B).13,27 The free energy cost of bilayer flattening becomes higher upon addition of 
precipitants that cause the intrinsic bilayer curvature to increase (Figure 1.4C).21,28,32-34 Moving 
another protein molecule into the already flattened bilayer region from elsewhere in the 
mesophase, however, is energetically favorable because it reduces the cumulative bilayer 
bending stress in the system. This provides the driving force for crystal nucleation, which occurs 
with locally flattened (lamellar) bilayers surrounding protein clusters (Figure 1.4D), eventually 
driving phase separation of a protein crystal from the surrounding mesophase,13,27 in agreement 
with experimental observations. 
While high mean bilayer curvature favors MP crystal nucleation in meso, it may arrest 
protein diffusion required for crystal growth. Bilayer curvature is not uniform throughout the 
mesophase, and protein molecules are believed to reside in bilayer regions with low local 
curvature and to traverse bilayer regions with locally high curvature at a high energy cost during 
diffusion.27 Successful in meso crystallization trials have been correlated with conditions that 
correspond to a high protein mobile fraction and a fast diffusion rate.35,36 Thus, MP crystal 
formation in meso relies on a delicate balance of conflicting requirements for crystal nucleation 
and growth. 
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1.2.3  Optimization of in meso crystallization 
The efforts to engineer mesophase properties to improve success rate of crystallization 
trials relied heavily on the mechanistic understanding of crystallogenesis and its relation to the 
microstructure of mesophases.  
Of primary importance for in meso crystallization is the presence of a cubic phase in the 
crystallization system. Here, compatibility of crystallization screens with cubic phase formation 
has been tested16,37,38 and suitable precipitant kits are commercially available, for example, the 
CubicTM Screen from Emerald Biosystems. To address poor low-temperature stability of MO 
cubic phases (Chapter 1.2.3), monoacylglycerols39 and isoprenoid lipids23,24 with a cubic phase 
stable at temperatures lower than that of MO have been developed and successfully used for 
membrane protein crystallization.24,39 The isoprenoid lipids, due to their branched structure, were 
also shown to stabilize protein-protein contacts in the crystal, potentially facilitating 
crystallization.24  
The importance of hosting lipid is highlighted in the studies of monoacylglycerol 
homologues of with lipid tail lengths of 14, 15, and 16 carbon atoms and different positions of 
the double bond within the chain as matrices for the crystallization of an outer membrane sugar 
transporter OprB.22 Only one of the three 15-atom homologues tested in that work produced 
diffraction-quality crystals of OprB, although small crystals formed in 15- and 16-carbon 
monoacylglycerols, as well as in monoolein.  
Lipidic sponge phases have been reported as suitable crystallization matrices for 
membrane proteins with sizeable hydrophilic domains that are too large to be accommodated by 
the aqueous channels of highly structured cubic phases.25 Sponge phases (Figure 1.2C) are 
isotropic liquids that consist of disordered lipid bilayers suitable for membrane protein 
reconstitution and sufficiently flexible to conform to the size of hydrophilic domains. Sponge 
phase formation can be induced by various additives in the precipitant addition step, such as low-
molecular weight polyethyleneglycols, Jeffamine, and alcohols.25,40 Because of the flexibility of 
lipid bilayers in the sponge phases, the mechanism of crystallization is likely different from that 
in highly structured lipidic mesophases. Here, the formation of favorable contacts between 
hydrophilic domains of membrane proteins may be expected to play a major role. A set of 
sponge phase-inducing precipitants has been reported40 and is available in a commercial 
crystallization kit from Molecular Dimensions. 
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A number of high-throughput methods for assessing successful crystallization conditions 
have been reported, such as testing the compatibility of precipitants with the cubic mesophase 
formation,37,38 and deducing optimal crystallization conditions based on the rate of protein 
diffusion.36 Host lipid screens are used in state of the art crystallization protocols.41 
 
1.2.4  Implementations of the in meso method 
The very first in meso crystallization protocol relied on the introduction of salt crystals 
into protein-laden mesophase in order to induce crystal growth.8 The approach currently used in 
structural biology relies on a modification42 of the original protocol with solutions of 
precipitants, instead of solid salts, added to the mesophase (Figure 1.1). Three distinct 
implementations of this method have been reported.15,43,44 Although all implementations rely on 
the same sequence of steps, the protocols for mesophase formulation and incubation with 
precipitant, as well as relative amounts of lipid, protein solution, and precipitant, differ between 
the methods. 
 
Figure 1.5. Workflow in the standard protocol for in meso crystallization. (A) (1) Protein-loaded mesophase is initially formed 
by coupling two syringes (one filled with 60% monoolein and the other with 40% protein solution) and by mixing of the two 
components with repetitive cycling of the entire combined volume from one barrel to the other. (2) The mesophase-filled syringe 
is attached to a ratchet dispenser. (B) The mesophase is dispensed into each microwell with the ratchet dispenser (3, 4). 
(Reprinted by permission from Macmillan Publishers Ltd: Nature Protocols (M. Caffrey, V. Cherezov, Nature Protocols, 2009, 
4(5), 706-731), © 2009.) (C) Precipitant solutions fill the wells of a crystallization tray (5), a single well also shown (6). (D) The 
wells are sealed with clear transparent tape (7) and stored (8). The protein-containing mesophase is stable in an excess of 
overlaying liquid (6-9). Crystals appear only within the lipid matrix (9). Even though less than 200 nL of material is required per 
crystallization well, at 5-20 µL of the protein solution is necessary for mesophase preparation. (Reprinted by permission from E. 
Wallace, D. Dranow, P. D. Laible, J. Christensen and P. Nollert, Public Library of Science ONE, 2011, 6, e24488, © 2011.) 
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The most widely used variant of the method15 (Figure 1.5) relies on the preparation of a 
uniformly mixed mesophase with homogeneous protein loading. Monoolein is typically mixed 
with the protein solution in the ratio of 60:40 w/w (v/v). Due to the extremely high viscosity of 
lipidic mesophases a coupled syringe mixer (Figure 1.5A) is typically used in this step. The 
mixer consists of two syringes connected with an airtight coupler, with one syringe containing 
the protein solution, and the other syringe with a molten lipid. Mixing is achieved by pushing the 
contents back and forth between the syringes. A small amount of the mesophase (20-100 nL) is 
dispensed into a crystallization well and a large excess of precipitant (microliters) is added 
directly on top of the mesophase. Again, due to the high viscosity of the mesophase, accurate 
dispensing requires either a crystallization robot45 or a ratchet dispenser46 (Figure 1.5), and may 
be challenging even with these tools. 
The protocol described above has been used in almost all reported in meso crystallization 
trials to date. The most common crystallization setup for this approach is the microbatch format 
(Figure 1.6A), although the method is amenable to other trial formats typical for crystallization 
from solutions (Figure 1.6). The major drawback of the method is the large amount (at least 
several µL) of the protein solution required for the mesophase preparation in the coupled syringe 
mixer, although only nanoliter or even picoliter47 amounts of the sample are required for the 
crystallization. This limits the flexibility of the method and imposes constraints when working 
with scarcely available protein samples. 
 
Figure 1.6. Types of in meso crystallization experiments that can be performed with commercially available plates and pre-
mixed protein-loaded mesophase. The types of plates used include (A) microbatch, (B) sitting drop and (C,D) hanging drop. In D 
and E, a sandwich is made of the mesophase (red) by placing a small glass coverslip (hatched) (D) below or (E) above the bolus. 
The precipitant solution is colored a shaded pale blue, the vacuum grease is yellow and the sealing tape is gray. (Reprinted by 
permission from Macmillan Publishers Ltd: Nature Protocols (M. Caffrey, V. Cherezov, Nature Protocols, 2009, 4(5), 706-731), 
© 2009.) 
A recently reported protocol43 (Figure 1.7), termed post lipidic cubic phase formation 
incorporation (PLI), omitted mesophase formulation with homogenous protein loading. Instead, 
a lipid/water mesophase was prepared in coupled syringes and dispensed into crystallization 
wells (Figure 1.7A). A protein solution was added to this pre-formed mesophase, and the protein 
was found to spontaneously partition into the mesophase upon incubation, which took up to 12 
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hours (Figure 1.7B, C). Crystallization was then carried out in the sitting drop format (Figure 
1.6B, Figure 1.7D), with the precipitant solution added on top of the mesophase in the well, and 
incubated against a reservoir with the same precipitant. Under favorable conditions protein 
crystal growth was observed within the mesophase (Figure 1.7E). The protein 
solution/mesophase (or monoolein) ratio was maintained at 2:1 v/v, different from that typically 
used with homogeneous mesophase formulation. Remarkably, the protocol was efficient even 
upon incubating the protein solution with dry monoolein. In this case the mesophase must form 
spontaneously due to diffusion of water into monoolein, which happens significantly faster than 
diffusion of the protein into the mesophase due to the very large differences in molecular sizes. 
 
Figure 1.7. Workflow in the PLI43 and CIMP44 protocols for in meso crystallization. (A) In the PLI protocol the mesophase or 
molten MO (grey) is dispensed into microwells using airtight syringes. In the CIMP approach a well-plate pre-coated with MO 
(Quiagen) is used. (B) A solution of membrane protein (red) is dispensed into the well by conventional pipetting and is incubated 
with lipidic material for several hours, resulting in (C) protein incorporation into the mesophase. (D) Precipitating reagents (pale 
blue) are added. In the PLI approach identical solutions are used in the well and the reservoir. In the CIMP approach a diluted 
precipitant is added in the well and a concentrated precipitant is used in the reservoir. (E) The wells are sealed and stored. 
Crystals only appear within the lipid matrix. Amounts of material required per crystallization well in the two methods are 
indicated for steps 1, 2, and 4. (Parts of the figure are reprinted by permission from Macmillan Publishers Ltd: Nature Protocols 
(M. Caffrey, V. Cherezov, Nature Protocols, 2009, 4(5), 706-731), © 2009, and from E. Wallace, D. Dranow, P. D. Laible, J. 
Christensen and P. Nollert, Public Library of Science ONE, 2011, 6, e24488, © 2011.) 
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The advantages of the PLI protocol include the elimination of the cumbersome 
mesophase mixing and dispensing steps (in the case when dry monoolein is used) and, unlike in 
the standard in meso protocol shown in Figure 1.5, the ability to carry out crystallization trials 
with proteins available in amounts insufficient for the coupled-syringe mixer. However, the PLI 
method has only been used to produce crystals of three highly similar membrane proteins,43,48 
and applicability of this method for a wide range of membrane proteins remains to be tested. 
Some of the potential problems associated with the method are (1) the long incubation time 
required for protein incorporation in the mesophase, which may be suboptimal due to the 
possibility of protein denaturation, and (2) the lack of control over protein transport into the 
mesophase in crystallization well with implications for reproducibility of crystallization trials. 
On the other hand, passive mixing for mesophase formulation may be advantageous because the 
proteins are not subjected to substantial and potentially damaging shear forces in the mixing step.  
A slightly different protocol,44 termed controlled in meso phase crystallization (CIMP), 
combines the PLI approach with vapor diffusion commonly used in the crystallization from 
solutions. The protocol involves two steps: (i) the protein solution is incubated with dry 
monoolein; and (ii) precipitant solution is added to the mesophase and the reservoir well. 
Precipitant solutions in the crystallization well and the equilibration reservoir have different 
concentrations, providing a way to probe a larger parameter space than in the PLI method. The 
CIMP method has been tested with two previously crystallized membrane proteins and also used 
to obtain diffraction-quality crystals of a novel protein.44 
 
1.2.5  Microfluidic platforms for in meso crystallization 
Sophisticated microfluidic devices routinely automate fluid handling and formulation of 
samples on the nanoliter scale for screening of a large number of experimental conditions in a 
wide range of applications.49-54 These systems typically rely on the well-developed methods of 
multilayer soft lithography to fabricate complex microfluidic networks with channel heights and 
widths on the order of tens to hundreds of micrometers.55,56 Multilayer devices fabricated in 
elastomeric material polydimethylsiloxane (PDMS) provide fluid routing capabilities via 
pneumatic valve actuation (Figure 1.8), where a thin elastomeric membrane deflects under a 
pressure gradient to close or open the fluid channel of the other fluidic layer.55 
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Figure 1.8. Operation of valves in multilayer microfluidic devices fabricated in polydimethylsiloxane (PDMS).55,56 (A) Normally 
open valves.55 (B) Normally closed valves.57-60 Image courtesy of Dr. J. Tice, University of Illinois. 
Various microfluidic approaches to microfluidic screening of crystallization conditions of 
soluble proteins in aqueous solutions have been demonstrated, as summarized in a recent review 
article.61 However, only two microfluidic platforms have addressed the in meso crystallization 
protocol,48,62 the main difficulties arising from handling viscous mesophases on the microscale. 
The plug-based system developed by Li et al.48 emulates the PLI method described in Chapter 
1.2.4. The platform automates mesophase-precipitant formulation for in meso crystallization 
trials with ~80 nL of mesophase per trial, but the mesophase, with or without the protein, must 
be prepared on the microliter scale in coupled syringes off-chip. 
Figure 1.9. Optical micrograph of a microfluidic platform for in meso protein crystallization. A. A complete platform. After 
mixing the lipid (L) with protein solution (Pr) in the lipidic mixer (blue, purple), the resulting mesophase is transferred to the 
crystallization chamber, and combined with the precipitant from the precipitant chamber. Fluid manipulation is achieved by
pneumatic actuation of isolation valves (black) and injection valves located on top of every fluid chamber. B. A magnified 
image of the lipidic mixer configuration from panel A. C. Optical micrographs of 9.95 mg/mL solution of membrane protein 
bacteriorhodopsin mixing with monoolein in a microfluidic chip (observed through partially crossed polarizers). Blue lines 
delineate the edges of the fluidic channels. (a) Filling of chambers with protein solution and lipid (arrows); (b) Straight-line 
injection of lipid into the side chambers containing protein; (c-e) Chamber-to-chamber injection of the fluid mixture through 
different sets of inlets to create a circulating motion. The cycle repeats starting at (b). (f) The slightly birefringent mixture after 
mixing. Scale bar: 500 μm. (Reprinted with permission from S. L. Perry, G. W. Roberts, J. D. Tice, R. B. Gennis, P. J. A. Kenis, 
Crystal Growth and Design, 2009, 9, 2566-2569, © 2009 American Chemical Society.) 
The only reported platform that truly scales down the amount of sample required for 
mesophase formulation is the lipidic mixer developed in by Kenis et al.62 The individual 
mesophase samples can be prepared at a scale of ~20 nL (Figure 1.9A, B). Mixing is achieved by 
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a sequence of actuations of valves located over each compartment of the mixer (Figure 1.9C).  
 
1.3  Lipidic mesophases  
This section describes structure and properties of lipidic mesophases, with the focus on 
types of phases relevant for this work. In Chapter 1.3.1 reported types of lipidic mesophases and 
their topology are reviewed. Mathematical relationships between molecular structure of 
amphiphiles, mesophase type, and mesophase composition are summarized in Chapter 1.3.2. 
Properties of monoolein/water mesophases and are described in Chapter 1.3.3 along with the 
effects of salts and detergents, the two common additives in the in meso protein crystallization. 
 
1.3.1  Types and topological properties of lipidic mesophases 
Lipidic mesophases are self-assembled soft materials with long-range order that form 
upon mixing water or aqueous solutions with certain lipids, either synthetic or naturally 
occurring.11,17 Lipid molecules are amphiphilic, with small polar head groups and long apolar 
hydrocarbon tails. 
 The distinguishing feature of lipidic mesophases is their structure comprised of ordered 
lipid bilayers. Mesophases can form with different arrangements of bilayers referred to as phase 
types,63-65 which are established from small-angle X-ray scattering (SAXS) data15,63,66,67 through 
a procedure described in detail in Appendix A. Several types of mesophases have been 
discovered so far in lipid-containing systems:11,17 1D-ordered lamellar mesophases, 2D-ordered 
inverse hexagonal HII, and 3D-ordered cubic mesophases of different morphologies (Figure 
1.10). 
Cubic mesophases belong to a fascinating class of bicontinuous amphiphilic systems, 
where both lipid bilayers and aqueous channels are continuous throughout the mesophase (Figure 
1.10). All types of bicontinuous cubic mesophases discovered so far have a rigorous geometrical 
definition:29,68 the midplanes of lipid bilayers form infinite periodic minimal surfaces (IPMS) 
that are saddle-shaped at every point in such a manner that the sum of principal curvatures is 
zero. Cubic mesophases with IPMS of gyroid (G), primitive cubic (P) and double diamond (D) 
types have been discovered in various lipidic systems.11,17 These symmetries correspond to 
crystallographic cubic space groups Ia3d (Q230), Im3m (Q229), and Pn3m (Q224). All three 
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notations, i.e., the IPMS symmetry, the crystallographic space group name, and the 
crystallographic space group number, are used interchangeably in literature. 
 
Figure 1.10. Lipid phases. Cartoon representations of the various liquid (fluid isotropic phase, FI), solid (lamellar crystal phase, 
Lc), mesophase states (lamellar liquid-crystal phase, L; cubic Pn3m phase [Q224]; cubic Ia3d phase [Q230]; cubic Im3m phase 
[Q229]; and inverted hexagonal phase, HII) adopted by lipids. Individual lipids are shown as lollipop figures, with the pop and 
stick parts representing the polar headgroup and the apolar acyl chain, respectively. The blue, green and red colored regions 
represent water. (Reprinted from M. Caffrey, Current Opinion in Structural Biology, 2000, 10(4), 486-497, with permission from 
Elsevier.) 
In addition to the lattice type, ordered phases are characterized by the lattice parameter, 
i.e., the size of the smallest repeating unit of the periodic lattice,2 which is also established from 
SAXS data. The unit cells of cubic mesophases are of cubic symmetry according to the 
crystallographic classification,69 and only one value is required to characterize all three 
dimensions of the 3D cell. The procedure for lattice parameter determination of cubic phases is 
described in Appendix A. 
The Lα phase consists of stacks of monoolein lipid bilayers separated with layers of 
water1 and is only ordered in one dimension. Here the lattice parameter refers to the distance 
between the midplanes of bilayers because it is the only regular repeat parameter for this 
arrangement of bilayers. 
The hexagonal HII phase is comprised of aqueous cylinders of infinite length with lipid 
headgroups packed on cylinder surfaces (Figure 1.10). The cylinders are packed in a hexagonal 
honey-comb like arrangement, placing this phase type accordingly in the family of hexagonal 
symmetry. The repeat distance for this phase may be represented as either the center-to-center 
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distance between the cylinders or the length of the side of the hexagon circumscribing the 
cylinder. The two are mathematically related to each other through simple trigonometry.   
 
1.3.2  Structure-composition relationships for cubic lipidic mesophases 
Below we review relationships between molecular shape, mesophase microstructure, and 
mesophase composition relevant for this work. A wider range of relationships and mesophase 
types is covered in a detailed review by Kulkarni et al.67 Table 1.1 lists notations used in this 
section and in other chapters of this dissertation to describe mesophase geometry and 
composition.  
Table 1.1 Notations used to describe mesophase geometry and composition 
Notation Variable 
γp Amphiphile packing parameter70 (Equation 1.1) 
vl Volume of the amphiphile tail 
l Length of the amphiphile tail 
ahead Headgroup area per amphiphile 
fl Volume fraction of the lipid in the mesophase 
faq Volume fraction of the aqueous compartments in the mesophase 
d Lattice parameter of the mesophase 
rw Radius of the aqueous channels of the mesophase 
σ, χ Geometrical parameters of cubic mesophases (Table 2) 
Lipid mesophases of interest here are of the inverse type (type II, Figure 1.11), i.e., the 
area occupied by the heads of the amphiphiles is smaller than the area occupied by amphiphile 
tails. Seminal work by Israelachvili et al.70 related the general types of structures formed by 
amphiphiles to their molecular shape, which is represented in terms of the packing parameter γp: 
la
v
head
l
p     Equation 1.1 
where vl is the volume occupied by the hydrocarbon tail, l is the length of the tail, and ahead is the 
optimal headgroup area of the amphiphile polar head. Schematic representations of different 
molecular shapes and corresponding values of packing parameters are shown in Figure 1.11. 
Inverse assemblies require that the amphiphile have a cone-like shape with a relatively small 
hydrophilic head and a voluminous hydrophobic tail (Figure 1.11). The concepts of the 
amphiphile molecular shape and the packing parameter have been successfully used to explain 
multiple types of self-assembled structures formed by amphiphiles. For monoolein mesophases, 
these concepts have also been invoked to rationalize the effects of various additives on the 
microstructure of the mesophase, as discussed in Chapter 1.3.3.  
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Figure 1.11. Relationship between molecular shape and types of self-assembled amphiphilic structures. Depending on the 
molecular shape of an amphiphile, type 0, I or II micelles are formed. The geometry of an aggregate or self-assembly is 
determined by the dimensionless critical packing parameters (γp) based on the theory by Israelachvili et al.70 Double headed 
arrows indicate the range of most preferred geometries: spherical (γp = 0–1/3), cylindrical (γp = 1/3–1/2), lamellar (γp = 1/2–1) 
and inverse (type II) micelles (γp > 1). Increasing yellow color towards right indicates an increase in the hydrophobic character of 
an amphiphile. (Reproduced from C. V. Kulkarni, W. Wachter, G. Iglesias-Salto, S. Engelskirchen and S. Ahualli. Physical 
Chemistry Chemical Physics, 2011, 13, 3004-3021, with permission from the Royal Society of Chemistry.) 
The molecular structure of amphiphiles can be linked to the composition of the 
mesophase through relationships established for IMPS structures based on their topology:64 
3
3
42 




d
l
d
l
l    Equation 1.2 
and 
3
22 22
d
ldva
l
lhead 
    Equation 1.3 
where φl is the volume fraction of the lipidic compartments, d is the lattice parameter of the 
cubic phase, and σ and χ are geometric characteristics of a given cubic phase (Table 1.2). The 
lipid bilayer thickness is twice the value of l. The volume fractions of the lipidic compartments φl 
and of the aqueous compartments φaq add up to unity: φl  + φaq  = 1. 
Another important aspect of cubic mesophase geometry is the radius of the aqueous 
channels, which can be calculated using two different approaches.71,72 Based on the topological 
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properties of the IPMS surfaces, the radius of the aqueous channels rw is calculated simply as72  
ldrw  

2    Equation 1.4. 
The amphiphile length l can be calculated from equation 1.2 based on the composition φl and the 
lattice parameter d. 
Table 1.2. Values of parameters used in structure-composition relationships for cubic mesophases. 
Phase type σ65 χ65 λ71 kv 71 
Pn3m 1.919 -2 23  0.780 
Ia3d 3.091 -8 81  0.491 
Im3m 2.345 -4   
In another approach the aqueous compartments of mesophase are represented as a 
network of cylindrical rods with junction points. The volume is of each rod is71  
  drkdrv wvwrod  /12    Equation 1.5 
where l and kv are constants for a given phase type. Rod volume is related to the volumetric 
composition of the mixture: 
3d
nvrod
aq      Equation 1.6 
where n is the number of rods per unit cell. The radius of the channels rw is calculated by 
simultaneously solving equations 1.5 and 1.6. The values of l, kv, and n for Pn3m and Ia3d 
phases are listed in Table 1.2. As demonstrated by Briggs et al.,72 for monoolein/water 
mesophases the radii calculated using the two approaches differed by less than 1 Å for a wide 
range of temperatures. 
 Finally, the surface-averaged values of mean curvature (sum of the two principal 
curvatures) and Gaussian curvature (product of the two principal curvatures) at the distance l 
from the bilayer midplanes are calculated as 
mean curvature65 
22 2
2
ld
lH 

   Equation 1.7 
and Gaussian curvature64 
2
2
d
K 
   Equation 1.8. 
Equation 1.7 indicates that mean bilayer curvature increases with decreasing lattice 
parameter, and decreases with decreasing lipid tail length. Equation 1.8 shows that for a given 
mesophase type Gaussian curvature depends only on the lattice parameter. 
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We note that all relationships above rely on the assumption of the additivity of volumes. 
Thus, for the binary lipid/water system the volume fractions of aqueous and lipidic 
compartments are calculated simply based on the gravimetric composition of the sample and 
densities of lipid and water, although true volumetric relationships between the two 
compartments may deviate from the nominal ones due to non-zero volumes of mixing. Another 
standard assumption used in all equations listed above is that the lipid tail length, and, 
consequently, the bilayer thickness, is constant throughout the mesophase. For monoolein 
mesophases the variation in the lipid tail length and volume are believed to be associated with 
significant unfavorable free energy contributions,73 justifying the assumption of their constant 
values. 
 
1.3.3  Phase behavior of monoolein mesophases  
Phase behavior monoolein/water mesophases. Monoolein, the lipid most commonly 
used for in meso crystallization, exhibits rich thermotropic and lyotropic phase behavior when 
mixed with water. Monoolein forms as many as six different phase types,70,72 of which four are 
ordered, including two63 cubic phases, as shown in the temperature-composition phase diagram 
in Figure 1.12. Some properties of monoolein mesophases are summarized in Table 1.3. All 
mesophases formed in monoolein/water systems are of the inverse type (type II, Figure 1.11), 
due to the “conical” amphiphile shape brought about by the trans double bond in the hydrophilic 
tail (Figure 1.2). 
Monoolein and other monoacylglycerols have a propensity to form persistent 
undercooled metastable cubic phases,74 and its observed phase behavior between 0 and 20 °C is 
differed depending on whether data were collected by heating (stable, Figure 1.12A) or cooling 
(metastable, Figure 1.12B) the samples. Remarkably, the undercooled metastable phases showed 
a series of reproducible phase transitions that obeyed the phase rule, mimicking equilibrium 
phase behavior and complicating the studies of phase transitions for monoolein and other 
monoacylglycerols.72,74 To escape the metastable zone and to resume stable behavior upon 
heating in that temperature range, sample cooling to -13 °C was required.74 The persistent 
metastable behavior has been attributed to small free energy differences between different types 
of mesophases and the high energy barrier for scission of the lipid bilayers as necessary for 
cubic-to-lamellar phase transition.74 Note that most in meso crystallization protocols with 
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uniformly mixed protein-loaded mesophases rely on molten monoolein for mesophase 
formulation, and thus are likely to result in the metastable regime if incubation with precipitant is 
carried out below 20 °C. 
 
Figure 1.12. Temperature/composition phase diagram for the monoolein/water system. (A) Equilibrium phase diagram74 and (B) 
metastable phase diagram.72 Points I, II, and IV along the 20 °C isotherm correspond to single-phase regions with Pn3m, Ia3d, 
and Lα phases, respectively. Point II corresponds to a two-phase system where the Pn3m phase coexists with excess aqueous 
phase. (Reprinted from M. Caffrey, Current Opinion in Structural Biology, 2000, 10(4), 486-497, with permission from Elsevier.) 
Table 1.3. Selected properties of various phases found in monoolein/water mixtures; adapted from references 74, 63, 
75, and 66. 
Notation Lc FI Lα HII Pn3m Ia3d 
Phase type Lamellar crystal Fluid isotropic Lamellar 
Inverse 
hexagonal Cubic Cubic 
Physical state Solid Fluid Fluid Fluid Fluid Fluid 
Molecular ordering 1D-ordered Disordered 1D-ordered 2D-ordered 3D-ordered 3D-ordered 
Continuity - 
- 
(Homogenous 
solution of water 
in lipid) 
- 
Hydrophobic 
layers are 
continuous for 
small molecules
Bicontinous Bicontinuous 
Optical properties Birefringent Non-birefringent Birefringent Birefringent Non-birefringent Non-birefringent
Apparent viscosity,66 
relative to viscosity of 
water 
N/A 30 x 104 x  107 x 107 x 
Lipid bilayers Flat - Flat Curved Curved Curved 
Overall, the studies of the phase behavior and, especially, of the microstructure of 
monoolein mesophases are complicated due to closely spaced phase transitions in the 
temperature range of interest (20-25 °C) and batch-to-batch variation of monoolein. Samples 
with nominally identical compositions were found to belong to different phase types, and lattice 
parameters of samples with identical composition depended on the batch of monoolein.76 
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In the range of temperatures of interest in this work, 20-25 °C, monoolein/water 
mesophases show stable behavior regardless of their thermal history. Monoolein proceeds 
through the following sequence of phases upon increasing hydration level (Figure 1.12):72,74 
lamellar crystal Lc, lamellar liquid crystal Lα, cubic Ia3d, and cubic Pn3m, with regions of two-
phase coexistence in-between. The latter phase can only contain up to 40-43 wt% of water in this 
range of temperatures,74,76 and a bulk aqueous phase separates from the water-saturated (fully 
hydrated) Pn3m mesophase if the overall water content of the sample is above that value. 
Lattice parameters of monoolein mesophases shrink with increasing temperature due to 
the decrease in both the radius of the aqueous channels and the thickness of lipid bilayers 
(Equation 1.4). Briggs et al.72 established a correlation for the length of the monoolein lipid tail 
as a function of temperature based on Equation 1.2 and SAXS data on lattice parameters as a 
function of sample composition: 
     Tel 0019.018    Equation 1.9 
where T is sample temperature in °C, and l is in Å.  
Effect of salts on the microstructure of monoolein mesophases. Salts are the most 
common components in precipitant cocktails used for protein crystallization, but data on the 
effect on individual salts on the phase behavior of monoolein mesophases are extremely 
scarce.32-34 Typically, the studies are carried out for monoolein coexisting with excess salt 
solution at a single temperature. 
 
Figure 1.13. Effect of kosmotropic salts on the lattice parameter of fully hydrated mesophases of monoolein.33,34 
The effect of salts on the phase behavior of monoolein mesophases and on their 
microstructure correlates with the Hofmeister series. Kosmotropic salts33,34 (Figure 1.13) cause 
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the lattice parameter of the Pn3m phase to decrease compared to monoolein/water systems and in 
several cases result in the Pn3m – HII transition as the salt concentration in solution increases. 
Interestingly, at a given pH the Pn3m – HII transition for different salts, in spite of different salt 
concentrations, appeared to take place in a very narrow range of Pn3m lattice parameters, 77-
81Å, suggesting a common curvature-driven mechanism of the phase transition. Chaotropic salts 
and urea,25,34 on the contrary, cause the lattice parameters to increase (Figure 1.14) and may 
drive a Pn3m – sponge phase transition in these systems. 
 
Figure 1.14. Comparison of the effect of chaotropic salts KSCN25 and NaSCN34 on the phase behavior of monoolein mesophases 
at 20 °C. Mixtures with KSCN were prepared using 60 wt% of monoolein and 40 wt% of the KSCN solution. Mixtures with 
NaSCN were prepared with an unspecified excess of the NaSCN solution. 
Larger or smaller lattice parameters in monoolein/salt solution systems have been 
attributed to the effect of respective salts on the area of the lipid/water interface within the 
mesophase, with kosmotropes causing the area to shrink and chaotropes causing it to 
increase.67,77,78 The length and volume of the lipid tail are usually assumed to vary little at a 
given temperature.73 Combined, these assumptions indicate that the lipid bilayers become more 
curved in mixtures with kosmotropic salts and flattened in mixtures with chaotropic salts 
(Equations 1.4, 1.7, and 1.8). The lipid headgroup area ahead must vary accordingly to meet 
structure-composition relationships, becoming smaller in mixtures with kosmotropic salts and 
larger in mixtures with chaotropic salts. However, convincing explanations of the mechanism 
underlying these changes have not been put forward so far. 
Two studies of similar chaotropic salts, KSCN and NaSCN,25,34 allow for a comparison 
of the phase behavior under different compositional conditions at 20 °C (Figure 1.14). Mixtures 
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with KSCN were prepared using 40 wt% of salt solution and 60 wt% of monoolein,25 whereas 
mixtures with NaSCN were formulated with a large excess of salt solution.34 Interestingly, 
coexisting Pn3m and Lα phases were observed in the former set above KSCN concentration of 
0.5 M, whereas in the set with NaSCN only pure Pn3m phases are observed. Although these 
observations may be related to an insufficiently wide range of NaSCN concentrations, they may 
also reflect the differences in the water contents of the two sets of samples. We note that based 
on our data presented in Chapter 2, potassium and sodium have almost identical effects on the 
lattice parameter and are not expected to cause the differences of the observed magnitude. 
Effect of detergents on the microstructure of monoolein mesophases. Detergents are 
introduced into in meso crystallization mixtures as a necessary component of the membrane 
protein solutions (Chapter 1.1, Figure 1.1). Early reports indicated that detergents promote 
formation of lamellar phases unfavorable for crystallization, and their effect on the phase 
behavior of lipidic mesophases has been studied in a number of works to assess compatibility of 
detergents with the in meso method. Below we focus on the properties of monoolein mesophases 
with detergent β-octylglucoside (OG),14,76,79-84 one of the most common detergents for 
membrane protein solubilization. Other members of the alkylglucopyranoside family of 
detergents76,79,80 show trends similar to those for OG, as expected based on the similarity of 
their structures. 
Due to their amphiphilic properties, detergents are 
incorporated in the lipid bilayers of the mesophase, and their 
effect on the microstructure of monoolein mesophases has been 
rationalized in terms of molecular shape.13,76,80 In particular, 
OG (Figure 1.15) has a larger polar glucoside headgroup and a 
significantly less voluminous 8-carbon tail chain hydrophobic tail compared to monoolein. These 
structural differences result in lowering of the average amphiphile packing parameter (Equation 
1.1) in mixed bilayers and favor mesophases with less curved bilayers (Figure 1.11). The 
flattened bilayers in cubic mesophases can accommodate aqueous channels of larger radii, 
producing mesophases with larger lattice parameters. However, despite the different tail lengths 
of the amphiphiles, the thickness of the lipid bilayers in the Pn3m mesophase was found to 
remain almost constant upon mixing of monoolein with detergent solutions containing up to 10 
wt% (0.34M) OG.85 
Figure 1.15 Structure of βOG with the 
polar head group shaded in blue and the 
hydrocarbon tail shaded in grey. 
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The effect of detergents has been studied almost exclusively using mixtures of monoolein 
with detergent solutions prepared in the 60:40 w/w ratio,76,79,80 presumably to mimic the first step 
of the original protocol for in meso crystallization. In these systems, as the detergent 
concentration in solution increased, the detergent/monoolein ratio in the final mixture increased 
as well, whereas the water/monoolein ratio decreased. Only a few datasets are available for other 
types of mesophase formulations,14,76,79 with a notable exception of a very detailed ternary phase 
diagram for the monoolein/OG/water system.81-83  
 
Figure 1.16. The identity and location in temperature-composition space of the various phases present in the 
monoolein/OG/water system determined by x-ray diffraction. Samples were prepared with 60% (w/w) monoolein (MO) and a 
40% (w/w) aqueous solution of OG. (A) Measurements made in the heating direction from  -15 °C to 40 °C. The identity of 
each of the phases is as follows: (-) Lc, (□) Lα, (◊) ice, (×) cubic-Ia3d, and (○) cubic-Pn3m. (B) Measurements made in the 
cooling direction from 30 °C to -15 °C, and in the heating direction from 25 °C to 40 °C. The identity of each of the phases is as 
follows: (□) Lα, (×) cubic-Ia3d, and (○) cubic-Pn3m. The samples were incubated at each temperature for a minimum of 4 h. The 
solid lines represent phase boundaries and are drawn to guide the eye. (Reprinted from Y. Misquitta and M. Caffrey, Biophysical 
Jounal, 2003, 85, 3084-3096, with permission from Elsevier.) 
In mixtures of monoolein with solutions of OG in water prepared using the 60/40 
monoolein:solution weight ratio, the mesophase types changed in a highly systematic fashion as 
the detergent concentration in solution increased (Figure 1.16 A, B),79 and the sequence of phase 
transformations matched that for monoolein/water mixtures upon dehydration (Figure 1.12). 
Lattice parameters of cubic phases, however, were significantly larger than those established in 
monoolein/water mesophases at the same temperature, as anticipated based on the larger 
preferred radii of aqueous channels and constant bilayer thickness (Equation 1.4). Metastability, 
characteristic of monoolein/water mesophases, was also observed in monoolein/OG/water 
mixtures: phase behavior in the 0-12 °C range depended on the thermal history of the sample 
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(Figure 1.16 A, B). In another report80 metastability was observed upon mesophase cooling to as 
low as -25 °C for a number of detergents, including OG. 
 
Figure 1.17. Dependence of monoolein phase behavior on 
detergent concentration at 20 °C in mixtures initially 
prepared with 60 wt% of monoolein and 40 wt% of OG 
solutions (A) without further manipulation, (B) upon 
addition of excess water to the mixtures, or (C) upon 
addition of an excess of 2 M Na/K phosphate, pH 5.6. The 
OG concentration on the X-axis refers to that in the initial 
preparation. The identity of each of the phases is as 
follows: (□) Lα, (×) cubic-Ia3d, and (○) cubic-Pn3m. The 
solid lines superimposed on the cubic-Pn3m phase data 
represent a linear fit of form: d = 96.4 M + 106 in B, and d 
= 33.4 M + 91 in C, where d is the lattice parameter of the 
cubic-Pn3m phase (in Å) and M is the molar concentration 
of the OG solution. The linear fit in C was from 0 to 0.93 
M OG solution. The last two data points at 1.01 and 1.09 
M OG solution were not included because the 
corresponding diffraction patterns consisted of a few 
relatively broad low-angle reflections and therefore their 
lattice parameters could not be accurately determined. 
(Reprinted from Y. Misquitta and M. Caffrey, Biophysical 
Jounal, 2003, 85, 3084-3096, with permission from 
Elsevier.) 
Figure 1.17B shows the types and lattice parameters of monoolein/OG/water 
mesophases that contained an excess of water,79 with notable differences in the phase behavior 
compared to mesophases with a limited amount of water at the same detergent concentration in 
solution (Figure 1.17A). These findings suggest that the samples in Figure 1.17A are 
significantly water-stressed, and the mesophases could accommodate larger amounts of water at 
a given OG/monoolein ratio. Datasets for mesophases under both water-stressed and excess 
water conditions are in excellent agreement with the full ternary diagram for 
monoolein/OG/water mixtures at 20 °C mapped using NMR techniques.81-83 Compared to their 
water-stressed counterparts, fully hydrated mesophases with mixed OG/monoolein bilayers 
may be more suitable proxies for assessing the phase behavior of the system in crystallization 
trials that always take place under excess aqueous solution conditions. Indeed, in 
monoolein/OG mesophases prepared with excess of 2M K/Na phosphate (Figure 1.17C), the 
cubic phase persisted at even higher detergent loadings than in fully hydrated mixtures with 
water shown in Figure 1.17B, which would be almost impossible to infer from data on partially 
hydrated systems in Figure 1.17A. Overall, these comparisons highlight the difficulties in 
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inferring the phase behavior of complex multicomponent systems in a wide range of 
compositions from a limited set of data. Nevertheless, data on water-stressed mixtures may be 
useful for assessing the suitability of the mesophase for protein stabilization in the first step of 
the protocol before precipitant addition because membrane proteins are known to be unstable in 
lamellar phases.14  
 
1.4  Key challenges 
1.4.1  Crystallization of membrane proteins in lipidic mesophases 
As in any protein crystallization method, crystallization in meso is achieved in a trial-and-
error manner and requires sampling of a large number of conditions. For example, over 15000 
crystallization trials were set up to obtain a few diffraction-quality crystals of β2 adrenergic 
receptor.15 This approach presents the typical challenges, such as the large amount of protein 
sample required for crystallization efforts on that scale, and manually intensive set up of 
crystallization trials. Liquid-handling robots are expensive and may be beyond reach of many 
structural biology labs. 
In addition to those challenges, the in meso method is perceived as difficult in the 
structural biology community, not least due to the special tools required for almost every step of 
the standard protocol (Figure 1.5), such as the coupled syringe mixer and the ratchet dispenser. 
Because of the non-uniform appearance of bulk mesophases, the in meso method also requires 
special glass sandwich well plates86 to facilitate observation of protein crystals. These plates are 
not suitable for the relatively user-friendly variants of the in meso method, such as PLI43 and 
CIMP44 (Figure 1.6). 
The last and possibly the most important challenge is the manual harvesting of fragile 
protein crystals for crystal X-ray diffraction, which may also be detrimental for crystal quality. 
The high viscosity of the mesophase, coupled with the typically small size of membrane protein 
crystals (5-50 µm), make this step difficult, yet several hundred crystals may need to be 
harvested in order to obtain quality X-ray diffraction data. 
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1.4.2  Phase behavior of lipidic mesophases 
Precipitants used to induce crystallization are complex mixtures of multiple components, 
such as polyethyleneglycols (PEGs) of various molecular weights, organic and inorganic salts, 
and small organic molecules such as short-chain saturated alcohols and cholesterol.16 In addition 
to these components, protein-solubilizing detergents are also incorporated into the mesophase 
along with the proteins.13,14,76,79-83 All these components are known to affect the phase behavior 
of monoolein, as summarized in Chapter 1.3.3.14,32-34,76,79-84 An in meso crystallization system 
contains at least two phases, the aqueous precipitant solution and the viscous mesophase with 
embedded protein (Figure 1.1D). The enormous complexity of such multiphase multicomponent 
systems precludes a priori predictions of the phase behavior under crystallization conditions. 
Thus, extensive experimental phase behavior studies are required to ensure that the components 
are compatible with the formation of the cubic phase. 
Detailed information about phase transformations in real, highly complex multi-
component multi-phase crystallization mixtures is necessary to improve the understanding of the 
mechanism of in meso crystallization. Monoolein/water systems exhibit rich mesomorphism and 
intricate phase behavior at temperatures relevant for protein crystallization, with Pn3m, Ia3d or 
Lα mesophases forming depending on the hydration level and the thermal history of the 
sample.72,74 Although multiple studies showed that both detergents14,76,79-81,84 and salts32-34 affect 
the phase behavior of monoolein (Chapter 1.3.3), their combined effects have rarely been 
investigated. Furthermore, few studies14,76,79 mimic crystallization systems by independently 
controlling the monoolein/detergent ratio and the amount of aqueous phase, as determined by the 
two steps of the crystallization process. The distributions of components between the phases in 
the two-phase system, and, in turn, the properties of the mesophase, are likely to depend on 
relative amounts of the mesophase and the solution. However, only little information is available 
about the location of the hydration boundary in crystallization-like systems and about actual 
conditions experienced by the protein within the mesophase during crystallization.  
Phase behavior studies require the preparation of a large number of samples with 
different compositions to obtain a detailed map. For example, the phase diagram of the binary 
monoolein/water system in Figure 1.12A is based on data from 25 samples.72 Over 200 samples 
had to be prepared to assess compatibility of commercial protein crystallization screens with the 
formation of the cubic phase.16 State-of-the-art procedure15 involves mixing lipids and aqueous 
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solutions in the coupled syringe mixer (Figure 1.5) followed by dispensing the mesophase into 
thin-walled glass capillaries for SAXS analysis. Mixing in the coupled syringe mixer requires 5-
20 µL (mg) of both lipid and the aqueous solution. The overall procedure is highly laborious, 
repetitive, sample-consuming, and not easily amenable for automation, which all impediment for 
studies to unravel the phase behavior of lipidic mesophases as necessary for the optimization of 
in meso crystallization and for the fundamental studies in soft matter. 
 
1.4.3  X-ray-compatible microfluidic platforms for mesophase formulation and in meso 
crystallization 
Microfluidic approaches offer great potential for providing inexpensive tools for in meso 
crystallization and studies of the phase behavior of lipidic mesophases by automating sample 
formulation and reducing the amount of materials. The main challenges in both applications are 
(1) on-chip handling of the viscous mesophases and (2) development of an X-ray transparent 
chip architecture. The latter is a requirement for in situ mesophase analysis by SAXS, and is 
highly desirable for in situ protein crystal X-ray diffraction analysis to eliminate cumbersome 
and damaging crystal harvesting steps.   
Development of X-ray compatible platforms capable of mesophase handling is a non-
trivial task and platforms of this type have not been reported to date. Available platforms for 
both protein crystallization and phase behavior studies are mostly limited to handling of low-
viscosity aqueous solutions, with the exception of the two systems described in Chapter 1.2.5. 
Established methods of rapid prototyping56,87 and fabrication of microfluidic devices with 
integrated fluid handling capabilities55 produce devices with mm-thick layers of PDMS on a 
glass substrate (Chapter 1.2.5) and are unsuitable for in situ X-ray analysis due to X-ray 
attenuation by the chip materials.88 
Microfluidic systems for phase behavior studies typically rely on phase transitions driven 
by composition changes due to diffusion of solutes,89-94 evaporation of water,95-99 and osmotic 
stress.91,100 These platforms are unsuitable for the formulation of viscous mesophases with strict 
pre-set ratios of volume or weight of components. In addition to those limitations, X-ray 
compatible chip architectures for phase behavior studies have not been reported so far.  
Only a few X-ray transparent microfluidic chips have been reported for protein 
crystallography, mainly for on-chip crystallization and in situ crystal X-ray diffraction of soluble 
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proteins.88,101-110 The chips, with a single exception,110 are fabricated in rigid polymeric materials 
and are thus incapable of fluid valving and routing necessary for formulating complex arrays of 
multicomponent mixtures on-chip in an automated fashion. 
As discussed in Chapter 1.2.2, the microstructure of the mesophase is of key importance 
for the outcome of crystallization trials. The ability to study both protein crystals and mesophase 
properties in X-ray transparent microfluidic platforms would be invaluable for further 
elucidating the mechanism of in meso crystallization and engineering crystallization systems to 
improve the success rate of the crystallization process. 
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Chapter 2. 
Phase behavior of monoolein mesophases with 
detergent β-octyglucoside and phosphate salt solutions 
Abstract 
This chapter summarizes the results of the studies of phase behavior of mesophases of monoolein 
(MO) mixed with additives frequently used in the in meso membrane protein crystallization, 
namely, sodium and potassium phosphate salts and the detergent -octylglucoside (OG), in a 
wide range of compositions relevant for in meso crystallization of membrane proteins. Two types 
of systems were studied: (1) mixtures of MO with salt solutions above the hydration boundary, 
and (2) mixtures of MO with OG and salt solutions in a wide range of hydration conditions.  In 
the latter case, series of samples with constant values of OG/MO ratios (ROG/MO) were 
analyzed.  At a given value of ROG/MO, the salt solution content in the samples varied from 10 to 
80 wt%, covering a range of conditions below and above the hydration boundary. We discuss the 
implications of our findings for the investigation of the mechanism of membrane protein 
crystallization in lipidic mesophases and for the studies of the suitability of precipitants for in 
meso crystallization.   
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2.1  Introduction 
As discussed in Chapter 1.2.2, phase transformations and properties of lipidic mesophases 
themselves have been shown to play a highly important role in the in meso crystallization 
process.1-7 However, in spite of the advances in mechanistic studies, in meso crystallization 
remains a trial-and-error process, and detailed information about phase transformations in real, 
highly complex multi-component multi-phase crystallization mixtures would enhance the 
understanding of the mechanism. Mixtures of monoolein (MO) and water exhibit rich 
mesomorphism and intricate phase behavior at temperatures relevant for protein crystallization, 
with Pn3m, Ia3d or Lα mesophases forming depending on the hydration level and the thermal 
history of the sample (Chapter 1.3.3).8,9  Multiple studies showed that both detergents10-16 and 
salts,17-19 the two major non-protein components in crystallization mixtures, affect the phase 
behavior of MO, but their combined effects have rarely been investigated.10 Furthermore, few 
studies10-13,16 mimic crystallization systems by independently controlling the MO/detergent ratio 
and the amount of aqueous phase, as determined by the two steps of the crystallization process 
(Section 1.2.4). The distribution of components between the phases in the two-phase system, 
and, in turn, the properties of the mesophase, are likely to depend on relative amounts of the 
mesophase and the solution. Consequently, little information is available about the actual 
conditions experienced by the protein within the mesophase during crystallization.  
Here we report a study of the phase behavior of MO mesophases with detergent -
octylglucoside (OG) and sodium or potassium dihydrophosphate solutions, which are often 
used as precipitants in the crystallization of membrane protein bacteriorhodopsin. We 
investigated two types of systems: (1) MO mixed with salt solutions above the hydration 
boundary, and (2) MO mixed with OG and salt solutions in a wide range of hydration 
conditions. In the latter case, we analyzed series of samples with constant values of OG/MO 
ratios (ROG/MO). At a given value of ROG/MO, the salt solution content in the samples varied from 
10 wt% to 80 wt%, covering a range of conditions below and above the hydration boundary. 
Phase types and lattice parameters of all samples were determined by SAXS. To the best of our 
knowledge, no data of this type for crystallization-like systems are available for a wide range of 
conditions. We discuss the trends in phase behavior and component distribution and implications 
for membrane protein crystallization. 
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2.2  Materials and methods 
Sample preparation. Homogeneous solid mixtures with fixed ratios of MO and βOG 
were prepared gravimetrically as follows. Target amounts of MO (Sigma Aldrich, 99%) and 
βOG (Anatrace, Anagrade) were weighed in a glass vial and dissolved in chloroform (Sigma 
Aldrich, ≥99.8%). The solvent was removed under a stream on nitrogen gas. Solid samples were 
dried in a desiccator under vacuum at room temperature (21-23 °C) overnight.  
Solutions of potassium dihydrophosphate (Sigma-Aldrich) and sodium dihydrophosphate 
(EMD Chemicals) were pH-adjusted to pH of 5.50. 
Mesophase samples containing solid MO or solid OG/MO mixtures (lipidic part) and 
salt solutions (aqueous part) were formulated gravimetrically in a coupled-syringe mixer20 at 21-
23 °C. The total mass of each sample in the composition range of 50-90 wt % of the lipidic part 
was approximately 40 mg. Samples containing 10-40 wt % of the lipidic part were prepared with 
approximately 15 mg of the lipidic part.  
After mixing the samples were dispensed into 2 to 4 borosilicate glass capillaries (0.9 
mm, Charles Supper Company), depending on the amount of sample available. Capillaries were 
sealed with Critoseal (Leica Microsystems) and Quick-set epoxy (Henkel) to minimize water 
loss. Samples were stored at –12 °C in the dark for at least 12 hrs between sample preparation 
and data collection.  
SAXS data collection.  Prior to SAXS data collection the samples were equilibrated for 
at least 3 hrs at the data collection temperature. For series prepared with 1.3M NaH2PO4 and 
studied at two temperatures, 20 and 25 °C, the samples were kept at 20 °C overnight and further 
maintained at 25 °C for 4 hours prior to SAXS data collection. Although freezing is known to 
affect the phase behavior of mesophases at low temperatures by triggering the transition from a 
metastable to a thermodynamically stable sequence of phases, metastability was not observed for 
MO/detergent mixtures in the temperature range of interest here,12 20-25 °C, and is not expected 
to be an issue in this work. 
For samples prepared with sodium dihydrophosphate solutions SAXS data were collected 
in a helium chamber using a Bruker M18XHF rotating anode generator supplying a Cu Kα (λ = 
1.541838 Å) radiation beam that was collimated using a pinhole collimator.  Kβ radiation was 
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filtered out with a Ni filter. A Highstar multiwire detector was used to collect the data. Samples 
were mounted in the He chamber on an automated goniometer at sample to detector distance of 
63.2 cm and calibrated using silver behenate as the standard.21 To prevent X-ray scattering by 
air, the chamber was continuously purged with helium gas during data collection. Temperature 
was maintained using a custom-built temperature-controlled sample holder. 
Diffractograms were convolved and integrated in Bruker-SAXS 4.0 software. Phase 
assignment was carried out based on the presence of characteristic sets of reflections of lipidic 
mesophases as described in Appendix A. Phase assignments were done in DIFFRACplus Topas 3 
(Bruker AXS GmbH, Karlsruhe, Germany, 2005) based on whole powder pattern 
decomposition22,23 for cubic phases, as implemented in the software, with added individual peaks 
for lamellar phases if necessary. Lattice parameters of cubic phases were calculated 
automatically during the phase assignment. Lamellar phases are only ordered in one dimension 
and cannot be automatically handled by DIFFRACplus Topas 3. For lamellar phases, lattice 
parameters were calculated directly from Bragg’s law based on fitted peak positions of the 
highest-intensity reflection (Appendix A).  
SAXS data for samples prepared with potassium dihydrophosphate solutions were 
collected on protein crystallography beamline LS-CAT 21-ID-D at the Advanced Photon Source 
(APS), Argonne National Lab. A detailed description of the setup is available elsewhere.24 For 
SAXS measurements, a vacuum flight tube and an adjustable beam stop with an incorporated 
pin-diode were installed between the sample and the CCD detector (Rayonix MX300). The 
beamline was equipped with a microdiffractometer (MAATEL MD2) consisting of a goniometer, 
XYZ micropositioner and an on-axis video microscope.  The latter was used to monitor the 
position of the sample in the X-ray beam. The size of the X-ray beam was 20 µm. The beam 
energy was 8 keV. Attenuation of the incident X-ray beam and exposure time were adjusted to 
avoid radiation damage.25 
Raw diffractograms were integrated in Fit2D software (v. 12.077, A. P. Hammersley, 
ESRF, 1994). Integrated diffractograms were processed in MATLAB (R2008a, v. 7.6.0.324, The 
MathWorks Inc., Natick, MA). Publicly available MATLAB code (findpeaks.m, T. C. O’Haver, 
v2, revised Oct 27, 2006) was used for locate peak center positions. A series of MATLAB scripts 
was developed for baseline correction, and phase assignment for integrated diffractograms. 
Accuracy of all phase assignments was verified manually. For phase assignment, diffraction 
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angles were converted into d-spacings using Bragg’s law. Mesophases were identified based on 
characteristic sets of reflections and lattice parameters were calculated using the peak position of 
the highest-intensity reflection (Appendix A). In this approach full fitting of the intensity profile 
and simultaneous fitting of multiple peaks was not performed in the lattice parameter 
calculations. The accuracy of lattice parameters calculated with Matlab was verified by 
performing whole powder pattern decomposition22,23 in DIFFRACplus Topas 3 for several 
samples. The difference between the lattice parameters calculated using the two methods was 
found to be within 0.5 Å, smaller than the difference in multiple measurements for identical 
samples.  
Validation of mixed OG/MO samples. To verify that solid OG/MO mixtures did not 
deteriorate during the formulation of homogeneous detergent/lipid mixtures, mesophase samples 
with identical overall compositions were prepared with (i) solid OG/MO mixtures and 
phosphate buffer solution (25 mM NaH2PO4, pH 5.5), and (ii) solid MO mixed with a solution of 
OG in the same phosphate buffer. For the latter case, 5%, 10%, and 15% w/v solutions of OG 
in phosphate buffer (25 mM NaH2PO4, pH 5.5) were used. Phases identified in samples of 
identical compositions prepared by the two methods were identical. The lattice parameters of 
cubic phases and lamellar phases differed by less than 3 and 2 Å, respectively. The differences in 
the lattice parameters may be attributed to inevitable slight deviations in sample composition. 
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2.3  Results 
Findings on the effect of sodium and potassium phosphate salts and detergent -
octylglucoside on the phase behavior of MO mesophases are presented below. In the first part we 
investigated the effect of salt concentration in solution on the lattice parameter of MO 
mesophases above full hydration and discuss plausible mechanisms underlying our observations. 
In the second part we studied combined effects of phosphate salts and detergents on the phase 
behavior of MO mesophases in a wide range of hydration levels. We conclude by discussing the 
implications of our findings for the studies of membrane protein crystallization systems as well 
as for the studies of crystallogenesis in meso in Chapter 2.4. 
Because of the complex composition of systems discussed below and the presence of 
multiple phases within a single sample, a number of variables are required to for detailed 
description. The concentration of salt in solutions used for sample formulation is denoted as csalt, 
and the overall weight fraction of salt solution in the sample is denoted as waq. In contrast, 
volume fraction of salt solution φaq refers strictly to the combined volume fraction of water and 
salt only within the mesophase, rather than to the overall composition of the multiphase mixture. 
Because salt ions are unlikely to partition into non-polar lipid bilayers, φaq reflects the volume 
fraction of the aqueous compartments of the mesophase. 
 
2.3.1  Mesophases of monoolein and phosphate salt solutions under conditions of full 
hydration 
Figure 2.1 shows lattice parameters of monoolein mesophases prepared with K and Na 
phosphate salt solutions of 0.7 - 2.0 M and containing 40-80 wt% of the respective salt solution. 
All mesophases in these systems were of the Pn3m type and all samples contained excess 
aqueous phase. Both K and Na salts showed similar effects and caused the lattice parameter of 
the mesophase to decrease as the salt concentration increases, in quantitative agreement with 
available data.18 The lattice parameters in all salt-containing systems studied here, 76-96 Å, were 
noticeably smaller than in water-saturated monoolein mesophases, ~108 Å at 25 °C. At the same 
molarity of the salt solution (csalt) and overall sample composition (waq) the lattice parameters in 
K and Na salts differed, on average, by 1 Å. This result is not unexpected because the magnitude 
of the effect of ions on the lattice parameter is known to correlate with the position of ions in 
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Hofmeister series,26 where K and Na are located immediately next to each other. Due to the 
small differences in the values of relevant lattice parameters and the slightly different 
temperatures at which K- and Na-containing samples were measured we did not further compare 
the results obtained with, respectively, the K and Na salts. 
 
 
Figure 2.1. Lattice parameters of mesophases obtained upon mixing of MO with phosphate salt solutions as a function of salt 
concentration in solution (K or Na) and salt solution content (waq = 40, 50, or 80 wt%) in the sample: samples prepared with 
solutions of (A) KH2PO4 and (B) NaH2PO4. Error bars correspond to one standard deviation (N = 3 or 4). Lines are linear fits to 
data. 
Detailed inspection of samples and of lattice parameter values revealed several 
interesting trends: (i) all samples had lattice parameters lower than in MO/water mesophases and 
contained excess aqueous phase in addition to the mesophase, whereas MO/water mesophases 
contain ~43% of water at the onset of bulk aqueous phase separation;12 (ii) values of lattice 
parameters for the Pn3m phases were not only smaller than in fully hydrated MO/water mixtures, 
but were also lower than those accessible in MO/water systems before the Pn3m-Ia3d 
transition,8,9 as reported previously for monoolein with various small solutes;12,17-19,27,28 and (iii) 
the lattice parameter of the mesophase depended not only on the concentration of salt in the 
system, but also on the amount of excess aqueous phase (salt solution/monoolein ratio).  
Phase transitions in lipidic mesophases are typically explained on the basis of curvature 
elastic free energy of bilayer bending.29-31 However, clear explanations of the origins of the 
effect of small solutes on bilayer bending have not been put forward so far.  Below we argue that 
our findings can be explained by considering a complementary free energy contribution, the 
interfacial tension (IFT) between the hydrocarbon part of the bilayer and the aqueous channels of 
the mesophase, as done in the classical theory of self-assembly of amphiphiles.32  IFT is known 
to be important in the micellization of non-ionic surfactants,33,34 and may serve as a 
complementary contribution to the curvature elastic free energy of bilayer bending typically used 
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to explain phase transitions in lipidic mesophases.29-31 Although IFT has not yet been included in 
models for phase behavior of lipidic mesophases, presumably due to their mathematical 
complexity, it may provide a general way to explain the effect of small solutes on the curvature 
of lipid bilayers observed experimentally.  
Although data on the effect of phosphate salts on the IFT at the hydrocarbon/aqueous 
solution interface are not available, the IFT is likely to increase upon the addition of phosphate 
salts.  In the Hofmeister series phosphates are located between chloride and sulfate anions,35 both 
of which are known to increase the IFT36 compared to systems with pure water.  Because ions of 
sodium and potassium phosphate salts are sufficiently small to enter the aqueous channels of the 
mesophase, they are likely to have the same effect on the bilayer/channel IFT in the mesophase. 
Under this assumption, to reduce the energy penalty of interface formation, the area per MO 
headgroup ahead is expected to decrease compared to mesophases prepared with pure water. 
Changes in the other two packing parameters, the lipid tail length l and the hydrocarbon chain 
volume vl, are believed to be associated with significant unfavorable contributions to the free 
energy,31 and variations of these two parameters are usually assumed to be minimal at a given 
temperature. We also note that because MO headgroups are uncharged, electrostatic screening 
effects, important for ionic amphiphiles, are unlikely to account for the observed trends.  
The phase behavior observed in MO mixtures with salt solutions is fundamentally 
different from that caused by a purely osmotic effect upon decrease of the activity of water in the 
bulk aqueous phase coexisting with the mesophase,37 as was noted previously.12,17-19,27,28  In the 
latter case the sequence of phase transformations and of values of lattice parameters would be the 
same as in partially dehydrated MO/water mesophases. Purely osmotic effects were observed, for 
example, in the presence of polyethylene glycols of high molecular weight37 that are excluded 
from the mesophase due to steric constraints. 
Lattice parameters and hydration boundary in MO/salt solution mixtures. Although 
exact location of hydration boundaries in salt-containing systems is not known, a crude estimate 
for φaq yielded a range, albeit rather wide, of 26-39% v/v at full hydration in MO mixed with salt 
solutions, lower than the 43% in MO/water systems. The estimate of the hydration boundary is 
based on the following observations: phase separation was observed at 40 wt% salt solution in all 
systems studied here, providing the upper limit. Mixtures of MO with 2M NaH2PO4 at 30 wt% of 
the solution resulted in homogeneous mesophases (Chapter 2.3.2), indicating the lower limit for 
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the hydration boundary. Because the density of salt solutions is higher than that of MO, 40% 
w/w translates into 39% v/v at most, and 30% w/w into 26% v/v at the least. We also note that 
the exact location of the hydration boundary likely depends on the concentration of salt in 
aqueous solutions used for the mesophase preparation. 
The hydration boundary in the first approximation is determined by the accessible values 
of packing parameters (Equation 1.1) of lipid molecules in the mesophase. The observed shift to 
lower φaq values, as well as lower values of lattice parameters, are consistent with the smaller 
allowed headgroup area in mesophases prepared with salt solutions. The dependence of φaq on 
ahead can be intuitively explained as follows: the inverse mesophases can be very crudely 
represented as lipid monolayers draped over cylindrical aqueous channels with polar lipid heads 
packed on the surface of the channel.38  Provided that the phase type does not change, the radii of 
aqueous channels in the mesophase must shrink compared to systems with pure water for ahead to 
decrease. Smaller radii of aqueous channels lead to a lower ratio of the aqueous volume to the 
lipidic volume in the mesophase (Equation 1.4), i.e., lower accessible values of φaq. Although 
precise measurements were not carried out, we expect that the hydration boundary will shift to 
lower φaq values as the phosphate salt concentration increases since the area per headgroup likely 
decreases with increasing salt concentration. 
Figure 2.2 shows the subset of calculated accessible values of the lipid headgroup area 
and tail length given the values of Pn3m lattice parameter and the range of φaq values at the 
hydration boundary established here. Calculations were based on equations 1.2 and 1.3 and the 
standard assumption of the additivity of volumes of MO and the aqueous solution upon 
mesophase formation. The point corresponding to fully hydrated MO with pure water is also 
shown in Figure 2.2. The optimal value of the lipid tail length, lopt = 17.2 Å, was selected as the 
average for 22.5 °C and 25 °C based on the correlation by Briggs et al.8 (Equation 1.9). As can 
be seen in Figure 2.2, if the lipid tail length is maintained at lopt, the smallest accessible value of 
the lattice parameter of the Pn3m mesophase within the range of hydration boundaries is ~80 Å, 
with a concomitant decrease in the headgroup area compared to the MO/water system. However, 
the values of lattice parameters of Pn3m mesophases in MO/salt solution systems measured here 
were as low as 76 Å, requiring that the length of the MO tail become smaller than lopt to remain 
within the plausible range of hydration boundaries. Therefore, local packing of MO in salt-
containing mesophases likely involves changes in the packing of hydrocarbon tails in addition to 
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the decrease in the headgroup area. The magnitude of this effect is difficult to assess precisely 
because of the uncertainty in the exact location of the hydration boundary and the assumptions 
made in the calculations. 
 
Figure 2.2. Relationship between headgroup area per lipid molecule ahead and lipid tail length l in Pn3m mesophases, the lattice 
parameter of the mesophase dPn3m, and the volume fraction of the aqueous component φaq based on equations 1.2 and 1.3 
(Chapter 1). Solid lines correspond to constant values of tail length l; dashed lines correspond to constant values of φaq. The black 
dot corresponds to the fully hydrated Pn3m mesophase in the MO/water system at 25 °C. Values of the lattice parameters for MO 
mixed with salt solutions measured in this work are located between the areas shaded in grey. 
Available data on other systems appear to lend support to our hypothesis about the effect 
of the bilayer/channel IFT on the lattice parameter of MO mesophases at full hydration for 
solutes that do not partition into the lipid bilayer.  For example, in MO mesophases prepared 
with solutions of sodium iodide that decrease the IFT,36 lattice parameters were reported to 
increase as the salt concentration increased.19  The aqueous solution content in mesophases at 
full hydration is expected to change accordingly in those systems. 
Lattice parameters of MO/salt solution mesophases are not accessible in MO/water 
systems. The lattice parameters of the Pn3m phases established here and in other reports under 
similar conditions are in the range of 79 - 96 Å.  In MO/water mesophases, on the other hand, the 
Pn3m-Ia3d transition occurs as the lattice parameter of the Pn3m falls below 100-102 Å.  The 
main driving force of this phase transition is believed to be the curvature free energy of lipid 
bilayers.29-31 
Persistence of Pn3m phases in salt-containing systems can potentially be explained by the 
smaller headgroup area compared to Ia3d phases under otherwise identical conditions (Figure 
2.3). The energy penalty of the lipid bilayer/aqueous channel interface formation would be 
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reduced in this case, offsetting the suboptimal free energy of the bilayer bending associated with 
forming Pn3m phases with a small lattice parameter. Figure 2.3 shows that the difference in the 
headgroup areas between the two types of mesophases increases as φaq decreases, making the 
associated free energy contribution more pronounced in MO/salt solution mesophases than in 
MO/water mesophases. Incidentally, consideration of the IFT contribution may also explain 
formation of Pn3m phases in water-saturated systems, lifting the energetic degeneracy of Pn3m 
and Ia3d phases predicted by curvature-only models that assume constant bilayer thickness.29,30 
We note however, that other effects, such as the free energy of bilayer compression,31 must also 
play an important role in the prevalence of the Pn3m phase over the Im3m phase in MO systems 
because the latter has the lowest ahead values of the three cubic mesophases. 
 
Figure 2.3. Headgroup area per lipid molecule ahead as a function of lipid tail length l and the volume fraction of the aqueous 
component φaq in Pn3m and Ia3d mesophases calculated using equations 1.2 and 1.3 (Chapter 1).  
Dependence of lattice parameters on the amount of excess salt solution. At the same 
value of csalt, in solution, lattice parameters of mesophases were found to increase as the overall 
amount of solution in the mixture waq increased (Figure 2.1). Because all mixtures studied here 
contained excess bulk aqueous phase, this effect could not be attributed to swelling of the 
mesophase to accommodate ever increasing amounts of the aqueous phase. Using φaq = 0.35 as a 
crude estimate of the hydration boundary based on our observations, the volume of excess 
aqueous phase varied from ~0 in mixtures formulated with 40 wt% of salt solutions, to 
approximately three times that of the mesophase in mixtures with 80 wt% of salt solutions. To 
the best of our knowledge, dependence of lattice parameters on the amount of excess solution has 
not been reported previously in MO mesophases mixed with solutions of salts, presumably due 
to the lack of studies with varied amounts of the excess aqueous phase.  
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The variation in the lattice parameters at a given temperature is not possible without 
changes in the internal composition of the mesophase, and is not observed in binary MO/water 
systems above the hydration boundary, in agreement with the phase rule. In the ternary 
MO/water/salt systems studied here, compositional changes likely originated from the re-
distribution of salt between the aqueous compartments of the Pn3m phase and the coexisting 
bulk aqueous phase. The increasing values of lattice parameters indicate that csalt in the aqueous 
channels of the mesophase decreased relative to the nominal value of csalt in the solution used for 
sample preparation. This trend appears more prominent as the amount of excess aqueous phase 
increases, as expected for a system where one component distributes between two immiscible 
phases. The change in the composition of the mesophase may be quite significant. For example, 
the lattice parameter of the mesophase prepared with 80 wt% (3-fold excess) of 1.3M KH2PO4 
solution corresponds to ~0.8M on the 40 wt% trendline (Figure 2.1A). The lattice parameters at 
40 wt% of the salt solution provide the closest estimate for the true value of csalt in the aqueous 
compartments of the mesophase because those samples are closest to the onset of the bulk 
aqueous phase separation.  
Different concentrations of salt within the aqueous compartments of the mesophase and 
the coexisting bulk aqueous phase must result in osmotic stress that must be offset by other free 
energy contributions. As the unit cells of the mesophase become larger, some sources of strain 
relief may be: (i) curvature elastic free energy is reduced as curvature of lipid bilayers decreases 
and becomes closer to the spontaneous curvature;37 (ii) chain compression stress31 of the 
hydrocarbon tails decreases because tail lengths closer to the optimal value lopt become attainable 
(Figure 2.2); and (ii) steric repulsion between MO headgroups32 decreases as the area per 
headgroup becomes larger. 
 
2.3.2  Mesophases of monoolein and 2M NaH2PO4 in a wide range of hydration conditions 
 Figure 2.4 shows the sequence of phases observed in MO mixed with 10-80 wt% of 2M 
NaH2PO4 at 22.5 °C for two different batches (indicated as the vendor batch number on the MO 
container). The sequence of phase types in a wider range of conditions upon increasing waq 
(Figure 2.4A) followed that of the MO/water system, with one notable exception: at 30 and 35 
wt% of salt solution either an Ia3d or an HII phase was observed. In the second batch of MO only 
an HII phase was observed in mixtures with 30 and 40 wt% of salt solution. The lattice 
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parameters of cubic mesophases were lower than those in the MO/water systems, in agreement 
with our findings discussed in Chapter 2.3.1 and with previously published reports (Chapter 
1.3.3).17-19 Although the fully hydrated Pn3m aqueous phase appeared at slightly different values 
of waq for the two MO batches, its lattice parameter increased consistently as the amount of 
aqueous phase increased, as discussed in detail in Section 2.3.1. Batch-to-batch variations for 
MO mesophases have been observed previously.12 
 
Figure 2.4. Types of mesophases identified in SAXS analysis of MO mixed with solutions of 2M NaH2PO4, pH 5.5 for two 
different batches (A, B) of MO. Each data point represents an independently prepared sample. Mesophases are denoted as 
follows: Pn3m (circles), Ia3d (crosses), Lα (squares), and HII (triangles). A. Intermittent formation of Ia3d and HII phases was 
observed at 30 and 35 wt% of solution (area shaded in grey), depending on the sample. Coexisting Ia3d and HII phases were not 
observed within a single sample. Lattice parameters of mesophases were calculated as described in Appendix A. 
The appearance of the HII phase in our samples was remarkable because this phase does 
not consistently form in MO/water mesophases at temperatures below 90 °C (Figure 1.12) and 
has not been observed in mixtures with 2 M phosphate salts at ambient temperature under full 
hydration conditions (Chapter 2.3.1 and Figure 1.14 in Chapter 1.1.3). While the HII phase has 
the values of ahead lower than that in any cubic phase at a given composition, it has the highest 
curvature at the lipid/aqueous channel interface and is also known to require significant packing 
frustrations of lipidic chains.39  
Another interesting feature is the intermittent appearance of HII and Ia3d phases at a 
given value of waq (Figure 2.4A). We emphasize that coexisting HII and Ia3d phases were not 
observed in our samples, and the two phases shown at the same sample compositions in Figure 
2.3A represent two different independently prepared samples. We attempted to establish whether 
metastable behavior of MO mesophases9,10,15 may account for the observed differences by 
preparing a large amount of sample with waq = 30% followed by dispensing into several 
capillaries, maintaining the capillaries at -12 °C or -80 °C overnight, and then at 22.5 °C prior to 
data collection at the same temperature. Samples in all capillaries were of the HII type, 
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suggesting that metastability did not account for our observations of intermittent Ia3d and HII 
phase appearance. Therefore, our observations may have been caused by the slight differences in 
sample compositions in different preparations. 
Overall, our data for MO/salt solution systems demonstrate the complex nature of 
phenomena governing phase behavior and microstructure of mesophases even upon addition of 
relatively simple additives that affect bilayer geometry through dispersion interactions rather 
than through direct incorporation into the bilayer. These phenomena are significantly more 
complex than pure osmotically-driven MO/water phase transformations37 that match simple 
dehydration behavior. 
 
2.3.3  -Octylglucoside/monoolein/phosphate salt solution systems 
Here series of samples with constant OG/MO ratios were analyzed. At a given ROG/MO, 
salt solution content in the samples varied from 10 wt% to 80 wt%, covering a range of 
conditions below and above the hydration boundary. The conditions were chosen to reflect the 
compositions of mixtures typical in crystallization trials of membrane protein bacteriorhodopsin, 
where a protein solution containing up to 15% of OG is mixed with monoolein in a 60:40 v/v 
ratio,10 and crystallization is induced by the subsequent addition of a concentrated salt solution. 
Thus, the OG/MO ratio remains fixed throughout the trial and is independent of the amount of 
the aqueous phase and its salt concentration. Samples with three OG/MO weight ratios, 0.033, 
0.066, and 0.099 w/w were used, which correspond to the OG concentrations of 5, 10, and 
15%, respectively, in the 60:40 MO:detergent solution mixture. Concentrations of salt csalt in 
solutions used here, 0.7-1.3 M KH2PO4 and 1.3-2.0 M NaH2PO4, are also within the range used 
for crystallization of bacteriorhodopsin.3,10 The range of salt concentrations for KH2PO4 was 
limited by its solubility in water at ambient temperature, slightly above 1.3 M.  
The location of phase boundaries and the values of lattice parameters found in this work 
were accounted for by the interplay between competing effects of detergents and phosphate salts 
on the microstructure of lipidic mesophases. As discussed in the previous section, phosphate 
salts favor mesophases with higher bilayer curvature, smaller lipid headgroup area, and smaller 
radii of aqueous channels, and extend the range of the Pn3m phase formation to lower hydration 
levels compared to MO/water mesophases. Detergent additives are known to have the opposite 
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effect, favoring microstructures with less curved bilayers: cubic phases form with larger lattice 
parameters, extending the range of the Lα phase formation higher hydration levels.10-16  
Incorporation of OG in MO bilayers and subsequent changes in molecular packing due to the 
differences in the molecular shapes of lipid and detergent molecules provide a rationale for this 
behavior.10,14,32,40 Indeed, a significantly bulkier headgroup of OG compared to that of MO and, 
consequently, a larger average area per amphiphile headgroup in mixed MO/OG bilayers, 
should lead to observed changes in the microstructure based on the relationship between 
molecular parameters and mesophase composition (Equations 1.2 and 1.3). The differences in 
the hydrocarbon tail length of the two molecules are likely to be less important in defining the 
microstructure: incorporation of OG in MO mesophases was found to have little effect on the 
thickness of the bilayers.41 
 Trends in the phase behavior and values of lattice parameters. Figure 2.5 shows the 
types of mesophases found in the mixtures as a function of OG and salt solution content and 
sample temperature, along with approximate locations of hydration boundaries established based 
on the appearance of the sample.  
Remarkably, despite the complexity of the quaternary mixtures, the sequence of phases in 
each series was highly regular and was identical to that in MO/water mesophases at similar 
temperatures.8,9 The lamellar Lα phase formed in the “dry” end of the phase diagram. As the 
amount of the aqueous phase in the mix increased, the Lα -Ia3d transition, followed by the Ia3d-
Pn3m transition took place, and at full hydration all mesophases were exclusively of the Pn3m 
type. At a given salt solution content waq, lattice parameters were found to increase with 
increasing detergent loading, and to decrease with increasing salt concentration csalt in solution. 
Some of the latter decrease could be attributed to the lower water content in the system and a 
smaller volume of solutions used because of the higher density at higher salt concentrations. 
However, identical trends for systems with a large excess of solutions coexisting with the Pn3m 
mesophase indicated that the changes in the salt concentration in solutions used for sample 
preparation were the defining factor for the values of the lattice parameters. 
The regularity in the sequence of phases likely stemmed from the mutually mitigating 
effects of OG and phosphate salts on the curvature of the lipid bilayers, as discussed above, as 
well as from the relatively low detergent loading and salt concentrations in solutions. Previous 
reports provided evidence that phase behavior of MO with additives does not necessarily 
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replicate that of MO/water mesophases. For example, certain OG/MO ratios and mesophase 
hydration levels give rise to phenomena not found in MO/water mesophases both with10 and 
without13,16,42 significant amounts of salt in the system, such as the coexistence of Pn3m and Lα 
phases, although regular sequences of mesophases similar to those in MO/water systems have 
also been observed.10 We also note that coexisting Pn3m and Lα phases discovered in 
crystallization systems in the vicinity of protein crystals were not found anywhere in the entire 
phase space tested here. In only one sample in this work coexisting Pn3m, Ia3d, and Lα 
mesophases were observed, but the lattice parameter of the lamellar phase was 44 Å, 
significantly lower than 50-55 Å of the lamellar mesophase surrounding protein crystals.4 At the 
same time, the lattice parameters of Pn3m phases found here are in agreement with values of 85-
97 Å in crystallization mixtures with protein crystals.4 These findings provide additional 
evidence that the combination of coexisting Pn3m and Lα phases is brought about by the 
crystals, presumably due to elastic constrains on the bilayers in proximity of membrane protein 
molecules packed in sheets within the crystal. 
 
Figure 2.5. Phase diagrams of MO/βOG/salt solution mixtures as a function of weight fraction of salt solution waq at (A) constant 
βOG/MO ratios and (B) constant salt concentrations. K and Na denote KH2PO4 and NaH2PO4, respectively. Mesophases are 
denoted as follows: (□) Lα, (×) Ia3d, (○) Pn3m. Mesophase identity was established by SAXS. The solid curves indicate 
approximate locations of hydration boundaries based on the appearance of samples and are drawn to guide the eye. 
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The range of mixture compositions in which specific types of mesophases appeared 
varied as expected based on the known effects of detergents and phosphate salts. Specific trends 
are discussed below. 
Dependence of phase behavior on salt concentration at constant OG/MO ratio. As 
the salt concentration increased, boundaries of all phases (Lα, Ia3d, and Pn3m) shifted towards 
the lower content of the salt solution in the mixture (Figure 2.5A). This change was not 
unexpected and agreed with the anticipated effect of phosphate salts that extend the range of 
cubic phase formation and promote mesophases with higher bilayer curvature and smaller values 
of lattice parameters. For example, in the mixtures with the ROG/MO of 0.066 w/w, the Ia3d phase 
was observed at up to 50 wt% of the salt solution at the salt concentration of 0.7 M KH2PO4, but 
only at up to 40 wt% of solution at 1.0 and 1.3 M KH2PO4. At the same time, the interval of 
lamellar phase existence decreased from 10-40% of the salt solution at 0.7 M KH2PO4 to 10-20% 
with 1.0 and 1.3 M KH2PO4. 
Systems with other OG/MO ratios prepared with solutions of KH2PO4 followed similar 
trends, as did mixtures containing NaH2PO4 solutions of 1.3 M and 2.0 M concentrations at 20 
°C. An exception among the samples with NaH2PO4 was the series with the ROG/MO of 0.033, the 
lowest one studied here. At the aqueous solution loading of 20 wt% in this series the trend was 
seemingly reversed compared to other systems: a lamellar phase is observed in the mesophase 
samples with 2.0 M NaH2PO4, but not with 1.3 M NaH2PO4. The series with 2.0 M NaH2PO4 
also deviated if trends with respect to varying OG/MO ratio at a given salt solution 
concentration are considered, as described in the following section. A number of factors may 
account for this behavior, for example, a noticeably lower volume fraction of solution in mixtures 
with the higher salt concentration, as well as a significantly lower water/salt ratio as the 2.0 M 
NaH2PO4 solution contains 25 wt% of the salt. These factors could lead to unattainable 
constraints on the packing parameters in the bilayer or significant effects of specific interactions 
between the solution and the hydrophilic heads of MO and OG. Highly curved bilayers caused 
by 2.0 M NaH2PO4 could lead to phase separation of a detergent-rich phase, with insufficient 
detergent at RβOG/MO = 0.033 to counteract the curvature induced by the high salt concentration, 
unlike in series with higher detergent loadings. We note that pure MO mixed with a 2.0 M 
NaH2PO4 solution below full hydration also exhibited highly unusual behavior, forming either an 
Ia3d phase or a hexagonal HII phase at the salt solution content of 30 wt% at 22.5 °C (Chapter 
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2.3.2). For comparison, MO only forms hexagonal mesophases at temperatures above 
approximately 90 °C when mixed with water.8 Hexagonal phase formation in MO/excess salt 
solution systems at ambient temperature requires a significantly higher concentration of salt in 
solution.17 
 
Figure 2.6. Lattice parameters of MO/βOG/salt solution mesophases prepared with KH2PO4 as a function of weight fraction of 
salt solution waq at three different salt concentrations csalt and three different βOG/MO ratios. (A1-A3) Each panel represents 
samples formulated with constant csalt at different βOG/MO ratios. (B1-B3) Each panel represents samples formulated with a 
constant βOG/MO at different csalt values. Mesophases are denoted as follows: (□) Lα, (×) Ia3d, (○) Pn3m. Mesophase 
microstructure was established by SAXS. 
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Figure 2.7. Lattice parameters of MO/βOG/salt solution mesophases prepared with NaH2PO4 as a function of weight fraction of 
salt solution waq at two different salt concentrations csalt and three different βOG/MO ratios. (A1, A2) Each panel represents 
samples formulated with constant csalt at different βOG/MO ratios. (B1-B3) Each panel represents samples formulated with a 
constant βOG/MO ratio at different csalt values. Mesophases are denoted as follows: (□) Lα, (×) Ia3d, (○) Pn3m. Mesophase 
microstructure was established by SAXS. 
Dependence of phase behavior on OG/MO ratio at constant salt concentration.  At 
the same salt concentration, the boundaries for all phases tended to shift in the direction of higher 
salt solution content in the mixture as the OG/MO ratio increases (Figure 2.5B). These shifts 
were consistent with the effect of OG on the average molecular packing parameters32 in the 
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bilayers of the mesophase, resulting in the formation of mesophases with lower bilayer curvature 
and larger values of lattice parameters (Figures 2.6 and 2.7). As an example, in mixtures 
prepared with 1.0 M KH2PO4 salt solutions the boundary for pure Pn3m phase formation shifted 
from 40 wt% of the salt solution to 60 wt% as the ROG/MO ratio increased from 0.033 to 0.099 
w/w. The Lα phase range extended from 10 wt% to 50 wt% of the salt solution. Similar trends 
take place for mixtures with NaH2PO4 solutions. The series with the OG/MO ratio of 0.033 and 
the salt concentration of 2.0 M appeared to be an outlier again, as the Lα phase and the Ia3d 
phase persist to higher salt solution contents at the OG/MO ratio of 0.033 than at 0.066. 
Comparison with MO/water mesophases.  Interestingly, the trends in phase behavior 
observed upon increased detergent loading or decreased salt concentration were very similar to 
those in MO/water mesophases at decreasing temperatures (Figure 1.12),8,9 although exact 
locations of phase boundaries were different in the two classes of systems. The major changes, 
based on data for systems with KH2PO4, were: (i) the shift of the hydration boundary to the 
higher aqueous loading, as discussed above; (ii) widening of the Lα + Ia3d coexistence region at 
the expense of (iii) narrowing of the pure Ia3d phase region of the phase diagram; and (iv) larger 
values of lattice parameters. At the same time, the pure Pn3m phase region near the hydration 
boundary in quaternary systems appeared to remain narrow, similar to the behavior observed in 
the binary MO/water system. The Pn3m + Ia3d coexistence was only observed in a few samples, 
making related trends difficult to infer unambiguously. 
The trends in the phase behavior outlined above were likely brought about by the 
similarly changing packing of amphiphiles in the bilayers. In MO/water systems at lower 
temperatures,8,9 as well as in MO/OG/salt solution mesophases at higher OG loadings or lower 
salt concentrations, the bilayer curvature tends to decrease. Therefore, the minimal values of 
lattice parameters attainable in cubic phases become higher. Because the values of lattice 
parameters also decrease as the aqueous loading in the mesophase decreases, the Ia3d - Lα phase 
separation occurs at larger values of waq to maintain preferred molecular packing in the bilayer 
becomes larger as the bilayers become flatter, causing observed changes. Preferred hydration 
levels of lamellar phases did not appear to vary significantly in the systems studied here. 
Effects of different salts on the phase behavior. Two of the series of samples had 
identical temperature of 25°C and salt concentration of 1.3M, and the only difference was the 
cation, Na or K, of the phosphate salt. Figure 2.5A and B show that Na had a stronger cubic  
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Figure 2.8. Lattice parameters of MO/βOG/salt solution 
mesophases as a function of temperature at different weight 
fractions of salt solution waq and βOG/MO ratios. All samples 
were prepared with 1.3M NaH2PO4. Mesophases are denoted 
as follows: Pn3m (circles), Ia3d (crosses), Lα (squares). 
Mesophase identity was established based on SAXS data. 
Figure 2.9. Effect of the cation on lattice parameters of 
MO/βOG/salt solution mesophases at different weight fractions 
of salt solution waq and βOG/MO ratios and the salt 
concentration of 1.3M. Mesophases are denoted as follows: 
Pn3m (circles), Ia3d (crosses), Lα (squares). Mesophase 
identity was established based on SAXS data. 
phase-promoting effect than did K, which is evident in the persistence of the Pn3m phase to 
lower values of waq in mixtures with the sodium salt than in otherwise identical mixtures with the 
potassium salt. Also, lattice parameters of mesophases prepared with NaH2PO4 were lower than 
of those prepared with KH2PO4 under otherwise identical conditions (Figure 2.9). This finding 
was somewhat unexpected as the effects of cations on uncharged lipidic mesophases are believed 
to correlate with their position in the Hofmeister series, where Na and K are found immediately 
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next to each other. The lower water/salt ratio, 35:1 mol/mol in 1.3M NaH2PO4 solutions, vs. 41:1 
mol/mol in KH2PO4 solutions, and the resulting lower water/amphiphile molar ratio under 
seemingly identical conditions may have played a role in the observed differences. 
Lattice parameters of mesophases below full hydration. Lattice parameters of 
mesophases below the hydration boundary (Figures 2.6-2.9) changed as anticipated based on the 
effects of OG and phosphate salts on the packing parameters and curvature of lipid bilayers, as 
well as on the effect of hydration level waq on the lattice parameters. An increase in the OG/MO 
ratio caused the lattice parameters to decrease, and an increase in csalt caused the lattice 
parameters to decrease at a given value of waq, with a few outliers possibly resulting from 
imperfectly formulated samples. Lattice parameters of mesophases consistently grew larger as 
waq increased in single-phase as well as in coexisting-phase regions. The latter indicated that the 
compositions of coexisting phases varied with the overall composition in the quaternary systems 
studied in this work, unlike in the binary MO/water mixtures. In binary systems the phase rule 
requires that compositions, and, consequently, lattice parameters of coexisting phases be 
invariant at a given temperature regardless of the overall composition of the mixture. The 
changing lattice parameters in coexisting phases in the quaternary systems could result from 
increasing hydration levels in both coexisting phases, from the redistribution of detergent 
between the phases, and from redistribution of salt between the aqueous compartments, and were 
likely a combination of all these factors. Thus, the OG/MO ratios and salt concentrations in the 
aqueous compartments of the coexisting phases must be different from the nominal ones used for 
sample preparation, making the regular trends in the phase behavior observed here ever more 
remarkable. 
Closer inspection of data revealed noticeable quantitative differences in the trends for 
lattice parameters of mesophases above and below full hydration. Above full hydration changes 
in salt concentration, OG/MO ratio, and sample temperature caused significant variations in the 
values of aPn3m at a given value of waq, as discussed below. On the contrary, below full hydration, 
where mostly Ia3d and Lα phases formed, the hydration level waq had the prevailing effect on the 
lattice parameters. At fixed values of waq, lattice parameters of Ia3d phases varied little 
compared to lattice parameters of Pn3m mesophases above full hydration upon identical changes 
in csalt, ROG/MO, and sample temperature in almost all sets of samples (Figures 2.6 and 2.7). 
Lattice parameters of lamellar phases were defined almost exclusively by the values of waq and 
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followed a linear trend aLα = 0.36waq + 35.6 regardless of the presence of Ia3d phase and the 
range of the lamellar phase existence. At a given waq the values of aLα did not differ by more than 
3.5 Å among all samples regardless of all other parameters. Another interesting feature in the 
series where the Ia3d phase formed in a wide composition range was the near-constant slope 
daIa3d/dwaq at a given OG/MO ratio (Figures 2.6 and 2.7). The slope was practically 
independent of the salt concentration and of the presence of coexisting phases of other types. The 
specific type of coexisting phase also did not appear to affect the trend for the lattice parameters 
of Ia3d phases, as highlighted by data for samples with ROG/MO = 0.066, where values of aIa3d for 
pure Ia3d, Ia3d + Lα, and Ia3d + Pn3m samples fell on the same linear trend. These observations 
may indicate that lattice parameters below full hydration were largely defined by geometry 
constraints related to the relatively small volume of the aqueous sub-compartments of the 
mesophase. These constraints force the amphiphiles to pack with suboptimal values of tail 
lengths and headgroup areas, with phase separation providing a route for re-distribution of 
components and formation of bilayers with more favorable packing. On the other hand, in fully 
hydrated systems the amount of aqueous solution within the mesophase and the lattice 
parameters of the mesophase are likely determined by optimal packing parameters, resulting in 
noticeable changes when these parameters change. 
Effect of additives on the hydration boundary and lattice parameters at full 
hydration. All mesophases coexisting with excess aqueous phase were of the Pn3m type (Figure 
2.5), suggesting that this was also the mesophase type adopted at the onset of aqueous phase 
separation, analogous to MO/water mesophases in a similar temperature range. The hydration 
boundaries shifted in the direction of higher aqueous solution content as the OG/MO ratio 
increased or as the concentration of salt decreased (Figure 2.5A, B). The location of the 
hydration boundary appeared more sensitive to the OG/MO ratio than to the concentration of 
salt in solution, as evidenced by more frequent observations of hydration boundary shifts in 
datasets with constant csalt and varying ROG/MO (Figure 2.5B) than in datasets with constant 
ROG/MO ratio and varying csalt (Figure 2.5A). As discussed in Chapter 2.3.1, the hydration 
boundary shifts to lower values of waq to satisfy geometry/composition relationships as the lattice 
parameters decrease, and, conversely, is expected to shift to higher values as the lattice 
parameters increase. In mixtures with KH2PO4 the lattice parameters of Pn3m mesophases at full 
hydration increased by ~6.5 Å if ROG/MO in the sample increased by 0.01, whereas for salt 
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solutions the lattice parameter decreased by 3.3 Å if the salt concentration increased by 0.1M. 
Because the location of the hydration boundary was only established to within 10 wt% of salt 
solution in the sample, several ways of selecting data for the analysis were tested, yielding 
similar values in all cases (see Appendix B for details). 
In this work ROG/MO was varied in increments of 0.033, and, to offset the effect of OG, 
salt concentration would have to increase by more than 0.6 M for every increment. This value is 
slightly larger than the range of concentrations of KH2PO4 used here and, coupled with the 
uncertainty in the determination of the hydration boundary, may explain our observations on the 
stronger effect of OG compared to the effect of salt. Values in systems with NaH2PO4 were 
different from those in systems with KH2PO4 and appeared to depend on the detergent loading, 
further complicating the issue (see Appendix B for details). In series with NaH2PO4 containing 
0.066 and 0.033 OG/MO we estimated an increase of 2.6 Å per a ROG/MO increase of 0.01 for 
the effect of OG and 3.3 Å per an increase of 0.1M in the salt concentration. The series with 
ROG/MO = 0.099 was an outlier in the dataset with NaH2PO4, with respective values of ~6 Å for 
the effect of OG and 5.4 Å for the effect of salt. 
Remarkably, the quantitative effect of additives on the values of lattice parameters of 
Pn3m mesophases in quaternary mixtures at full hydration was different from that calculated 
based on data for ternary MO/water/additive mixtures. Without detergent the lattice parameters 
decrease by only about 1.0-1.4 Å if either KH2PO4 or NaH2PO4 salt increases by 0.1M according 
to our own and previously published data.18 Therefore, the introduction of detergent resulted in 
the enhancement in the effect of salt on the lattice parameter, where the decrease of at least 3.3 Å 
per 0.1M of salt concentration was observed. Although the origin of this effect is not clear, we 
speculate that shorter chains of OG compared to MO may relieve chain packing frustrations 
upon bilayer bending, providing access to mesophases with smaller lattice parameters. 
Additionally, our data on mixtures with NaH2PO4 indicate that the effect of salt on the lattice 
parameter in hydrated mesophases may vary depending on the detergent loading. Similarly, the 
average effect of OG on the lattice parameter appeared to vary as a function of csalt and may 
differ from that in ternary systems under certain conditions, as illustrated by our findings for 
samples containing NaH2PO4. The correlation obtained by Misquitta and Caffrey for ternary 
OG/MO/water systems10 (Figure 1.17) produced the value of 5 Å for every 0.01 increase in 
ROG/MO. This value is similar to our estimates for quaternary OG/MO/water/salt systems at all 
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KH2PO4 concentrations and ROG/MO values, as well as at both NaH2PO4 concentrations and the 
ROG/MO  = 0.099. However, the respective effect of OG on the lattice parameters in mixtures 
with NaH2PO4 and the OG/MO ratios of 0.033 and 0.066 was significantly less pronounced at 
3.4 Å, and the value deduced for mixtures with 2M Na/K phosphate10 is even lower at 1.7 Å. Our 
data are based on at least four measurements for every data point, and the quantitative 
differences outlined above are unlikely to arise due to aberrant sample compositions. 
Lattice parameters of mesophases beyond the hydration boundary. Although all 
mesophases coexisting with excess aqueous phase maintained Pn3m symmetry, their lattice 
parameters showed dependence on the amount of excess aqueous solution even if all other 
parameters (csalt, ROG/MO, sample temperature) were constant, as shown in Figures 2.6-2.9. At 
low salt concentrations (0.7 and 1.0 M) a maximum in the values of lattice parameters was 
observed at waq of 60-70%. As the salt concentration increased, the maximum disappeared, and a 
steady increase in the values of lattice parameters beyond the hydration boundary took place 
(Figures 2.6 and 2.7). These trends may be explained by considering partition of salt and 
detergent between the mesophase and the coexisting bulk aqueous phase. Our findings for 
MO/salt solution systems strongly suggest that salt re-distributes between the aqueous channels 
of the mesophase and the bulk aqueous phase so that the effective salt concentration in the 
mesophase becomes lower, as discussed above. This phenomenon may account for the increasing 
values of lattice parameters observed here for MO/detergent/salt solution mesophases. On the 
other hand, the maxima and subsequently decreasing values of lattice parameters at relatively 
low salt concentrations could be explained by partition of OG between the mesophase and the 
bulk aqueous phase, causing the effective OG/MO ratio in the bilayers to decrease. Lower 
solubility of OG at higher salt concentrations may explain the apparent lack of this trend in 
samples prepared with salt solution concentrations above 1.0 M, where partition of salt 
dominates likely the changes in the lattice parameters. These observations strongly suggest that 
the effective salt concentration in the aqueous channels of the mesophase, as well as the 
OG/MO ratio in the bilayers, differ from the nominal values in mesophases beyond the 
hydration boundary. 
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2.4  Discussion 
2.4.1  Implications for membrane protein crystallization 
The outcome of a crystallization trial must be determined by the exact conditions 
experienced by the protein molecules within the mesophase. Certain mesophase properties, such 
as the diffraction pattern, the lattice type, and the lattice parameter of the mesophase are easily 
established and may provide information about the size of the aqueous channels within the 
mesophase,43,44 important for protein diffusion and crystallogenesis.45,46 At the same time, our 
data illustrate the difficulties in assessing the exact compositional makeup of the mesophase in 
crystallization systems and its effect on crystallization. Some of the parameters that are sensitive 
to OG/MO ratio in bilayers and the salt concentration within the channels are the viscosity and 
elasticity of bilayers, and electrostatic screening between the hydrophilic domains of the protein. 
A better understanding of the effect of those variables could provide routes for optimizing 
crystallization protocols and improving the success rate of in meso crystallization.  
 
2.4.2  Implications for assessment of compatibility of detergents and crystallization screens 
with in meso crystallization 
Because mesophases of cubic type are required for membrane protein crystallogenesis in 
meso, compatibility of crystallization screens as well as detergents with cubic phase formation 
has been investigated in a number of reports.5,47,48 However, only a single data set for MO 
combined with detergents and precipitants at crystallization-relevant concentrations is 
available.10 Most studies focused on either MO mixed with detergent solutions in the 60:40 v/v 
ratio, as in the original protocol for in meso crystallization, or for MO mixed with excess, usually 
unspecified, of a multi-component precipitant solution (Section 1.3.3). Nevertheless, such data 
have been invaluable in assessing general trends on the effect of certain components on the 
microstructure of MO mesophases and the relative magnitude of this effect as, for example, in 
the data for series of n-alkyl--D-glucopyranoside detergents.10,12,15 
Our results, however, highlight the difficulty of inferring the microstructure of the 
resultant mesophase in the crystallization trial from the information on the effect of individual 
additives on the phase behavior of MO under a limited range of conditions, as discussed in 
Chapter 1.3.3. For example, our samples with OG/MO ratios of 0.033, 0.066, and 0.099 
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produced Ia3d, Ia3d + Lα, and Lα phases, respectively, when mixed with water to match the 
60:40 MO:detergent solution ratio, yet all formed Pn3m cubic phases when mixed with an excess 
of a phosphate salt solution in a wide range of concentrations csalt. These observations agree with 
previously reported data.10 Information on detergent-containing mesophases at full hydration in 
absence of precipitant may provide a relevant starting point for assessing the phase behavior in 
crystallization systems, yet data for MO/detergent/water mesophases with hydration level varied 
independently of detergent loading are scarce10-13,16 and typically cover a very limited range of 
phase space, although the ternary MO/OG/system has been investigated in great detail.10,11,13,16 
Additionally, our results showed that quantitative effects of individual components on the lattice 
parameter of MO mesophases at and above full hydration are affected by the presence of other 
components in the systems. Thus, if fine-tuning of lattice parameters in crystallization systems is 
of interest, the analysis of the complete system including MO, detergents, and precipitants under 
conditions expected during a crystallization trial, would be necessary until reliable modeling 
approaches or correlations become available.  
The systems studies here were relatively simple due to easily discernible 
compartmentalization of additives. One additive (salt) remained in the aqueous environment both 
within and outside of the mesophase, and the incorporation of the second additive (detergent) in 
the bilayers was determined by its amphiphilic properties, making qualitative prediction of trends 
relatively straightforward. If solely the resultant phase type and the plausible trend in the 
variation of the lattice parameters are of interest in such systems, partial data on the effect of 
individual components may suffice, especially for fully hydrated mesophases. Commercially 
available crystallization screens, however, contain components that may partition between the 
aqueous compartments and the bilayers of the mesophase, significantly complicating the phase 
behavior. Phase types and lattice parameters of lipidic mesophases in these systems may be 
expected to depend strongly on the amount of excess precipitant in the mixture, further 
necessitating experimental studies of the phase behavior to assess compatibility of crystallization 
screens. 
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2.5  Conclusions 
We investigated the phase behavior of mesophases of MO mixed with additives 
frequently used for in meso membrane protein crystallization, namely, sodium and potassium 
phosphate salts and the detergent -octylglucoside. The compositions of mixtures were selected 
to closely resemble conditions during membrane protein crystallization in meso: OG/MO and 
salt/water ratios were kept constant, while varying the hydration level (the weight fraction of the 
salt solution in the mixture) in the mixture. MO mixtures with salt solutions without detergent 
under conditions of excess aqueous phase were also studied.  
Quaternary MO/OG/water/phosphate salt mesophases studied here exhibited a 
remarkably regular behavior with a sequence of phases tracing that of MO/water mesophases as 
a function of aqueous solution content. Locations of phase boundaries and values of lattice 
parameters both above and below the hydration boundary shifted in agreement with previously 
established effects of detergents and phosphate salts on the microstructure of MO mesophases. 
At the same time, quantitative effects of each additive (detergents or phosphate salts) on lattice 
parameters in fully hydrated mesophases in the quaternary systems differed from those estimated 
from data for ternary MO/water/additive systems, making a priori quantitative predictions of 
lattice parameters in crystallization mixtures difficult. Additionally, we found evidence of re-
distribution of both types of additives between the mesophase and the aqueous solution, 
potentially causing significant changes in the compositional makeup of the mesophase, such as 
the OG/MO ratio and the salt concentration in the aqueous channels within the mesophase.   
In summary, our findings strongly suggest that compatibility of precipitants with cubic 
phase formation, a requirement for protein crystallogenesis in meso, must be probed under 
conditions of crystallization trials, i.e., with detergent present in the mixture, and with a large 
amount of precipitant. Exact amount of precipitant in the mixture may be expected to be of 
special importance for precipitants containing small molecules that may partition between 
aqueous and lipidic environments. Even if the propensity of MO mesophases for the formation of 
persistent metastable phases is ignored, the multitude of detergents and precipitants available, as 
well as the lack of fine control over detergent concentrations in protein solutions used for 
crystallization, make the parameter space enormous. Recent developments47,48 in the high-
throughput SAXS analysis of lipidic mesophases may aid greatly in these studies. 
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Chapter 3. 
An X-ray transparent microfluidic platform for 
screening of the phase behavior of lipidic mesophases1 
Abstract 
This chapter describes a microfluidic platform that enables the formulation of highly viscous 
lipidic mesophases and the subsequent probing of their phase behavior with small-angle X-ray 
scattering (SAXS). The X-ray compatible platform is comprised of thin polydimethylsiloxane 
(PDMS) layers sandwiched between cyclic olefin copolymer (COC) sheets for a total thickness 
of 220 µm. The mesophases are formulated on-chip by mixing lipid with aqueous solutions using 
less than 40 nL of each material per sample, which is a significant reduction from the microliter-
scale necessary when using the current standard for sample preparation, a coupled-syringe mixer. 
To prepare uniform mesophases, an active on-chip mixing strategy is employed, coupled with 
periodic cooling of the sample to reduce the viscosity. The platform was validated by preparing 
and analyzing mesophases of lipid monoolein (MO) mixed with aqueous solutions of different 
concentrations of β-octylglucoside (βOG), a detergent frequently used in membrane protein 
crystallization. Four samples were prepared in parallel on chip, by first metering and 
automatically diluting βOG to obtain detergent solutions of different concentration, then 
metering MO, and then mixing by actuation of pneumatic valves. Integration of detergent 
dilution and subsequent mixing significantly reduces the number of manual steps needed for 
sample preparation. SAXS data revealed three different types of mesophases on-chip. 
Furthermore, identical samples formulated on different chips exhibited excellent agreement in 
microstructural parameters. Similarly, phase behavior observed on-chip corresponded well with 
that observed for 300-fold larger samples prepared via the traditional coupled-syringe method 
(“off-chip”), further validating the utility of the microfluidic platform for on-chip 
characterization of mesophase behavior.   
                                                 
1 Part of the work presented in this chapter has been submitted for publication: D.S. Khvostichenko, E. 
Kondrashkina, S.L. Perry, A.S. Pawate, K. Brister, P.J.A. Kenis. “An X-ray transparent microfluidic platform for 
screening of the phase behavior of lipidic mesophases”. D.S.K. designed and fabricated chips, formulated samples, 
collected and analyzed SAXS data. S.L.P. fabricated chips and collected SAXS data, A.S.P. collected SAXS data, 
E.K. and K.B. developed the setup for SAXS data collection. D.S.K. and P.J.A.K. wrote the manuscript. The figures 
shown here were created by D.S.K. with input from P.J.A.K. 
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3.1  Introduction 
Certain lipids, when mixed with water or aqueous solutions, self-assemble into lipidic 
mesophases whose structure consists of highly ordered arrangements of continuous lipidic 
bilayers interpenetrated with aqueous channels.1 The phase type, i.e., the arrangement of lipid 
bilayers, is highly sensitive to the composition of the mixture as well as temperature, and can be 
reliably identified from small-angle X-ray scattering (SAXS) data.2,3 Lipidic mesophases have 
been used in a number of applications such as drug delivery4 and biosensing.5 Most importantly, 
lipidic mesophases serve as matrices for stabilizing and crystallizing integral membrane proteins 
that are otherwise very difficult to handle, owing to their amphiphilic nature.3,6 In the in meso 
crystallization approach, membrane proteins are reconstituted into the lipid bilayers of the 
mesophase, which prevents the protein from unfolding. Crystallization is triggered by adding a 
multi-component precipitant solution, with protein crystals growing within the lipidic mesophase 
in a successful crystallization trial. To date the in meso method accounts for ~10% of all 
structures of membrane proteins available in the public domain.6 Among recent successes of the 
method are structures of the human β2 adrenergic receptor,7 the dopamine D3 receptor, 8 and the 
κ-opioid receptor.9 
The lipid most commonly used for in meso crystallization is monoolein (MO).3 Under 
crystallization-relevant conditions it usually forms three types of mesophases: lamellar phase Lα 
and two cubic phases of different symmetries referred to as Pn3m and Ia3d.10-15 The lamellar 
phase consists of stacks of lipid bilayers with one-dimensional spatial periodicity, whereas Pn3m 
and Ia3d phases contain curved lipid bilayers in complex geometries, are bicontinuous and 
periodic in three dimensions.2,10,11,16,17 
The type of mesophase is crucial for the success of crystallization trials as protein crystal 
growth has only been reported from bulk cubic phases.15,18 The components of the crystallization 
mixture affect phase behavior in a non-trivial way.19 In particular, detergents used to stabilize the 
protein prior to its incorporation in the mesophase have a profound effect on the phase behavior 
and tend to promote the formation of lamellar mesophases which are unsuitable for 
crystallization.13,14,20  
Exploration of phase diagrams to unravel trends in phase behavior requires preparation 
and analysis of a large number of samples, a highly arduous task. For lipidic mesophases the 
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situation is exacerbated by their high viscosity.21 In the state of the art procedure, each 
mesophase sample is prepared by mixing the lipid with water in a coupled-syringe mixer on a 
milligram (microliter) scale.3 The resulting mixture is then dispensed into a glass capillary for 
SAXS analysis.3 Recently, mixing of lipid and an aqueous component was automated in a 96-
well plate format,22 but still 30 µL of MO and solution had to be metered manually for each 
sample. While only 50 nL of mesophase is required for analysis in another recently published 
approach for high-throughput SAXS analysis of lipidic mesophases,23 the sample had to be 
formulated on a bulk scale in a coupled-syringe mixer and dispensed in small boluses using an 
expensive robotic system. Furthermore, the high-throughput SAXS methods reported to date23,24 
are limited to the formulation of lipidic mesophases in equilibrium with a large excess of 
aqueous solutions, excluding a large region of the phase space. 
Microfluidics offers the potential to automate metering and simultaneous preparation of 
multiple samples, making it very attractive for the studies of the phase behavior. Previously, a 
microfluidic platform capable of preparing uniformly mixed mesophases on a ~20 nL scale was 
demonstrated. The platform relied on an active mixing strategy,25 unlike a number of other 
microfluidic platforms reported for less challenging phase behavior studies.26-39 The chip was 
validated by the in meso crystallization of membrane protein bacteriorhodopsin. Microfluidic 
systems developed to date for phase behavior studies are only applicable to low-viscosity 
solutions and typically rely on phase transitions driven by composition changes due to diffusion 
of solutes,26,27,34-37 evaporation of water,29-33, and osmotic stress.38,39 Such platforms are not 
suitable for the formulation of viscous mesophases with strict pre-set ratios of volume or weight 
of components. Furthermore, platforms with integrated fluid handling capabilities are usually 
incompatible with advanced analytical techniques, including SAXS, due to signal attenuation 
caused by device materials.40 On the other hand, although X-ray transparent microfluidic devices 
are available, they lack (with a single exception41) sophisticated architecture needed for 
mesophase formulation on-chip. 
 The microfluidic platform reported here combines active mixing capabilities and X-ray 
transparency for the analysis of the phase behavior of lipidic mesophases. The platform is 
specifically designed to assess the effect of detergent on the phase behavior and is capable of 
simultaneously preparing four mesophase samples with different compositions using less than a 
total of 200 nL of detergent solution and lipid, which represents a 300-fold reduction compared 
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to the standard method. To demonstrate the utility of this platform we mapped a section of a 
phase diagram for MO mixed with solutions of β-octylglucoside (βOG), a detergent commonly 
used in the isolation and purification of membrane proteins.3,13 
 
3.2  Materials and methods 
3.2.1  Device fabrication 
Hybrid microfluidic chips consisted of a flat cyclic olefin copolymer (COC) top layer (4 
mil, 5013 or 6013, TOPAS Advanced Polymers), a thin PDMS (RTV 650, Momentive 
Performance Adhesives) control layer, a thin PDMS fluid layer, and a flat COC bottom substrate 
(Section 3.3.1, Figure 3.1). The patterned PDMS layers were fabricated using standard soft 
lithographic procedures42,43 as described below. Photoresist-on-silicon masters were created 
using SPR-220-7 photoresist (Shipley) for the fluid layer with the feature height of ~14 µm, and 
SU8-25 photoresist (Microchem) for the control layer with the feature height of ~25 µm. Positive 
photoresist was reflowed by heating at 120 °C for 2 min to ensure complete closure of channels 
upon valve actuation.42,43 PDMS control layers were prepared by spin-coating PDMS with the 
monomer : cross-linker ratio of 12:1 followed by curing at 90 °C for 7-9 min to obtain a 45 µm-
thick film. PDMS fluid layers were prepared by spin-coating PDMS with the monomer : cross-
linker ratio of 5:1 followed by curing at 80 °C for 3 min to obtain a 25 µm-thick film. 
COC sheets were flattened between glass slides at 177 °C and a load of 150-200 kg in a 
laminating press (Carver, Model 3851) prior to use to obtain sheets with smooth surface. A 
PDMS block with the thickness of 4-7 mm was bonded in the inlet area. PDMS-to-PDMS 
bonding was done using the standard multilayer soft lithography method43 by placing layers of 
PDMS with different monomer : cross-linker ratios in conformal contact and heating them at 70 
°C for 2 hrs. All PDMS-to-COC bonding was achieved using amine/epoxy chemistry as reported 
by Tang and Lee44 using 3-aminopropyltrimethoxysilane (Sigma-Aldrich, >97%) and 3-
glycidyloxypropyltrimethoxysilane (GPTMS, Sigma-Aldrich, 98%). 
The chips were assembled as follows: (i) inlet holes were drilled in the thick PDMS block 
and in the top COC sheet using a 750 μm drill bit; (ii) the PDMS block was bonded to the top 
COC layer; (iii) the PDMS-COC assembly was bonded to the PDMS control layer; (iv) the 
resulting PDMS-COC-PDMS assembly was bonded to the PDMS fluid layer; and (v) the 
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assembled chip was bonded to the bottom COC substrate and kept at 70 °C for 1 hour to 
facilitate bonding. To prevent permanent closure of normally-closed valves in the final 
permanent bonding step, the corresponding control lines were actuated using a vacuum pump 
prior to bringing the two parts of the device in contact, and remained actuated at all times until 
the water-rinse step. After at least 3 hours, the fluid layer was filled with a solution of 1M TRIS 
buffer, pH 8.0, to neutralize remaining active epoxy groups of the GPTMS layer on the inner 
surface of fluid channels and chambers. After at least 1 hour the fluid layer was rinsed with 
deionised water and dried with nitrogen gas.  
 
3.2.2  Device operation 
During filling and mixing, microfluidic devices were monitored using an upright 
microscope (Leica MDG33) equipped with a macro lens and a digital camera (Leica DFC295). 
Prior to filling and mixing operations, fluid-routing control lines (Chapter 3.3.1, Figure 
3.1a) were filled with Fluorinert FC-40 (3M) to prevent gas leakage from the control layer 
through valve membranes to the fluid layer and subsequent bubble formation in the samples. 
For pneumatic actuation we used a 32-line solenoid valve manifold (Fluidigm). The 
pressure in the manifold and the sequence of valve actuations were controlled by Genie V2 
software (Fluidigm). The dead-ended fluid chambers were filled with samples by applying a 
pressure of 5.5 psi to the filling fluid to displace air from the chambers. Pressure of 22.5 psi was 
used to actuate fluid-routing valves. Pressure of 13-17 psi was used to actuate injection valves 
over the mixer chambers (Chapter 3.3.1, Figure 3.1a) during mixing steps. During mixing, an 
alternating series of forward and reverse sequences of lipidic mixer valve actuations44 was used 
to avoid formation of stagnation zones in the chambers. 
 
3.2.3  Chamber volume measurements 
To determine the ratio of volumes for the aqueous and lipidic components of the 
mesophase, we measured the ratio of fluorescent intensities of the two small chambers and the 
large chamber of the lipidic mixer filled with the same solution of a fluorophore. The chambers 
were filled with a saturated solution of fluorescein (Acros Organics) in deionised water under the 
pressure of 5.5 psi, and the isolation valves were closed without releasing the pressure from the 
fluid lines. Inter-chamber isolation valves were closed during filling to simulate formulation 
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conditions of lipidic mesophases. Fluorescent images were collected with a Leica N PLAN 2.5× 
(0.07 NA) objective on a Leica DMI 4000B microscope equipped with a xenon lamp. All images 
were collected with a charge-coupled device camera (Hamamatsu ORCA-ER, Model C4742-80). 
Images were processed using the ImageJ program (v. 1.46i, Wayne Rasband, NIH, USA) by 
performing a background correction and a flatfield correction. The ratio of volumes of the lipid 
compartment and the aqueous solution compartment was calculated as the ratio of cumulative 
fluorescent intensities of respective chambers after corrections, resulting in the value of 55 (lipid) 
: 45 (aqueous solution) v/v. Because the illumination intensity in the original images was visibly 
non-uniform, we tested the accuracy of the intensity correction procedure by analyzing two 
photographs of the same mixer that differed with respect to the orientation of the mixer in the 
field of view (180° rotation in one image with respect to the other). After background and 
flatfield correction, the calculated ratio of intensities of the chambers in the two images differed 
by less than 0.5%, confirming the validity of our analysis. 
 
3.2.4  Sample preparation 
MO (Sigma Aldrich, 99%) was used as received. A 20% v/w βOG (Anatrace, Anagrade) 
solution in 25 mM NaH2PO4, pH 5.5 was diluted volumetrically with a detergent-fee solution of 
25 mM NaH2PO4, pH 5.5, to obtain solutions with concentrations of 5% v/w and 10% v/w of 
βOG. NaH2PO4 was obtained from EMD Chemicals. Several drops of red food coloring solution 
(McCormick) were added to the 25 mM NaH2PO4, pH 5.5 buffer solution without detergent for 
visualization used for the preparation of on-chip samples. We established that addition of the 
food coloring did not affect the phase behavior of MO mesophases. 
On-chip samples were prepared 1-4 days prior to the measurements. After preparation, 
the fluid layer inlets were sealed with Crystal Clear Tape (Hampton Research) and devices were 
stored at -80 °C to avoid water evaporation. Prior to measurements, the samples were defrosted, 
and held at data collection temperature (25 ± 0.5 °C) for at least 2 hours. 
Samples prepared using coupled-syringe mixers were formulated gravimetrically for a 
total sample amount of 30-40 mg. Although samples on-chip were metered by volume, weight 
and volume compositions are nearly identical because densities of both MO and βOG solutions 
are very close to 1 g/mL.45-47 Each sample was dispensed into four thin-walled 0.9 mm glass 
capillaries (Charles Supper), and sealed with CritoSeal (Leica Microsystems) and QuickSet 
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Epoxy (Henkel Co.). The capillaries were stored at -80 °C and allowed to equilibrate at data 
collection temperature (25 ± 0.5 °C) for at least 2 hours prior to measurements.  
 
3.2.5  SAXS data collection 
SAXS data collection was performed on protein crystallography beamline LS-CAT 21-
ID-D at Advanced Photon Source (APS), Argonne National Lab. The beamline was equipped 
with a microdiffractometer (MAATEL MD2) consisting of a goniometer, XYZ micropositioner 
and an on-axis video microscope. For SAXS measurements, a vacuum flight tube and an 
adjustable beam stop with an incorporated pin-diode were installed between the sample and the 
CCD detector (Rayonix MX300). A detailed description of the setup is reported elsewhere.24 The 
position of the sample in the X-ray beam was monitored using the video microscope; the 
microfluidic chip was translated relative to the beam using the XYZ micropositioner. The 
footprint of the X-ray beam was 20 µm. The beam energy was 8 keV. Attenuation of the incident 
X-ray beam and exposure time were optimized to achieve highest signal-to-noise ratio while 
avoiding radiation damage.12,48 
Data were collected in a grid of points spaced approximately 250 µm apart, with 3 rows 
(along the long dimension of the chamber) of 8 points each in central chambers, and 2 rows of 6 
points each in side chambers of each lipidic mixer. 
 
3.2.6  SAXS data processing 
Raw diffractograms were integrated in Fit2D software (v. 12.077, A. P. Hammersley, 
ESRF, 1994). Because the diffractograms for different points within a single sample chamber 
differed negligibly with respect to peak positions, indicating identical sample properties 
throughout the chamber, for further analysis we used a sum of all diffractograms corresponding 
to a given chamber to obtain a higher signal/noise ratio. Integrated diffractograms were 
processed in MATLAB (R2008a, v. 7.6.0.324, The MathWorks Inc., Natick, MA). Publicly 
available MATLAB code (findpeaks.m, T.C. O’Haver, v2, revised Oct 27, 2006) was used to 
locate peak center positions. A series of MATLAB scripts was developed for baseline correction, 
and phase assignment for integrated diffractograms. Accuracy of all phase assignments was 
verified manually. Mesophases were identified based on characteristic sets of reflections and 
lattice parameters were calculated using the peak position of the highest-intensity reflection for a 
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given mesophase (Appendix A). Relative amounts of mesophases were calculated based on the 
intensity of the highest-intensity reflection for each phase type (Chapter 3.2.7). 
In calculating the average lattice parameters and relative amounts of each mesophase, the 
end points of each row of datapoints were excluded to avoid artifacts related to cross-talk 
between sample compartments and fluidic lines. We also noticed systematic differences within a 
given mixer (sample) between lattice parameters of samples in side chambers closest to the edges 
of the device and the other two chambers of the mixer. The lattice parameters of samples in outer 
chambers were smaller than the lattice parameters of central mixer chambers and side mixer 
chambers facing the center of the device, likely due to adsorption of water into PDMS. Thus, 
data points corresponding to outer chambers of mixers were also excluded in the averaging of 
lattice parameters and relative amounts of mesophases. We did not observe any systematic 
differences between the lattice parameters of samples in the central chamber of the mixer and the 
side chamber facing the center of the device in a given mixer. 
 
3.2.7  Estimating relative amounts of mesophases 
Amounts of mesophases in each sample were estimated based on the intensity of the most 
prominent reflection dmax of a given mesophase (d1 for Lα, d111 for Ia3d, d110 for Pn3m). Raw 
diffractograms were integrated from θ = 0 to θ = 4° in 0.001333°  increments for a total of 3000 
points for each integrated diffractogram. The scattering vector q reported in Figures 3.4-3.7 is 
related to the scattering angle θ as  /sin4q . 
The intensity corresponding to a given phase maxphaseI  was read from the diffractogram 
based on the value of lattice parameter in the phase assignment: 

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
 maxmaxmaxmax 2
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    Equation 3.1 
 
)( max
max corrphase II       Equation 3.2 
where a is the lattice parameter of a given phase, hmax, kmax, and lmax are the hkl indices of a 
highest-intensity reflection of a given phase, λ is the wavelength of the incident X-ray beam, 
corrI  is the intensity of the diffractogram after baseline correction to account for scattering 
around the beamstop, which is comparable in the intensity to the intensity of the sample (Chapter 
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3.3.5, Figures 3.4, 3.6, and 3.7).  
Fluctuations of beam intensity during data collection, typical for synchrotron X-ray 
sources, could result in variations in signal intensity from otherwise identical samples. To 
crudely account for the fluctuations, we used the scattering intensity around the beamstop, free 
from hkl reflections, as a measure of beam intensity for each diffractogram: 
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 Equation 3.3 
where n(θ) is the number of data point in the diffraction angle – diffraction intensity array 
corresponding to a given value of θ. For the calculations of sample composition the beam 
intensity-adjusted value of sample intensity was used: 
beam
phaseadj
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I
I
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       Equation 3.4. 
A value of standard signal intensity stdphaseI  was calculated for each mesophase type. This value 
corresponds to a sample containing a given phase type only, i.e., 100% of Pn3m, Ia3d, or Lα. For 
Ia3d and Lα phases available data points containing a single mesophase type were used to 
estimate the average “unit” signal intensity corresponding to 100% of a given phase type in the 
sample  
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where j spans only diffractograms containing solely a given mesophase type and jphase_only is the 
number of such diffractograms for a given phase type. For the Pn3m mesophase no such data 
were available because it was always observed together with at least one other phase. We used 
the model of Garstecki and Holyst49,50 for scattering patterns of cubic phases to estimate the unit 
signal intensity for the Pn3m phase. In the model the intensity modhklI  of a given hkl reflection of a 
mesophase is given by 
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where L is the lipid bilayer thickness in the mesophase and parameters *ShklF , hkl , and hklM  are 
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constants for a given phase type and hkl reflection, given by Garstecki and Holyst.50 Reflections 
110 and 111 for Pn3m and Ia3d phases, respectively, were used to obtain diffraction signal 
intensity. Hence, the unit signal intensity for the Pn3m phase can be estimated as 
mod
3,110mod
3,111
3
3 mPn
dIa
std
dIastd
mPn II
II      Equation 3.7 
In the calculations of modhklI  the value of the bilayer thickness L = 34.6 Å was selected based on 
the correlation for MO/water mesophases by Briggs et al.;10 the value does not change 
appreciably when detergent is added.51 Values of lattice parameters used in the calculation were 
a(Pn3m) = 148 Å, a(Ia3d) = 180 Å.  
Finally, for each lipidic mixer the average intensity of a given phase in the mixer is 
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where j spans the diffractograms in the mixer that contain a given mesophase type and jphase_mixer 
is the number such diffractograms for a given mixer. The average amount of the mesophase 
mixer
phasev  in the mixer is then  
std
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I
I
v        Equation 3.9. 
Ideally, the sum of values of v for different phases in the mixer must add up to unity. However, 
this was not the case here because certain parameters, such as the thickness of the sample and the 
beam intensity could not be controlled precisely during data collection. Therefore, the data were 
additionally rescaled: 
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If a certain phase type was absent in the mixer, the corresponding value of v was set to 0. Values 
of ϕ are reported in Figure 3.8 (Section 3.3.5). Based on the non-uniformity of signal intensities 
for Lα phases we estimate the relative error of ±20% in the calculations of ϕ. 
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3.3  Results and discussion 
The microfluidic platform developed here is capable of screening the phase behavior of 
lipidic mesophases by simultaneously preparing samples of different composition from only 
three stock solutions. The platform formulates mesophases by mixing a lipid with detergent 
solutions. For all on-chip samples the lipid/solution ratio is kept constant while the detergent 
concentration in solution is varied for different samples via automatic on-chip dilution. This 
situation where lipid/solution ratio is constant, but the detergent concentration varies is typical of 
membrane protein crystallization trials. These trials typically follow the same protocol for 
mesophase formulation, but have a poor control of the detergent concentration from one batch of 
protein solution to another.3,15 
 
3.3.1  Chip fabrication 
The microfluidic platform fabricated here met the two main requirements for the 
preparation and analysis of lipidic mesophases: (i) active mixing capabilities and (ii) X-ray 
transparency. The platform was fabricated using soft lithography methods with several 
modifications (see Section 3.2.1). 
To retain mixing capabilities while ensuring X-ray transparency, only thin PDMS control 
and fluid layers were retained in the device. The PDMS layers were sandwiched between thin 
COC layers that provided rigidity and served as a barrier for water evaporation (Figure 3.1c). 
The overall thickness of the device was ~220 µm, significantly smaller compared to traditional 
PDMS-on-glass microfluidic devices. The nominal height of sample compartments was ~15 µm, 
and the cumulative thickness of PDMS and COC layers above and below sample compartment 
was 180 µm. All layers were irreversibly bonded to each other, as required for active mixing. 
 
3.3.2  Chip design 
The chip is designed to screen the effect of an additive such as detergent on the phase 
behavior of lipidic mesophases. The chip is capable of preparing several different samples from 
just three stock solutions. Due to space constraints during X-ray data collection the size of the 
sample area was limited to 8 x 4 mm, and the overall size of the chip to 12 x 30 mm. Up to four 
sample preparation units could be incorporated per chip under those limitations (Figure 3.1a, b). 
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The same design principles can be used to scale out the number of samples per chip. 
The lipidic mixer was described in detail in our previous work.25 Briefly, the mixer 
consists of three chambers that are filled with desired materials and are connected with each 
other via short, narrow channels. Each mesophase sample was prepared in its own lipidic mixer 
by combining a lipid with detergent solutions. The central chambers of the mixers were 
designated for lipid, and the side chambers for detergent solution (Figure 3.1b). The lipid : 
solution ratio was thus fixed at 55 : 45 v/v, but the detergent concentration in solutions could be 
varied using round dilution chambers adjacent to the side chambers of respective mixers (Figures 
3.1b and 3.2a).  
 
Figure 3.1. (a) Superimposed control (orange, blue, red) and fluid (black) layers of the microfluidic platform for screening of 
lipid phase behavior. Circles at ends of lines designate the locations of inlet ports. Control layer: orange, normally open routing 
valves; red, normally closed routing valves; blue, injection valves. The inset shows the layout of fluid layer with compartment 
designations for the three components required for filling the chip: lipid (blue outline), detergent solution (red outline), and 
diluent for detergent solution (purple outline). (b) Schematic of the layers that comprise the thin part of the chip. (c) Photograph 
of an assembled chip mounted for SAXS data collection. Sample compartments are located in the thin part of the chip, with the 
fluid and control layer inlets connected via the thick PDMS block. 
For fluid routing during filling and mixing, the platform relied on normally open valves 
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that were controlled pneumatically. To minimize the number of control lines each set of valves 
performing identical functions was connected using a single control line (Figure 3.1a). 
Additionally, normally closed valves52 were incorporated at the inlets of all lipidic mixer 
chambers to minimize cross-talk during X-ray data collection when pneumatic actuation was not 
possible. 
 
3.3.3  Chip operation: filling and metering 
 
Figure 3.2. On-chip sample formulation. (a) Optical micrograph of a chip filled with solutions of food coloring to illustrate the 
composition of samples formulated on-chip. Blue color represents lipid; green, concentrated detergent solution; red, diluent for 
detergent solution. (b) Optical micrograph of a chip filled with components for mesophase preparation. Lipid: MO (colorless); 
concentrated detergent solution: 20% βOG in 25 mM NaH2PO4, pH 5.5 (colorless); diluent: 25 mM NaH2PO4, pH 5.5 (red). 
(c1-c4) Sample formulation protocol. Arrows indicate the direction of fluid movement. (c1) Central chamber of the mixer is filled 
with lipid (blue). (c2) Auxiliary round dilution chambers are filled with a diluent for detergent solution (red). (c3) Diluent is 
transferred into side chambers of the mixer by actuating injection valves on top of the round chambers. (c4) Side chambers are 
filled to volume with concentrated detergent solution (green). Scale bar: 1 mm. 
The typical filling protocol is illustrated in Figure 3.2(c1)-2(c4). Central chambers of the 
mixer were filled with lipid, Figure 3.2(c1). To control the dilution of the detergent solution, the 
round chambers were filled with a diluent, Figure 3.2(c2) which was then transferred to adjacent 
chambers of lipidic mixers by actuating valve membranes on top of the round chambers, Figure 
3.2(c3). The partially filled chambers of lipidic mixers were then filled to volume with a 
concentrated detergent solution through a separate fluid line, Figure 3.2(c4). In this step the 
78 
 
small amount of diluent remaining in the round chambers was also moved to the lipidic mixer 
chambers by the flow of the detergent solution. 
All chambers, including round dilution chambers, were dead-ended and filling was 
carried out by pushing the filling fluid into the chambers and slowly displacing the air under the 
pressure of 5.5 psi. The inlet valves for each chamber of the mixer were closed without releasing 
the pressure from the fluidic lines. The applied pressure causes tenting of the valve membranes 
on top of each lipidic mixer chamber, thus altering the volume of each chamber from the 
originally specified design. The ratio of chamber volumes estimated from fluorescent intensity 
measurements was 55 (lipid) : 45 (solution) v/v, which deviated from the chamber footprint ratio 
of 1:1 v/v, presumably due to the tenting. We believe that releasing the pressure would have 
resulted in less accurate and reproducible metering due to uncontrollable sagging of valve 
membranes. The accuracy of our metering method is corroborated by the excellent agreement of 
SAXS data between different chips. The chip required a total volume of ~200 nL of each 
material (lipid, detergent solution, diluent) for filling, a 300-fold reduction compared to 
preparing four samples in coupled syringes. 
The nominal chamber volume calculated based on the footprint of the chamber and the 
height of photoresist was 13.2 nL for lipid chambers and 13.7 nL for detergent solution 
chambers. However, the actual volume was probably larger due to the membrane tenting 
described above, but should not exceed 36.8 nL and 38.2 nL for lipid and detergent solution 
chambers, respectively, as estimated from the footprint of the chambers and the sum of heights 
of chambers in the fluid and the control layer. 
 
3.3.4  Chip operation: mixing 
Mixing was achieved by pneumatic actuation of injection valves located over each 
chamber. These valves drive the fluid from one chamber to another (Figure 3.1a). The valve 
actuation sequence used in this work was identical to that used for the original lipidic mixer as 
described previously25 along with the mechanisms governing the mixing process. In the mixing 
tests here we established that solutions which resulted in lamellar phases were easily mixed and 
routed in the mixer. Cubic phases, however, could not be manipulated once formed, leading to 
partially mixed, non-uniform samples (Figure 3.3a). To circumvent this problem, we exploited 
the phase behavior of lipidic mesophases, which are known for their propensity to form lamellar 
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phases when cooled. Cooling was achieved by placing a piece of dry ice on the device to let the 
sample material freeze, inducing a cubic-to-lamellar phase transition. Active mixing was started 
as soon as the material thawed and was carried out for 1-2 min, after which the freeze-thaw-
mixcycle was repeated. Because the chips were thin, freezing and thawing itself took under 1 
min. Uniformly mixed lamellar samples were obtained after 5-7 cycles (Figure 3.3b). Although 
only tested for MO mesophases here, this strategy should be applicable to other 
monoacylglycerols, especially when mixed with detergent solutions, because formation of 
lamellar phases in a wide range of compositions at low temperatures is a general trend in their 
phase behavior.13,14,53 
 
Figure 3.3. Optical micrographs of mesophase samples during mixing. (a) Non-uniform mixtures of cubic (light) and lamellar 
(dark) mesophases at ambient temperature. (b) Fully mixed mesophases after several freeze-thaw-mix cycles; the dark color 
indicates a predominantly lamellar state in all mixers. (c) Samples from (b) after 30 min at 23 °C. Changes in the appearance of 
the samples indicate a phase transition from a lamellar phase to cubic phases. (d) Same as panel (c), under cross-polarized light. 
Numbers indicate initial βOG concentrations in aqueous compartments and are the same for all panels. Scale bar: 1 mm. 
The uniformly lamellar state did not represent the equilibrium phase behavior of our 
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mesophase samples at ambient temperature. After letting the samples rest at room temperature, 
we observed changes in sample appearance indicative of phase transitions (Figure 3.3c, d). The 
mesophases samples with the two lowest detergent concentrations appeared predominantly 
cubic, and the ones with higher detergent concentrations appeared predominantly lamellar. Note 
that the occurrence of interspersed lamellar and cubic regions seen, for example, in the sample 
on the bottom left in Figure 3.3d does not suggest poor mixing of the samples. Regions of 
equilibrium phase coexistence are found in MO/water systems with13,14 and without10,11 
detergent, depending on the composition. 
Because SAXS analysis could not be carried out immediately after preparation, all chips 
were frozen using dry ice with all chamber inlet valves in an actuated state to minimize 
evaporation of water from the samples. Since the control lines were filled with a fluid, the 
samples remained sealed in their respective compartments during storage. The samples were 
transferred to a freezer without defrosting and were stored at -80 °C for 1-3 days prior to the 
measurements. 
Prior to SAXS analysis, the samples were allowed to equilibrate at the data collection 
temperature (25 ± 1 °C) for 2 hours. At first we observed chaotic fluid movement during 
defrosting of the sample that was sufficiently powerful to cause failure of normally closed valves 
at chamber inlets. To avoid this, the respective control lines were actuated at a pressure of 30 psi 
during sample defrosting and equilibration. The lines were disconnected from the pressure 
source immediately prior to measurements. This type of fluid motion did not take place upon 
freezing/defrosting during sample formulation, and the quality of the samples was not 
compromised in that step. 
 
3.3.5  Analysis of the phase behavior of mesophases 
A high-intensity X-ray source was required for the analysis of on-chip mesophase 
samples because of their small path length. SAXS data collection was performed at beamline 21-
ID-D, of the Advanced Photon Source at Argonne National Lab. 48 locations were probed within 
each sample (lipidic mixer) using a 20 µm X-ray beam. An XY-positioner was used to move the 
chip in the X-ray beam; and exact beam position was monitored in an on-axis video microscope 
(Figure 3.4a). Although only a small part of the device was visible in the microscope, the beam 
position could be easily mapped to the location within the chip (Figure 3.4a). 
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Figure 3.4. (a) Section of sample compartment seen in the on-axis video microscope during SAXS data collection (top) and the 
corresponding sample location (bottom). The bright dot in the center of the top image corresponds to the footprint of the X-ray 
beam, 20 µm. (b, c) Comparison of diffraction patterns for samples on-chip and in glass capillaries. Composition of both 
samples: MO/detergent solution ratio 55:45 v/v; detergent solution: 5% βOG in 25 mM NaH2PO4, pH 5.5. (b) Raw diffractogram 
of a 15-µm thick on-chip sample and a corresponding integrated diffractogram with peak assignments for prominent reflections. 
The inset shows a magnified view of higher-order hkl reflections from the Ia3d phase. Lattice parameters: Ia3d, 180 Å, and Lα, 
48.9 Å. (c) Raw diffractogram of a ~0.9 mm-thick sample in a glass capillary and a corresponding integrated diffractogram with 
peak assignments for the most prominent reflections. The inset shows a magnified view of higher-order hkl reflections from the 
Ia3d phase. Lattice parameters: Ia3d, 177 Å, and Lα, 48.7 Å 
Phase type identification. Comparison of data for samples prepared and analyzed on-
chip to those prepared using the standard method (mixing in coupled syringes, analysis in glass 
capillaries) showed that the microfluidic platform reported here is suitable for the analysis of the 
nanostructure of lipidic mesophases (Figures 3.4b, c). Integrated diffraction patterns (Figure 
3.4b, c) and, consequently, the structural characteristics, were very similar for the two samples 
that had near-identical compositions. The main differences between the two types of samples 
were the significant background in the on-chip data in the range of q values under ~0.06 Å-1 and 
the higher signal/noise ratio for samples in capillaries than on-chip. We established that the 
background was predominantly due to scattering from PDMS present in array chips because the 
scattering from the COC films was comparable to that from air (Figure 3.5). The differences in 
signal/noise ratio are not unexpected given an up to 60-fold smaller sample path length on-chip 
and a significantly larger thickness, with 180 µm of PDMS and COC in the beam path, compared 
to X-ray glass capillaries with 10 µm-thick walls. The higher signal/noise ratio of samples in 
capillaries compared to on-chip samples is especially evident in the appearance of higher-hkl 
reflections of the Ia3d phase (insets in Figures 3.4b and 3.4c). However, signal intensity in the  
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Figure 3.5. Normalized scattering intensity for COC films, an empty array chip, and air as a function of scattering vector q. The 
array chip consists of two COC films with respective thicknesses of 100 and 50 µm and two PDMS films with the combined 
thickness of 70 µm.  
 
Figure 3.6. (a) A diffraction pattern of a sample containing Pn3m and Lα phases in a glass capillary collected after 2-hr 
equilibration at 25 °C and (b) a magnified view of Pn3m reflections.  Sample composition: MO/detergent solution ratio 55:45 
w/w; detergent solution: 10% βOG in 25 mM NaH2PO4, pH 5.5. Lattice parameters of mesophases: Pn3m, 174 Å; Lα, 50.1 Å. 
 
Figure 3.7. (a) A diffraction pattern of a sample containing Pn3m and Lα phases in a glass capillary collected after 24-hr 
equilibration at 25 oC and (b) magnified view of Pn3m reflections. Sample thickness ~0.9 mm. Sample composition: 
MO/detergent solution ratio 55:45 w/w; detergent solution: 10% βOG in 25 mM NaH2PO4, pH 5.5. Lattice parameters of 
mesophases: Pn3m, 150 Å; Lα, 50.0 Å. 
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on-chip data was sufficient for identifying the types of lipidic mesophases present in these 
samples. For example, both samples in Figure 3.4 contained a mixture of the Ia3d cubic phase 
and a lamellar Lα phase in equilibrium coexistence. Table 3.1 summarizes the phase assignments 
and lattice parameters of all on-chip samples tested in this work. Examples of diffractograms of 
samples containing mixtures of Pn3m and Lα phases are shown in Figures 3.6 and 3.7. Here the 
difference in background scattering between the capillaries appears not as pronounced as for 
diffractograms presented in Figure 3.4 due to the domination of the signal from the Lα phase in 
the diffractograms. 
Another noticeable difference was the presence of spotty rings in the raw diffraction 
pattern of the on-chip samples (Figure 3.4b) compared to mostly uniform rings of the sample in a 
capillary (Figure 3.4c). The spottiness is the result of the path length of the on-chip sample being 
of comparable size to the monocrystalline domains of the mesophase (up to 50 µm for cubic 
phases).12 The few monocrystalline domains in the X-ray beam path in a microfluidic device are 
insufficient to produce uniform diffraction rings, which require the presence of a large number of 
randomly oriented domains. Similar spotty patterns can also be observed for samples in 
capillaries if they are allowed to mature for several days. 
Trends in phase behavior of lipidic mesophases. Figure 3.8 shows relative amounts of 
various phase types identified for identical samples in four different chips. The excellent 
reproducibility of the phase behavior data between different devices illustrates the robustness of 
the microfluidic platform reported here. The phase type, the lattice parameters, and the relative 
amount of phases agree well between different chips, indicating the accuracy of on-chip metering 
to formulate samples with identical compositions. 
At the lowest βOG concentration tested in this work w predominantly Ia3d cubic phases 
were observed. As the amount of detergent increased the following was observed: (i) increasing 
amounts of the Lα phase; (ii) replacement of the Ia3d cubic phase with the Pn3m cubic phase; 
and (iii) increasing amount of Lα phase at the expense of the Pn3m cubic phase. These trends in 
phase behavior as a function of detergent concentration result from the flattening of lipid bilayers 
upon increasing the MO : detergent ratio due to the difference in their molecular shapes. The 
trends are in general agreement with those reported for samples prepared with the standard 
method.13,14,54,55 
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Table 3.1. Average lattice parameters and standard deviations (in Å) of mesophases at 25 ± 1 °C in samples 
prepared and analyzed on-chip and in samples prepared using coupled syringes and analyzed in glass capillaries. 
Chips A-D are the same as those in Figure 3.8. 
 Sample composition 
 MO / 5% βOG 55:45 v/v 
MO / 6.7% βOG 
55:45 v/v 
MO / 8.3% βOG 
55:45 v/v 
MO / 10% βOG 
55:45 v/v 
 Detergent solutions and mesophases formulated on-chip a 
 Pn3m Ia3d Lαb Pn3m Ia3d Lαb Pn3m Ia3d Lαb Pn3m Ia3d Lαb 
Chip A  182 ± 2   185 ± 3 49.2 136 ± 1 215 ± 12 49.9 144 ± 3  49.8 
Chip B  187 ± 3 49.1  183 ± 6 48.9 136 ± 1 190 49.7 146 ± 2  49.7 
Chip C  181 ± 2 48.9  198 ± 1 49.5 143 ± 3 191 49.9 144 ± 2  49.7 
Chip D  179 ± 1   193 ± 2 49.8 141 ± 2 215 ± 3 50.1 145 ± 2  50.0 
Detergent solutions formulated off-chip, mesophases formulated on-chip c 
Chip E  181 ± 2 48.6          
Chip F  182 ± 3 48.9          
Chip G          148 ± 3  49.8 
Chip H          148 ± 8  49.7 
Samples prepared in coupled syringes and analyzed in glass capillaries
CS-1  177 ± 2 48.4          
CS-2          173 ± 1  49.9 
a Lattice parameters were averaged for each of the four samples on-chip 
b Standard deviations of lattice parameters for Lα phases were <0.5 Å in all cases. 
c Four identical samples were prepared on a single chip. The reported value is the average for the four samples. 
 
 
Figure 3.8. Relative amounts of different phases in samples prepared and analyzed on-chip using four different microfluidic 
devices at 25 ± 1 °C. The amount of each phase was estimated from intensities of corresponding reflections in SAXS 
diffractograms. Relative amounts were obtained by normalizing data for each sample to yield the combined amount of all phases 
of 100%. 
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Lattice parameters of mesophases. The lattice parameters of the lipidic mesophases 
established for samples on-chip and in capillaries are reported in Table 3.1. The lattice 
parameters of cubic phases are highly sensitive to their composition and are highly important for 
understanding the properties that govern phase transformations as well as for assessing the 
suitability of certain mesophases for applications such as membrane protein crystallization or 
drug delivery. To assess the accuracy of metering on-chip we prepared a set of samples where 
detergent solution was diluted off-chip on a milliliter scale, and then formulated samples on-chip 
without dilution, i.e., skipping steps c2 and c3 in Figure 3.2. The results for samples prepared 
with 5% βOG solution and 10% βOG solution are also presented in Table 3.1. Lattice parameters 
of both Pn3m and Ia3d cubic phases are identical for samples prepared with and without on-chip 
dilutions, verifying the metering accuracy of the microfluidic platform and the filling method. 
Lattice parameters: comparison of on-chip and the standard method. To benchmark 
data on mesophase microstructure obtained from on-chip samples, we prepared identical 
mesophase samples of MO mixed with 5% or 10% βOG solution (MO : solution ratio 55:45 
w/w) using the standard method. The samples were prepared gravimetrically on a milligram 
(microliter) scale in a coupled-syringe mixer, followed by dispensing into 0.9 mm glass 
capillaries and SAXS data collection.  
Table 3.1 shows phase assignments and corresponding lattice parameters obtained for 
samples in capillaries as well as from on-chip samples. Data of samples prepared with the 5% 
βOG solution are in excellent agreement with respect to phase types and lattice parameters. In 
the samples prepared with the 10% βOG solution, the phase types for the on-chip and 
macroscopic samples are the same, Pn3m and Lα, but the lattice parameters for the Pn3m phase 
are noticeably different, 144-148 Å on-chip vs. 173 Å off-chip. Here, the results likely illustrate 
the difficulty of reproducibly preparing and analyzing mesophase samples containing cubic 
phases with large lattice parameters observed previously. For example, Caffrey et al.14 reported 
that samples with putatively identical compositions of MO : water 60:40 w/w may result in either 
Pn3m or Ia3d phases. Similar phenomena were also observed for detergent-containing samples.14 
Batch-to-batch variations in the lattice parameter of MO mesophases have also been reported.13 
We established that the discrepancy between on-chip and macroscopic sample behavior observed 
here did not result from potential inaccuracies in the ratio of volumes of chambers. At the same 
time, the value of 173 Å is at variance with previously reported lattice parameters of Pn3m cubic 
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phases of MO mixed with detergent solutions,13,14,34 which typically do not exceed 135-145 Å 
under conditions similar to ours. 
To further clarify the origin of mesophase behavior, observed here, we performed a new 
SAXS measurement of samples containing MO and 10% βOG solution in the 55 : 45 w/w ratio 
after 24 hrs of storage at 23 °C. We observed changes in the lattice parameters of the Pn3m 
phase in the four sealed capillaries that initially contained identical samples dispensed from the 
same coupled-syringe mixer. All samples contained the Lα phase (48.9 - 49.1 Å) coexisting with 
the Pn3m phase. The lattice parameters of the Pn3m phase varied significantly between 
capillaries, with one at the original value of 173 Å, one sample at 152 Å, and two samples at 144 
Å. The likeliest cause of such changes is the minute loss of water from the samples in sealed 
capillaries, indicating a very strong dependence of the Pn3m lattice parameter on mesophase 
hydration. The latter may account for previous lack of observations of Pn3m phase with very 
large lattice parameters of over 170 Å, since consistent observations of such values require very 
fresh samples. Indeed, the values of lattice parameters in slightly dehydrated samples measured 
here, 144-152 Å, are much closer to those reported previously and to our on-chip data. Given the 
aforementioned difficulties, the excellent reproducibility of phase types and lattice parameters 
for the mesophase samples containing 10% βOG solution between different chips serves as a 
proof of the robustness of our platform and the validity of our results, even though the lattice 
parameters are only in qualitative agreement with the initial values for samples in capillaries. 
The good agreement between on-chip and macroscopic samples containing 5% βOG solution 
with respect to both phase types and lattice parameters also validates our approach. 
 
3.4  Conclusions 
The microfluidic platform presented here is, to our knowledge, the first example of a 
microfluidic device that combines metering and active mixing capabilities with X-ray 
transparency for on-chip SAXS analysis. The capabilities of the platform were demonstrated by 
mapping a section of the phase diagram of lipid MO mixed with solutions of detergent β-
octylglucoside of different detergent concentrations, mimicking conditions of membrane protein 
crystallization trials. Four samples with different compositions were simultaneously prepared on-
chip. Despite the very small thickness of the samples, 15-40 µm, the three phase types typical for 
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MO mesophases at ambient temperature could be distinguished from on-chip SAXS data. 
Analysis of SAXS data revealed excellent reproducibility of the phase types and lattice 
parameters of lipidic mesophases between different chips, confirming the high accuracy of 
sample formulation on-chip. Similarly, data from on-chip samples agree well with those for 
samples prepared using the standard method by mixing in coupled syringes. 
The platform developed here is a viable alternative to the standard method of sample 
preparation. The platform reduces the amount of material required for sample formulation and 
analysis 300-fold, which makes it a valuable tool for analyzing the suitability of scarcely 
available novel lipids for membrane protein crystallization. Design principles used in this work 
can be used to scale out the number of samples per chip. With small modifications the platform 
could also be used to screen the phase behavior of lipidic mesophases in a wide range of 
lipid/solution ratios in order to gain understanding of driving forces behind phase transitions in 
liquid crystalline systems. 
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Chapter 4. 
 X-ray transparent SlipChip for 
the studies of the phase behavior of lipidic mesophases  
Abstract 
This chapter describes an X-ray transparent SlipChip for the study of the phase behavior of 
lipidic mesophases in a wide range of hydration levels. The chip consists of two 150-250 µm-
thick sheets of cyclic olefin co-polymer (COC). A novel lipid-filling strategy was developed to 
overcome unfavorable capillary effects that render the original SlipChip filling approach 
unsuitable for amphiphilic materials. The geometry of the chambers facilitates passive mixing 
between the lipid and the aqueous solution. The chip requires less than 100 nL of lipid to map 
out the phase behavior of mesophases containing 0-30 or 35-60 vol% of aqueous solutions in 
increments of 5%, a 600-fold reduction compared to the traditional macroscale methods. Six 
samples with different aqueous solution content could be prepared simultaneously on-chip. 
Preliminary studies showed that different types of lipidic mesophases can be identified from 
SAXS data collected on-chip. Furthermore, the previously reported sequence of phases in 
monoolein/water and monoolein/β-octylglucoside/water systems at increasing hydration levels 
could be successfully reproduced on-chip.  
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4.1  Introduction 
Phase diagrams of lipidic mesophases are required to advance the understanding of 
fundamental principles that govern the self-assembly in natural and synthetic lipidic systems. In 
membrane protein crystallization, studies of phase behavior of novel lipids may facilitate 
discovery of new matrices for crystallization1-4 and improve the success rate of crystallization 
trials. Studies of phase diagrams require the preparation and analysis of a large number of 
samples with systematic variations in the composition, and a number of microfluidic platforms 
that automate sample formulation and reduce the amount of material for phase behavior studies 
have been developed.5-16 However, on-chip studies of lipidic mesophases present several 
challenges that are not addressed in reported platforms: (i) formulation of mesophases of well-
defined pre-set compositions, (ii) manipulation of viscous mesophases in microfluidic channels, 
and (iii) on-chip small-angle X-ray analysis for the unequivocal identification of mesophase 
microstructure. Only one example of a microfluidic platform suitable for the studies of lipidic 
mesophases has been demonstrated (Chapter 3), with multilayer polydimethylsiloxane 
architecture, valve-based fluid routing strategies, and active mixing of the aqueous solution with 
the lipid to formulate a uniformly mixed mesophase. While the platform was successfully used to 
map a section of a phase diagram for a mixture of lipid monoolein, detergent -octylglucoside 
(OG), and a phosphate buffer solution, its fabrication was rather complicated, and the mixing 
strategy for mesophase formulation required special equipment and software.  
 
Figure 4.1. Schematic representation of the operation of a SlipChip. The side view corresponds to the cross-section of the chip 
along the red dotted line. (Reproduced from W. Du, L. Li, K. P. Nichols and R. F. Ismagilov. Lab on a Chip, 2009, 9, 2286-2292, 
with permission from the Royal Society of Chemistry.) 
The elegant SlipChip approach demonstrated by Ismagilov et al.17,18 (Figure 4.1) 
circumvents the complex fabrication procedure and mesophase formulation protocol required in 
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the lipidic mixer array chip. Briefly, the SlipChip consists of two rigid glass plates with reagent 
chambers and ducts etched into both plates so that they form continuous fluidic paths upon 
alignment. Once the separate sample compartments are filled, the plates are slipped relative to 
each other, bringing solutions from chambers in the top and the bottom plates in contact. The 
composition of the sample is controlled by the volume of the chambers. During slipping, 
solutions are held in their respective chambers by interfacial tension forces.17-19 The interstitial 
space between the plates and the samples is typically filled with a fluorinated solvent to prevent 
cross-talk between the samples.17-19 Even though mixing in the SlipChip occurs predominantly 
by mutual diffusion of components, the large interfacial area defined by the lateral dimensions of 
the sample chambers greatly facilitates mixing compared to traditional microfluidic designs with 
two large chambers connected via a narrow channel.20-22 The SlipChip has been successfully 
used in a variety of applications, as crystallization of soluble proteins,23 immunoassays,24 and 
polymerase chain reaction.25 
The SlipChip may provide an attractive route for the preparation of lipidic mesophases 
with a large range of hydration levels, which is not feasible with existing macroscale platforms 
for high-throughput phase behavior studies.26,27 Compared to microfluidic chips with pneumatic 
valve actuation, the SlipChip is significantly easier to fabricate. Because of the passive mixing 
approach, mesophases do not need to be routed on-chip once formed, simplifying sample 
formulation protocol and avoiding the problem of manipulating cubic lipidic mesophases 
(Chapter 3.3.4). However, reported implementations of the SlipChip for various applications17-
19,24,25,28 rely on patterning of millimeter-thick glass slides and are incompatible with in situ X-
ray analysis. 
Here we present an X-ray transparent SlipChip for the analysis of the phase behavior of 
lipidic mesophases. For X-ray transparency the chip is fabricated by hot-embossing of 150-250 
µm-thick sheets of cyclic olefin co-polymer. In Chapter 4.2 we describe fabrication methods, 
Chapters 4.3.1 and 4.3.2 describe chip design and sample formulation strategies, and Chapter 
4.3.3 summarizes preliminary results of the analysis of the phase behavior of monoolein/water 
and monoolein/OG/water mesophases in the SlipChip.  
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4.2  Materials and methods 
4.2.1  SlipChip fabrication  
Fabrication of photoresist-on-silicon masters. Photoresist-on-silicon masters were 
created with AZ50XT positive photoresist (AZ Electronic Materials) for patterns with 25-50 µm-
tall rounded features and with SU8-25 negative photoresist for patterns with 25 µm-tall features 
with vertical walls. Patterned positive photoresist was reflowed at 115 °C for 45 s to achieve the 
rounded profile.29 All photoresist-on-silicon masters were treated with (tridecafluoro-1,1,2,2-
tetrahydrooctyl) trichlorosilane (Gelest, Inc.) in a vacuum chamber for 4 hours for easy release of 
PDMS replicas.30 
Fabrication of patterned cyclic olefin co-polymer (COC) components. Patterned COC 
sheets (6013, TOPAS Advanced Polymers) were fabricated by hot embossing using high-
temperature epoxy molds (Conapoxy FR 1080) in a laminating press (Carver Inc., Model 3851) 
under the load of 150-200 kg. The thicknesses of the sheets used to pattern lipid and aqueous 
solution chambers were 6 mil and 4 mil, respectively. For high-fidelity pattern transfer, a stack of 
(i) 7-10 mm PDMS slab, (ii) an epoxy mold, (iii) a COC sheet, and (iv) a 7.5 × 5 cm microscope 
glass slide was placed between the platens of the press. The temperature of the assembly was 
brought to 350 °F (177 °C) and then to below 250 °F (121 °C) before removing the patterned 
layer. Holding at 177 °C for an extended period of time was not required for accurate pattern 
transfer. 
The SlipChip relies on capillary effects18,19 and requires a smooth flat surface of 
patterned COC sheets for successful filling and slipping. Because epoxy softens at the 
temperature required for hot-embossing, COC sheets larger than in size than the epoxy molds 
were used to avoid the imprints of sheet edges in the epoxy and compromising the smoothness of 
the surface of the mold. 
Holes were drilled in COC sheets with patterned solution chambers using a 750 µm drill 
bit (McMaster-Carr). Burrs around the holes were removed very carefully with a razor blade 
without scraping the rest of the surface of the chip. 
Fabrication of epoxy molds for hot-embossing of COC films. The epoxy molds were 
fabricated using the procedure developed by Guha et al.21 with minor modifications to ensure flat 
surface of resulting epoxy molds as required for SlipChip operation. Briefly, PDMS with 10:1 
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monomer : crosslinker ratio was used to fabricate a thick inverse master of the photoresist-on-
silicon master. Here we used exclusively positive photoresist masters with reflowed features to 
facilitate lift-off of COC films from epoxy molds in the hot embossing step. For flatness, two 
1/4"-thick polymethylmetacrylate (PMMA) spacers were placed on a 4-inch wafer with patterned 
photoresist and a 1/8"-thick 3" × 3" flat PMMA plate was placed on the spacers. PDMS was 
poured into the space between the wafer and the PMMA plate to completely fill the space 
without air bubbles (Figure 4.2). The assembly was baked for 2 hours at 75 °C on a hotplate or in 
an oven to cure PDMS. After curing, the top PMMA plate was removed and the inverse PDMS 
master of largest possible dimensions was cut out and peeled off the wafer. 
 
Figure 4.2. Schematic representation of the assembly for the fabrication of inverse PDMS molds. 
An epoxy master (Conapoxy FR 1080) for use in hot-embossing was then molded off the 
PDMS master. The epoxy components (83:100 hardener:epoxy, by mass) were mixed using a 
planetary centrifugal mixer (Thinky USA Inc.) for 15 min at 2000 rpm with rotation and then de-
foamed for 12 min at 2200 rpm. The inverse PDMS master was used for epoxy patterning. 
Again, precautions were taken to ensure that the epoxy mold with a smooth flat surface is 
obtained. The PDMS mold was placed on a 3-inch silanized silicon wafer without a pattern and a 
~1 cm-thick PDMS frame was placed on the mold to create a walled compartment for uncured 
liquid epoxy. To prevent evolution of gas bubbles from the PDMS master during epoxy curing, 
the assembly was degassed for ~10 min. After degassing, the assembly was placed on a level 
hotplate held at 120 °C, PDMS was thoroughly cleaned with Scotch Tape (3M), and epoxy was 
poured into the mold and cured for 4 hrs at 120 °C. To prevent buckling of PDMS, a 400 g 
aluminum block was kept on the assembly throughout the curing process. Although inverse 
PDMS molds remained flat throughout curing due to stiction with wafer surface and the weight 
placed on the assembly, the molds buckled upon removal from the wafer after epoxy curing, and 
were not re-used. 
Fabrication of thick PDMS assemblies for lipid filling. PDMS control layers of 5-10 
mm in thickness were prepared by pouring a mixture with the monomer : cross-linker ratio of 5:1 
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on the photoresist-on-silicon master followed by curing at 90 °C for 5-10 min. For the fluid 
layers we spin-coated photoresist-on-silicon masters using PDMS with the monomer: cross-
linker ratio of 15:1 to obtain a 45 µm-thick film. Fluid layers were cured at 90 °C for 7-9 min. 
Here we used photoresist-on-silicon masters with 25 µm-tall features fabricated in SU8-25 
(Microchem) for control and fluid layers. 
The chips were assembled as follows: (i) inlet ports were punched in the control layer 
using a 20 AWG needle with a thin wire plunger, (ii) control layers were irreversibly bonded to 
fluid layers by placing the two layers in conformal contact and heating at 70 °C for 2 hrs,29 and 
(iii) the thin membrane connecting the control and the fluid line (Chapter 4.3.2, Figure 4.6) was 
removed carefully with sharp tweezers.  
For lipid filling the control/fluid layer assembly was placed on a patterned COC 
substrate, and a reversible bond between the PDMS fluid layer and the COC substrate formed 
spontaneously.21 
 
4.2.2  Lipid filling strategy 
Lipid filling and mesophase properties on-chip were monitored using an upright 
microscope (Leica MDG33) equipped with a macro lens and a digital camera (Leica DFC295).  
Lipid chambers were filled into the patterned COC substrate using the thick PDMS 
assembly that was aligned with the substrate to form a continuous fluidic line. A piece of 30 
AWG PTFE tubing (Cole-Parmer) filled with ~0.5-cm-long plug of molten monoolein or 
monoolein/OG mixture was inserted into the corresponding the inlet port of the auxiliary thick 
PDMS assembly. Applying negative pressure (vacuum) caused pressure gradient to form in the 
fluid line/patterned chambers due to air permeability of PDMS and drew monoolein into the 
device. Prior to removing the preliminary PDMS assembly from the lipid-filled COC substrate, 
the lipid was frozen by placing a piece of dry ice on the device. Monoolein remained on COC in 
locations under patterned PDMS channels and was carefully removed with toothpicks and Scotch 
Tape (3M) as much as possible. Monoolein remaining outside of chambers was very carefully 
wiped using a Kimwipe (SCIENCE brand, Kimberly-Clark) slightly moistened in isopropanol so 
as not to dissolve monoolein in COC chambers. Using a vacuum pump to draw lipid into the 
fluid line caused the thin PDMS layer under the control line to lift off the substrate and 
monoolein to creep under the line. Hence, only house vacuum was used for lipid filling. 
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Monoolein (Sigma-Aldrich, 99%) was used as received. The monoolein/OG mixture 
with a OG/MO ratio of 0.033 w/w was prepared gravimetrically as follows. Desired amounts of 
monoolein and OG (Anatrace, Anagrade) were weighed in a glass vial and dissolved in 
chloroform (Sigma Aldrich, ≥99.8%). The solvent was removed under a stream on nitrogen gas. 
Solid samples were dried in a desiccator under vacuum at room temperature (21-23 °C) 
overnight. 
 
4.2.3  Solution filling strategy 
Prior to assembly, monoolein-filled COC sheets and empty COC sheets with chambers 
for aqueous solutions were spin-coated with Novec 1700 (3M) at 1200 rpm to form a ~0.25-0.3 
µm layer of a fluoropolymer on the surface of the sheets for higher hydrophobicity (Figure 4.3). 
Coating with the fluoropolymer was necessary to make sure that the aqueous solution did not 
spread beyond fluidic ducts and chambers upon filling and slipping. 
 
Figure 4.3. The surface of a COC sheet after spin-coating with Novec 1700. The dashed red line separates the coated region (left) 
from the non-coated region (right). 
Clamping the two patterned COC sheets together was found necessary for filling, 
similarly to the original glass-based SlipChip that is held together with binder clips. The thin 
COC sheets used in this work required a more complex assembly (Figure 4.4) that consisted of 
(top-to-bottom): a 1/4"-thick 2"×3" PMMA slide, a ~ 5-mm thick PDMS gasket, a 12.5 µm-thick 
Teflon film (FEP 50A, American Durafilm), and a 1/4"-thick 2"×3" PMMA frame (edge width 1 
cm). The gasket was required to ensure even pressure on the COC sheets and the Teflon sheet 
served to avoid adhesion between COC and PDMS, which caused problems during disassembly.  
The assembly was held together with four clamping screws with corresponding holes drilled in 
the corners of the acrylic slide/frame. Access holes for fluid inlets were drilled using a 750 µm 
drill bit in the acrylic slide and punched in the PDMS gasket using a 20 AWG needle. A small 
opening was cut out in the Teflon sheet in the area around the inlet ports for access. 
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Figure 4.4. Schematic representation of the clamping assembly used in the filling of the COC SlipChip with aqueous solutions. 
The assembly process was as follows: the acrylic slide, the PDMS gasket, the Teflon 
film, and the monoolein-filled COC sheet were aligned so that inlet ports in the four pieces 
overlapped. Several drops of Fluorinert FC-40 (3M) were placed on the COC sheet and the other 
COC plate was aligned with the assembly to match the pattern in the monoolein-filled sheet. The 
acrylic frame was carefully placed on the assembly without disturbing the alignment of the COC 
sheets and clamping screws were tightened. 
To remove air pockets remaining in the aqueous line, the line was flushed with Fluorinert 
FC-40 using a 1 mL syringe with a 27 AWG needle connected to 30 AWG PTFE tubing (Cole-
Parmer). The line was then filled with a saturated solution of fluorescein (Acros Organics) in 
deionized water. 
An inverted Leica DMI 4000B microscope equipped with a xenon lamp, a Leica N 
PLAN 2.5× (0.07 NA) objective, and a charge-coupled device camera (Hamamatsu ORCA-ER, 
Model C4742-80) was used to monitor filling of aqueous solutions into the chip. The amount of 
aqueous phase in chambers was estimated as the ratio of the area occupied by the fluorescent 
aqueous phase to the total area of the chamber. Calculations were done using the ImageJ 
program (v. 1.45s, Wayne Rasband, NIH, USA). 
After filling, the assembly was carefully taken apart, and the plates were carefully slipped 
in order to bring the chambers with aqueous solution and monoolein in contact. The sheets were 
sealed at long edges with Crystal Clear Tape (Hampton Research), and at short edges with 
QuickSet Epoxy (Henkel). Prior to sealing, FC-40 was added between the plates if air bubbles 
were visible. Inlet ports were also sealed with Crystal Clear tape. The chips were placed under 
FC-40 and stored at room temperature for ~24 hours for mixing between monoolein and the 
aqueous solution. Afterwards the chips were kept at -12 °C to reduce evaporation of water from 
the samples. Prior to SAXS data collection the chips were defrosted and kept under FC-40 for at 
least 2 hours for equilibration. 
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4.2.4  SAXS data collection 
SAXS data were collected on protein crystallography beamline LS-CAT 21-ID-D at the 
Advanced Photon Source (APS), Argonne National Lab. A detailed description of the setup is 
available elsewhere.31 For SAXS measurements, a vacuum flight tube and an adjustable beam 
stop with an incorporated pin-diode were installed between the sample and the CCD detector 
(Rayonix MX300). The beamline was equipped with a microdiffractometer (MAATEL MD2) 
consisting of a goniometer, XYZ micropositioner and an on-axis video microscope. The latter 
was used to monitor the position of the sample in the X-ray beam. The footprint of the X-ray 
beam was 20 µm. The beam energy was 8 keV. Attenuation of the incident X-ray beam and 
exposure time were adjusted to avoid radiation damage.32  
Data for each 500 x 500 µm2 chamber of a given SlipChip were collected on a grid of 
points spaced 150-180 µm apart along both dimensions of the chamber, for a total of 9 points per 
chamber (i.e., per mesophase composition).  
Raw diffractograms were integrated in Fit2D software (v. 12.077, A.P. Hammersley, 
ESRF, 1994). Because the diffractograms for different points within a single sample chamber 
differed negligibly with respect to peak positions, indicating identical sample properties 
throughout the chamber, for further analysis we used a sum of all diffractograms corresponding 
to a given chamber to obtain a higher signal/noise ratio. Integrated diffractograms were 
processed in MATLAB (R2008a, v. 7.6.0.324, The MathWorks Inc., Natick, MA). Publicly 
available MATLAB code (findpeaks.m, T.C. O’Haver, v2, revised Oct 27, 2006) was used to 
locate peak center positions. No baseline correction was required due to the very low background 
scatter of COC films. For phase assignment, diffraction angles were converted into d-spacings 
using Bragg’s law.33 Mesophases were identified based on characteristic sets of reflections and 
lattice parameters were calculated using the peak position of the highest-intensity reflection for a 
given mesophase (Appendix A).  
 
4.3  Results 
4.3.1  Design of the SlipChip 
The SlipChip described in this section was designed for mapping the phase diagram of 
lipidic mesophases in the interval of compositions of 0-60 vol% of the aqueous solution in 5 
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vol% increments. The volume of lipid required for each composition was 12.5 nL, and the 
volume of aqueous solution varied in the range of 1.4 - 18.8 nL to match the target composition 
of the sample. Because of the space constraints during SAXS data collection that limited the 
overall size of the chip, two chips with six sample chambers per chip (SlipChip30 for 0-30 vol% 
of solution and SlipChip60 for 35-60 vol% of solution) were required, as shown in Figure 4.5.  
 
Figure 4.5. The layouts of lipid chambers and ducts for the aqueous solution (orange) and the chambers for aqueous solutions 
(black) patterned in the two plates of the SlipChips for the formulation of mesophases containing (A) 0-30 vol% of the aqueous 
solution and (B) 35-60 vol% of the aqueous solution. (A1) and (B1) represent alignment of the SlipChip plates in the solution 
filling step with overlapping ducts (orange) and solution chambers (black), and (A2) and (B2) represent alignment of the 
SlipChip plates after slipping for mesophase formulation. The insets show an enlarged view of the mesophase chambers with 
labeled mesophase composition. The size of lipid chambers (orange) is 500 × 500 µm2, and the size of aqueous solution 
chambers (black) varies to achieve the target composition. SlipChip30 is designed for different depths of lipid and solution 
chambers (depthsolution = 1/2 depthlipid) in order to achieve target mesophase compositions; SlipChip60 is designed for identical 
depths of lipid and solution chambers. 
SlipChip30 was designed for different depths of lipid and solution chambers (depthsolution 
= 1/2 depthlipid) to achieve target mesophase compositions. Thus, chambers for aqueous solutions 
with very small lateral dimensions that would present challenges in the solution filling step were 
avoided. For the same reason SlipChip30 omitted the composition with 5 vol% solution. This 
chip also contained a lipid chamber without a matching solution chamber in order to assess the 
possibility of accidental cross-talk between sample chambers and/or fluidic ducts after slipping. 
The cross-talk would cause changes in the well-defined diffraction pattern of the solid lipid. 
SlipChip60 was designed for identical depths of lipid and solution chambers. The total volume of 
lipid required to fill each chip (6 compositions) was under 100 nL, whereas ~100 µL of solution 
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was required due to the dead volume of the syringe and the clamping assembly. 
 
4.3.2  Lipid filling 
The original glass SlipChip relies on capillary properties of liquids: even though the two 
rigid glass slides are likely separated with a very narrow gap, the samples are confined in sample 
chambers and ducts by ensuring that the liquids used to fill the chip do not wet its surface.18,19 
Thus, pressure required to push the liquids beyond the chambers is significantly higher than the 
pressure required to drive the fluids through the chambers for filling due to capillary effects: 
 cos11 

 
hw
pcap     Equation 4.1 
where Δpcap is the capillary pressure require to drive the fluid through an opening of width w and 
height h, θ is the contact angle between the solution and the chip surface, and γ is the interfacial 
tension between the solution and the fluorinated solvent typically used to fill the interstitial space 
between the plates.19 For fluidic chambers and ducts w and h represent height and width of the 
channels, whereas for non-patterned areas of the chip w ~ ∞ and h is the gap between the plates, 
which is significantly smaller than the height of the channels. Ismagilov et al. established that for 
accurate filling the contact angle must be at least 130°.18 Monoolein, being amphiphilic, wets 
hydrophobic as well as hydrophilic surfaces (θ ~0° on either), and can be expected to 
spontaneously spread between the plates, which was indeed observed upon filling SlipChips 
fabricated in COC with molten monoolein. 
To overcome the challenge of reliable lipid metering in the SlipChip, a two-step filling 
strategy was devised. In the first step monoolein was filled into the chambers of the 
corresponding COC plate using and auxiliary PDMS assembly with channels patterned to 
overlap with the sample chambers similarly to the original SlipChip (Figure 4.6). Because PDMS 
is elastomeric and sticky, it reversibly adhered to the COC plate, conforming to the imperfectly 
smooth COC surface and preventing the lipid from spreading during filling. The lipid was drawn 
into the chambers by the pressure gradient that was created by applying negative pressure 
(vacuum) to the control line passing over sample chambers and separated from them with a thin 
PDMS membrane. Once the lipid filled the chambers, it was solidified by cooling with dry ice 
and remained solid at room temperature (Tmelt = 37 °C) and remained in the plate upon removal 
of the PDMS assembly (Figure 4.6B-D), allowing for easy manipulation of lipid-filled COC 
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sheets. 
 
Figure 4.6. Filling the SlipChip with a lipid. (A) Design of the assembly used for filling respective compartments of the SlipChip 
with the lipid with the compartments hot-embossed in the COC plate (orange), and the auxiliary PDMS assembly (black, fluid 
layer, and blue, control layer). The thin PDMS membrane separating the two layers is removed in the location indicated with an 
arrow to connect the two parts of the fluidic line fabricated in different layers of the PDMS assembly. The inset shows a 
magnified view of the area with the lipid chambers. The size of the lipid chambers is 500 × 500 µm. (B-D) Optical micrographs 
of the assembly at different stages of the filling process: (B) the PDMS assembly with control and fluid lines aligned with the 
patterned COC sheet; (C) monoolein filled into the chambers and frozen prior to the removal of the PDMS assembly and (D) 
after removal of the PDMS assembly. Monoolein in interconnecting lines between the chambers remained on the COC plate and 
was carefully removed to retain monoolein in sample chambers only. Images in (C) and (D) were taken with crossed polarizers, 
making birefringent monoolein appear bright on a black non-birefringent background. 
 
4.3.3  Solution filling and mesophase formulation 
COC plates pre-filled with lipid were aligned with the plates patterned with aqueous 
chambers, the interstitial space between the plates was filled with a fluorinated solvent 
(Fluorinert FC-40), and respective sample compartments were filled with solution following the 
original SlipChip protocol18 with some modifications to ensure reliable contact between the COC 
plates (Chapter 4.2.3, Figure 4.4). Although some of the chambers were not completely filled 
(Figure 4.7), the volume of solution in the chamber could be quantified by measuring the area 
occupied with the solution relative to the total area of the chamber. A more precise quantification 
could be done based on the cumulative fluorescence intensity of the solution in the chamber as 
was done for the lipidic mixer array chip (Chapter 3). After slipping (Figure 4.7 B1-C2) the chips 
were sealed, stored under FC-40 at room temperature for 24 hours to allow for passive mixing 
(Figure 4.7 D, E), and then kept at -12 °C until SAXS data collection. Prior to SAXS analysis the 
chips were defrosted and kept under FC-40 for at least 2 hours at the data collection temperature 
(25 ± 1 °C). 
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Figure 4.7. Micrographs of a SlipChip30 during (A1, A2) solution filling, (B1, B2) intermediate slipping step, (C1, C2) 
solution/lipid contact, and (D) after 2 hrs. and (E) 24 hrs. of incubation at room temperature. (A-C) Pairs of brightfield (1) and 
fluorescence (2) images at each step are shown, illustrating clean filling and slipping of the fluorescent aqueous solution. The 
solid lipid in respective chambers remained non-fluorescent until (C) coming in contact with the solution. Due to the small field 
of view each image in (A-C) was obtained by stitching together two micrographs, resulting in the appearance with non-uniform 
illumination intensity in the brightfield images. (D, E). Mesophases remained in respective chambers during prolonged storage 
and the appearance changes little between 2 and 24 hrs, suggesting that mixing occurred in less than 2 hrs. The rainbow 
background is due to birefringence of the polystyrene Petri dish used for chip storage. Birefringent lipidic mesophases, such as Lc 
and Lα appear dark and are additionally labeled with red asterisks, and non-birefringent cubic mesophases appear light. The size 
of lipid chambers is 500 × 500 µm2.  
Two sets of chips were fabricated with a 1.5-month interval and used for mesophase 
formulation. Although fabrication procedures for the two sets were identical, the devices 
behaved differently with respect to filling and slipping. Devices from set #1 could be filled and 
slipped cleanly, with solution confined to the ducts and chambers in both steps (Figure 4.7 A1-
C2). Devices from set #2 presented multiple problems, with solutions leaking out of fluidic ducts 
upon de-clamping (Chapter 4.2.3) and especially slipping. Upon closer inspection we established 
that a small area immediately adjacent to sample chambers in the COC plate designated for 
aqueous solutions was not coated with the fluoropolymer used to enhance the hydrophobicity of 
COC (Chapter 4.2.3). Additional dip-coating of the plates with the fluoropolymer improved the 
success rate of sample formulation. However, out of 11 chips with the target composition of 0-
30% in set #2, four had to be discarded immediately after slipping, and one more device was 
discarded after SAXS data collection. The origin of the disparate behavior of the two sets of 
devices is being investigated. We note that even in chips discarded on the basis of SAXS 
analysis, the dry lipid material remained intact in its designated chamber in 6 out of 7 cases. 
Therefore, we conclude that the quality of on-chip samples is typically compromised at the 
sample formulation stage rather than during storage, and the fluorinated solvent filling the space 
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between the plates and the samples provides an adequate barrier against transport of water 
between samples of different compositions. 
 
4.3.4  SAXS data collection in a SlipChip 
SAXS data collection was performed at beamline 21-ID-D of the Advanced Photon 
Source at Argonne National Lab using a setup that combined excellent visualization with small-
angle X-ray diffraction capabilities.31 A total of 9 locations were probed within each 500 × 500 
µm2 sample chamber using a 20 µm X-ray beam. An XY-positioner was used to move the chip 
in the X-ray beam, and exact beam position was monitored in an on-axis video microscope. 
Although only a single sample chamber was typically visible in the microscope, its location 
within the chip, and, consequently, the nominal sample composition, could be easily established 
by translating the chip in the field of view. 
In comparison with the lipidic mixer array chip (Chapter 3), the SlipChip produced 
SAXS data of higher quality (Figure 4.8): (i) signal-to-noise ratio for samples in the SlipChip 
was consistently higher, presumably to the larger sample thickness (75-100 µm in the SlipChip 
vs. 15-40 µm in the lipidic mixer array, and (ii) the noticeable background scattering below q = 
0.06 Å-1 was absent in samples in the SlipChip, in agreement with scattering properties of 
materials (Chapter 3, Figure 3.5). Furthermore, the quality of samples themselves in the SlipChip 
was higher than in the lipidic mixer array chip. The lattice parameters at different locations 
within a given chamber in the SlipChip were found to be identical in most cases, indicating the 
uniformity of the sample and lending support to the passive mixing procedure for mesophase 
formulation. In the array chip, on the other hand, the points closest to chamber inlets were often 
found to differ from the rest of the sample in a given mixer, possibly due to the cross-talk with 
fluidic lines, and had to be excluded during data processing. The differences in the quality of the 
samples are illustrated in Figure 4.8. In the cumulative diffractogram for a given sample (Figure 
4.6B) higher-order reflections of the cubic phase remain as well-resolved as in the diffractogram 
for an individual datapoint (Figure 4.8A) in the sample formulated in the SlipChip. In the 
PDMS/COC array chip the higher-order reflections in the cumulative diffractogram form a wide 
band without resolving into individual peaks (Figure 4.8D), unlike in the diffractogram for an 
individual point in the same sample (Figure 4.8C), due to the variation in the lattice parameters 
between individual datapoints. 
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Figure 4.8. (A,B) Integrated SAXS diffractograms of lipidic mesophases formulated and analyzed in a SlipChip: (A) a single 
location within the sample chamber and (B) the sum of 9 diffractograms collected for the same chamber. Nominal sample 
composition: 25 vol% water, 75 vol% βOG/monoolein mixture (βOG/monoolein ratio 0.033 w/w); phase assignment: Ia3d, 145 
Å, and Lα, 47.1 Å. (C, D) Integrated SAXS diffractograms of lipidic mesophases formulated and analyzed in a PDMS/COC 
lipidic mixer array chip described in Chapter 3: (C) a single location within the mixing unit and (D) the sum of 48 diffractograms 
collected for the same mixing unit. Sample composition: 55 vol% of βOG in 25 mM NaH2PO4, pH 5.5 (βOG concentration 5% 
w/v), 45 vol% of monoolein; phase assignment: Ia3d, 199 Å, and Lα, 49.5 Å. A baseline correction was performed in each 
diffractogram prior to normalizing intensities. Peak assignments for prominent reflections are indicated in each panel. The insets 
in each panel show a magnified view of higher-order hkl reflections from the Ia3d phase for respective diffractograms. 
 
4.3.5  Phase behavior of lipidic mesophases 
The results of the SAXS analysis for two types of samples, (i) monoolein/water 
mesophases and (ii) monoolein/OG/water mesophases, are discussed below. Monoolein/water 
mesophases were prepared in both sets of SlipChips (Chapter 4.3.3), whereas the latter were 
prepared only as a part of set #2. SlipChip30 produced a diverse range of phase types and lattice 
parameters, providing a route to assess the accuracy of metering in the SlipChip based on 
existing data for monoolein/water mesophases. In agreement with properties of monoolein which 
is known to form a fully hydrated Pn3m mesophase at ~43 vol% of water,34,35 SlipChip60 
produced mostly water-saturated monoolein mesophases with no variation in the lattice 
parameter, with the exception of the samples with the lowest water content of the mesophase 
(nominal 35 vol%). All mesophases of monoolein/OG/water formulated in the SlipChip60 were 
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of the Pn3m type and their lattice parameters showed relatively little variation. 
Table 4.1. Types and lattice parameters of monoolein/water mesophases identified in five SlipChips as a function of 
nominal sample composition. 
Nominal sample 
composition, 
vol% water 
Types of 
mesophases Chip A
a Chip Ba Chip Ca Chip Da Chip Ea 
0 Lc 49.6 49.6 49.6 49.6 49.6 
10 
Pn3m      
Ia3d      
Lα 39.0 39.2 39.2  43.2 
15 
Pn3m      
Ia3d    114  
Lα 43.2 42.9 43.6 46.3 42.1 
20 
Pn3m      
Ia3d 116 125 123 115 114 
Lα 44.0    46.3 
25 
Pn3m      
Ia3d 144 139 138 133 135 
Lα      
30 
Pn3m 102    103 
Ia3d  138 155 148  
Lα      
a Numbers are lattice parameters of respective mesophases in angstroms. Several phases listed for a given sample 
compositions indicate equilibrium phase coexistence. 
Table 4.1 lists the types and lattice parameters of monoolein/water mesophases identified 
in five independently set up SlipChips with the target composition range of 0-30 vol% water for 
devices from set #1 (A-C) and set #2 (D, E). The results were in agreement with the properties of 
monoolein/water mesophases:34,35 as the amount of water in the sample increased, the Lα – Ia3d 
– Pn3m sequence of phases was observed, including several instances of coexisting Lα and Ia3d 
phases. The lattice parameters of mesophases increased with increasing content of water in the 
sample.34,35 Chip B in Table 4.1 is the one photographed in Figure 4.5, and SAXS data are in 
excellent agreement with the appearance of the samples: samples identified as lamellar by SAXS 
are birefringent in the photographs, and samples identified as cubic are non-birefringent. These 
results validate our storage and equilibration procedure. However, in several instances either 
different types of phases or identical mesophases with different lattice parameters were observed 
at the same nominal sample composition in different chips. These differences indicate the 
variation between actual sample compositions in the different chips, and could be partially traced 
to the incomplete filling of sample chambers. 
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Table 4.2. Types and lattice parameters of monoolein/βOG/water mesophases identified in three SlipChips as 
a function of nominal sample composition. The βOG/monoolein ratio was fixed at 0.033 w/w, while the amount of 
water in the samples was varied. 
Nominal sample 
composition, 
vol% water 
Types of 
mesophases Chip F
a Chip Ga Chip Ha 
0 Lc 36.1b 49.6, 35.6 49.6, 36.1 
10 
Pn3m    
Ia3d    
Lα 43.1 38.0 39.6 
15 
Pn3m    
Ia3d    
Lα 43.1 42.7 44.1 
20 
Pn3m    
Ia3d  140  
Lα 43.3 46.7 46.0 
25 
Pn3m    
Ia3d 147 145 148 
Lα 47.1 47.1 47.2 
30 
Pn3m    
Ia3d 149 154 159 
Lα 47.3   
a Numbers are lattice parameters of respective mesophases in angstroms. Several phases 
listed for a given sample compositions indicate equilibrium phase coexistence. 
b This sample likely represents a lamellar Lα phase that formed due to cross-talk with 
solution-containing chambers 
To formulate monoolein/βOG/water mesophases, we used a mixture of monoolein and 
βOG with a fixed ratio of components (βOG/monoolein 0.033 w/w) to fill the lipid chambers, 
followed by mixing with different amounts of water as defined by the volume of the chambers in 
the SlipChip. The mesophases formulated and analyzed on-chip (Table 4.2) showed expected 
differences  from the monoolein/water mesophases:36-38 the sequence of phases as a function of 
water content in the samples with detergent remained the same, but introduction of detergent 
caused the lattice parameters of the Ia3d phases to increase relative to mesophases without 
detergent (Table 4.1).  Furthermore, based on the results for samples formulated in SlipChip60, 
in the fully hydrated Pn3m phase the lattice parameter increased to 120 Å upon addition of 
detergent compared to the 103 Å established for the fully hydrated monoolein/water Pn3m phase. 
Both values are in quantitative agreement with previously reported lattice parameters.34,38 The 
solid mixed monoolein/βOG phase remained intact in most cases, and a peak at 35.6 Å appeared 
in addition to the peak at 49.6 Å observed for pure solid monoolein. Variation in sample 
compositions between nominally identical samples in different chips was observed (Table 4.2), 
similarly to our findings for monoolein/water mesophases. 
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Figure 4.9. The ratio between actual and nominal sample compositions (in vol% water) as a function of the nominal sample 
composition in five SlipChips. Nominal sample compositions used to calculate the ratios were adjusted based on the area of the 
fluorescent part of each chamber to account for incompletely filled chambers. Chip notations A-D correspond to those in Table 
4.1. Points with coexisting Lα and Ia3d mesophases are excluded due to the ambiguity in the sample compositions. 
To assess the accuracy of metering in the SlipChip, actual sample compositions were 
estimated based on the lattice parameter dependence of monoolein mesophases on the water 
content of the samples34 (Figure 4.9). The difference between nominal sample compositions and 
actual sample compositions appeared to increase systematically from the chamber with the 
lowest content of water (10 vol%) to the chamber with the highest content of water (30 vol%) in 
all SlipChips. The nominal amount of water in the sample could be exceeded by a factor of 1.3-
1.4x. For example, the sample with the target composition of 30 vol% water was found to 
contain 38 vol% water. Because all devices tested here were fabricated using a single 
photoresist-on-silicon master, this result may indicate that the height of the sample chamber 
varied due to the uneven thickness of the photoresist. Achieving highly uniform coating 
thickness with thick (> 25 µm) positive photoresists is difficult, yet highly precise sample 
formulation is required for the studies of the phase behavior of lipidic mesophases because of the 
possibility of several phase transitions within a very narrow range of compositions (Chapter 1, 
Figure 1.12). We note that even the etched-glass SlipChip that produced compositions within 0.9 
- 1.1x of the target18 may not be sufficiently accurate for such studies without additional 
calibration of sample volumes. Our findings suggest that precise calibration of chamber volumes 
and measurement of the volumes of samples in each chip is required for mapping of the phase 
behavior of lipidic mesophases.  
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4.4  Conclusions 
The X-ray transparent SlipChip demonstrated in this chapter is a viable concept for the 
studies of the phase behavior of lipidic mesophases, as illustrated by formulating and analyzing 
mesophases of monoolein/water or monoolein/OG/water of different compositions using 12.5 
nL per composition. The advantages of the all-COC SlipChip compared to hybrid PDMS/COC 
devices are the higher signal-to-noise ratio of SAXS data, lower background scatter from chip 
materials, and the higher degree of uniformity of samples within a given sample chamber. The 
three major mesophase types (Pn3m, Ia3d, Lα), and a solid crystalline phase Lc typical for 
monoolein mesophases under ambient conditions34,35 were successfully identified in the 
SlipChip. The sequence of phases and the values of lattice parameters established for both types 
of samples are in agreement with previously reported data. However, for highly accurate 
estimates of mesophase composition as required in the studies of the phase behavior, calibration 
of the exact volume of samples in the chambers is highly desirable and will need to be addressed 
in future work.  
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Chapter 5. 
 X-ray compatible microfluidic platform for 
in meso crystallization of membrane proteins 
Abstract 
In this chapter an X-ray compatible microfluidic platform for in meso crystallization of 
membrane proteins is reported. The platform was designed specifically to facilitate passive 
mixing between the protein solution and the lipid for the formation of protein-loaded 
mesophases, and to avoid on-chip routing of protein-loaded mesophases. The 12-well cyclic 
olefin co-polymer/polydimethylsiloxane chip described in this chapter is under 210 µm thick, 
and requires respectively 25, 40-65, and 215-300 nL of the lipid, protein solution, and precipitant 
per well. The approach was validated by crystallizing the membrane protein photosynthetic 
reaction center from R. Sphaeroides and successfully solving its structure at a resolution of 3.33 
Å using crystal X-ray diffraction data collected from multiple crystals on-chip. 
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5.1  Introduction 
Despite the biochemical importance of membrane proteins and recent advances in 
crystallization, detailed spatial structures of membrane proteins remain a somewhat elusive target 
of structural biology. Membrane proteins represent approximately 1% of all protein crystal 
structures available.1 The differences in the numbers of crystal structures available for soluble 
and membrane proteins presumably illustrate the respective combined difficulties of expression, 
purification, and crystallization, the latter being an important bottleneck. In large-scale screening 
efforts, only ~1% of crystallization trials for soluble proteins resulted in crystallogenesis, and 
only ~30% of soluble proteins could be crystallized.2 The success rate for membrane proteins is 
likely significantly lower.  
Crystallization of membrane proteins in lipidic mesophases3 (usually termed LCP or in 
meso) is a proven powerful alternative to the traditional crystallization approach from detergent-
stabilized solutions and has been used to crystallize a number of biologically and 
pharmacologically important proteins, such as human G-protein coupled receptors.4,5 
Nevertheless, the penetration of the in meso method in the wider structural biology community 
has been slow, likely due to the difficulties of handling of the toothpaste-like mesophases and 
substantial deviations of the in meso crystallization procedure from the traditional crystallization 
from solutions. Although relatively user-friendly alternatives appeared recently,6,7 the most 
common variant of the in meso method requires specialized tools in every step of the 
crystallization protocol:3,8 (i) a coupled-syringe mixer for mixing of lipid (typically monoolein) 
and the protein solution in the preparation of protein-loaded mesophases, (ii) a ratchet dispenser 
for dispensing the mesophase into crystallization well, and (iii) special glass sandwich well 
plates for crystal visualization due to the non-uniform optical properties of the mesophase. The 
glass sandwich plates make crystal harvesting especially cumbersome,4 and the problem is 
compounded by the typical small size of (often transparent) membrane protein crystals, 5-50 µm, 
and the viscosity of mesophases. While trial formulation can be automated with robotic 
systems,8,9 crystal harvesting from well plates is necessarily manual and the fragile crystals may 
get damaged due to shear and dehydration, compromising the quality of X-ray diffraction data. 
Inexpensive microfluidic systems have been successfully used to automate sample 
formulation and to reduce the amount of material per crystallization trial for protein 
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crystallization from solutions.10 Importantly, a number of X-ray transparent platforms for in situ 
crystal diffraction data collection have been demonstrated to eliminate the manual crystal 
harvesting step.11-21 These approaches would be highly desirable for working with scarcely 
available membrane proteins that form small fragile crystals, but only two microfluidic systems 
have been developed for in meso crystallization22,23 (Chapter 1.2.5). While an X-ray transparent 
variant for one of them, the lipidic mixer, has been demonstrated (Chapter 3), it is not suitable 
for the formulation of protein-loaded mesophases due to the requirement for cooling during 
mesophase mixing. 
Here microfluidic platforms are described for in meso crystallization that rely on passive 
mixing between lipid and protein solution for the formulation of protein-loaded mesophases, 
similar to the recently demonstrated macroscale methods.6,7 Chapter 5.2.1 and 5.2.2 describe the 
fabrication and operation of the chips. Sample formulation strategies in preliminary design 
concepts are outlined in Chapter 5.3. Chapter 5.4 describes a successful X-ray transparent array 
chip for in meso crystallization, with operation and sample formulation principles summarized in 
Chapter 5.4.1 and 5.4.2. The chip has been validated by crystallizing a membrane protein 
photosynthetic reaction center (RC) from R. Sphaeroides (Chapter 5.4.3) and collecting X-ray 
diffraction data in situ for crystal structure solution at the resolution of 3 Å (Chapter 5.4.4). 
 
5.2  Materials and methods 
5.2.1  Device fabrication  
Fabrication of photoresist-on-silicon masters. Depending on the desired feature height 
and profile, photoresist-on-silicon masters were created with SU8-2050 photoresist (Microchem) 
for 40-65 µm-tall vertical features, SU8-25 (Microchem) for the patterns with the 25 µm-tall 
vertical features, SPR-220-7 (Shipley) for 14 µm-tall rounded features, and AZ50XT (AZ 
Electronic Materials) for 50 µm-tall rounded features. SPR-220-7 masters were reflowed after 
patterning by heating at 120 °C for 2 min, and AZ50XT masters were reflowed at 115 °C for 45 
s to achieve the rounded profile.24 Specific feature heights are listed for all tested device types in 
respective sections. All photoresist-on-silicon masters were treated with (tridecafluoro-1,1,2,2-
tetrahydrooctyl) trichlorosilane (Gelest, Inc.) in a vacuum chamber for 4 hours for easy release of 
PDMS replicas.25 
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Fabrication of cyclic olefin co-polymer (COC) substrates. Patterned COC substrates 
(2 mil, 6013, TOPAS Advanced Polymers Inc.) were fabricated by hot embossing using high-
temperature epoxy molds (Conapoxy FR 1080) in a laminating press (Carver Inc., Model 3851) 
under the load of 150-200 kg. For high-fidelity pattern transfer, a stack of (i) 7-10 mm PDMS 
slab, (ii) an epoxy mold, (iii) a COC sheet, and (iv) a 7.5 × 5 cm microscope glass slide was 
placed between the platens of the press. The temperature of the assembly was brought to 350 °F 
(177 °C) and then to below 250 °F (121 °C) before removing the patterned layer. Holding at 177 
°C for an extended period of time was not required for accurate pattern transfer. The epoxy 
molds were fabricated using the procedure developed by Guha et al.21 Briefly, PDMS with 10:1 
monomer : crosslinker ratio was used to fabricate a thick inverse master of the photoresist-on-
silicon master. PDMS was baked for 2 hrs at 75 °C. An epoxy master (Conapoxy FR 1080) for 
use in hot-embossing was then molded off the PDMS master. The epoxy components (83:100 
hardener:epoxy, by mass) were mixed using a planetary centrifugal mixer (Thinky USA) for 15 
min at 2000 rpm with rotation and then de-foamed for 12 min at 2200 rpm. The epoxy mixture 
was poured into the inverse PDMS master and cured on a level hot plate at 120 °C for 4 hours. 
To prevent evolution of gas bubbles from the PDMS master during epoxy curing, the mold was 
either degassed for ~10 min under vacuum or heated on the hot-plate at 120 °C for 20 min prior 
to filling it with epoxy. The PDMS master could be re-used several times for epoxy molding. 
The non-patterned 2 mil-thick COC sheets were flattened between glass slides at 177 °C 
and a load of 150-200 kg in a laminating press prior to use to obtain sheets with smooth surface. 
Fabrication of thick PDMS devices. Thick PDMS devices (Chapter 5.3, Figures 5.1 and 
5.2) were fabricated for initial testing of designs with normally open and normally closed valves 
(Chapter 1.2.5) and for lipid filling into the patterned COC substrate (Chapter 5.4.1, Figure 5.3). 
The PDMS control layers of 5-10 mm in thickness were prepared by pouring a mixture with the 
monomer : cross-linker ratio of 5:1 on the photoresist-on-silicon master followed by curing at 90 
°C for 5-10 min. For the fluid layers photoresist-on-silicon masters were spin-coated using 
PDMS with the monomer: cross-linker ratio of 15:1 to obtain films of ~10 µm thicker than the 
height of the photoresist features. Fluid layers were cured at 90 °C for 7-9 min. Non-patterned 
PDMS films were fabricated in the same way as the fluid layers by spin-coating plain silane-
treated silicon wafers to obtain ~20 µm-thick films. 
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The chips were assembled as follows: (i) inlet ports were punched in the control layers 
using a 20 AWG needle with a thin wire plunger, (ii) control layers were irreversibly bonded to 
fluid layers by placing the two layers in conformal contact and heating at 70 °C for 2 hrs,24 and 
(iii) inlet ports for the fluid layer were punched. For preliminary device tests described in 
Chapter 5.3, the control/fluid layer assembly was permanently bonded to a microscope glass 
slide by activating the surfaces using atmospheric plasma treatment26  in the plasma cleaner 
(Harrick, Model PDC-001) for 1 min at 500-700 mTorr. To prevent permanent closure of 
normally-closed valves in this step, the corresponding control lines were actuated using a 
vacuum pump prior to bringing the two parts of the device in contact, and remained actuated for 
at least 3 hours.  
For filling the COC substrates with lipid the parts of thin membranes to be located over 
the lipid chambers were removed carefully with sharp tweezers (Chapter 5.4.1, Figure 5.3). The 
control/fluid layer assembly was then placed a patterned COC substrate, and a reversible bond 
between the PDMS fluid layer and the COC substrate formed spontaneously.21 
Fabrication of thin hybrid PDMS/COC devices. Hybrid microfluidic chips consisted 
of a 2 mil-thick flat cyclic olefin copolymer (COC) top layer (2 mil, 6013, TOPAS Advanced 
Polymers), a thin PDMS (RTV 650, Momentive Performance Adhesives) control layer, a thin 
PDMS fluid layer, and a patterned 2 mil-thick COC bottom substrate (Chapter 5.4.1, Figure 5.4). 
The PDMS layers were fabricated using standard replica molding procedures24,25 by spin-coating 
the photoresist-on-silicon masters to obtain a PDMS film height ~10 µm thicker than the 
corresponding photoresist feature height. For the fluid layer we used PDMS with the monomer : 
cross-linker ratio of 15:1 followed by curing at 90 °C for 7-9 min. For the control layer we used 
PDMS with the monomer : cross-linker ratio of 5:1 followed by curing at 80 °C for 3 min. 
The chips were assembled as follows: (i) a flat COC sheet was irreversibly bonded to the 
PDMS control layer, and (ii) the resulting COC-PDMS assembly was irreversibly bonded to the 
PDMS fluid layer. Permanent COC-PDMS bonding in step (i) was achieved by activating the 
surfaces using atmospheric plasma treatment26 in a plasma cleaner (Harrick, Model PDC-001) 
for 1 min at 500-700 mTorr. Permanent PDMS-PDMS bonding in step (ii) was done using the 
standard multilayer soft lithography method24 by placing layers of PDMS with different 
monomer : cross-linker ratios in conformal contact and heating them at 70 °C for 2 hours. Inlet 
holes for the control and the fluid layer were drilled in the COC-PDMS-PDMS assembly using a 
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750 µm drill bit (McMaster-Carr). The assembly was then placed on a patterned COC substrate 
pre-filled with lipid, and a reversible bond between the PDMS fluid layer and the COC substrate 
formed spontaneously.21   
 
5.2.2  Device operation 
During filling and mixing, microfluidic devices were monitored using an upright 
microscope (Leica MDG33) equipped with a macro lens and a digital camera (Leica DFC295). 
Thick devices with normally open valves. Prior to filling and mixing operations, fluid-
routing control lines (Section 5.3.1, Figure 5.1) were filled with Fluorinert FC-40 (3M) to 
prevent gas leakage from the control layer through valve membranes to the fluid layer and 
subsequent bubble formation in sample chambers. For pneumatic actuation we used a 32-line 
solenoid valve manifold (Fluidigm). The pressure in the manifold and the sequence of valve 
actuations were controlled by Genie V2 software (Fluidigm). The dead-ended fluid chambers 
were filled with samples by applying a pressure of 5.5 psi to the filling fluid to displace air from 
the chambers. Pressure of 22.5 psi was used to actuate fluid-routing valves. This pressure was the 
highest achievable with the Fluidigm solenoid valve manifold.  
Thick devices with normally closed valves. The dead-ended fluid chambers were filled 
with samples by applying a pressure of 5.5 psi to the filling fluid to displace air from the 
chambers. Valves were actuated using a vacuum pump (GAST, Model DOA-P704-AA). 
Thin hybrid PDMS/COC devices. For fluid routing and metering these chips rely on 
normally closed valves. Fluid chambers were filled by placing several microliters of solution 
onto fluid layer inlet ports and applying negative pressure (vacuum) to valve lines and auxiliary 
control lines (Chapter 5.3.2, Figure 5.2). A pressure gradient formed in the fluid layer due to the 
air permeability of PDMS, resulting in the solutions being pulled into the device. The solutions 
eventually replaced all air pockets in the sample chambers. Various chamber geometries were 
tested, as discussed in Chapter 5.4.2. The same strategy was applied for filling the lipid into the 
chambers patterned in the COC substrate (Chapter 5.4.1). The lipid used in this work 
(monoolein, Sigma Aldrich, 99%) melts at 37 °C and was heated with a hair dryer for filling. 
Prior to removing the preliminary PDMS assembly from the lipid-filled COC substrate, the lipid 
was frozen by placing a piece of dry ice on the device.  
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5.2.3  Sample preparation 
Monoolein (Sigma Aldrich, 99%) was used as received. 5% v/w and 10% v/w solutions 
of OG (Anatrace, Anagrade) were prepared by dilution from a 20% v/w OG solution in 25 
mM NaH2PO4, pH 5.5. NaH2PO4 was obtained from EMD Chemicals. 
Rhodobacter Sphaeroides photosynthetic reaction center (RC) in 10mM Tris pH 7.8, 280 
mM NaCl, 0.05% LDAO was a gift from Dr. Philip Laible, Argonne National Lab. The RC 
solution at an initial concentration of 6 mg/mL was concentrated in a Microcon centrifugal filter 
device (Millipore corp.) with a 10,000 Da cut-off by spinning in a microcentrifuge at 10,000 g in 
a cold room maintained at 4 °C. The volume of the concentrate was measured after every 5-min 
spin and the centrifugation was stopped when the final volume reached ¼ of the initial volume, 
yielding a solution with a calculated final concentration of 24 mg/mL. The filtrate was used to 
dilute this solution to obtain samples with RC concentration of 10-24 mg/mL. The solutions were 
either used immediately for crystallization trials or separated into 2-3 µL aliquots and kept in the 
freezer at -12 °C before using. 
Precipitants for protein crystallization trials were formulated by first preparing an 
aqueous solution of 1M HEPES (Sigma) and 1.15 M (NH4)2SO4 (Fisher) and adjusting the pH to 
7.5. Jeffamine M-600 (Hampton Research) was then mixed with the aqueous solution to obtain 
mixtures containing 11, 12, 13, and 14% w/v of Jeffamine. 
 
5.2.4  Crystallization of photosynthetic reaction center in well plates 
Protein crystallization in 96-well flat bottom microplates (Corning CrystalEX 3785) 
replicated the PLI6 protocol (Chapter 1.2.4) and the crystallization conditions established in the 
original report. Dry monoolein was used instead of preparing the lipid mesophase with water. 
Monoolein was dispensed into the well plate (0.2 µL/well) using a ratchet dispenser (Hampton 
Research), covered with Crystal Clear Sealing Film (Hampton Research) and cooled to -12 °C 
for freezing. Sealed monoolein-filled well plates were stored in the freezer for up to 3 weeks. 
Prior to use, the plates were brought to room temperature before removing the tape. 
 For crystallization, 0.4 µL of the RC protein solution was added on top of dry monoolein 
in the wells, sealed, and incubated for 4-14 hrs at 20 °C. Afterwards, 2 µL of the precipitant 
solution was added to the crystallization well and 5-10 µL of the same solution was added to the 
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reservoir well. The plates were sealed and incubated at 20 °C. Protein crystals of 5-60 µm in size 
formed in 24-48 hrs. 
 
5.2.5 On-chip crystallization of photosynthetic reaction center 
Protein crystallization on-chip was carried out with the same materials and incubation 
times as used in the crystallization in well plates. Solution volumes were set by the volume of the 
chambers of the chip. Chip operation and metering strategies are described in detail in Chapter 
5.4.1 and 5.4.2 (Figures 5.3 - 5.6). 
 
5.2.6  Crystal X-ray diffraction data collection 
Protein crystal X-ray diffraction data were collected at macromolecular crystallography 
beamlines 21-ID-F and 21-ID-D of the Life Sciences Collaborative Access Team (LS-CAT), 
Advanced Photon Source, Argonne National Lab. Both beamlines are equipped with 
microdiffractometers (MAATEL MD2) consisting of a goniometer, XYZ micropositioner and an 
on-axis video microscope. Beamline 21-ID-F operates at a fixed wavelength (λ = 0.979 Å, 12.7 
keV) and has a MarMosaic 225 detector (Rayonix). Beamline 21-ID-D is fully tunable and has a 
MX-300 detector (MarResearch). Here beam energy was kept at 12.7 keV for data collection to 
match that of the 21-ID-F station. Beam-defining apertures of 20 or 50 µm in diameter were used 
to control the footprint of the beam. 
 Protein crystals grown in well plates were harvested using microloops (Hampton 
Research), flash-frozen in liquid nitrogen without the addition of cryoprotectant,3,27 and kept 
under a cryostream during data collection. Up to 400 data frames could be collected per crystal 
without noticeable deterioration in data quality. 
 On-chip data collection was done at room temperature. The chip was trimmed to a size of 
~2×2.5 cm to conform to spatial requirements of the goniometer and mounted using a modified 
goniometer mount with magnetic base (Chapter 5.4.4, Figure 5.9). The position of the chip 
relative to the X-ray beam was monitored using the video microscope; the microfluidic chip was 
translated using the XYZ micropositioner to target different protein crystals within the chip. In a 
typical data collection protocol, frames were collected using 1° oscillation and 1 s exposure time 
per frame with beam attenuation of 70-80%. Depending on the crystal, 5-15 frames could be 
collected before radiation damage to the crystal became critical. 
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5.2.7  Analysis of crystal X-ray diffraction data 
Analysis of X-ray diffraction data collected at the synchrotron was performed using 
HKL2000 software for indexing, refinement, integration, and scaling (HKL Research Inc.).28 The 
resolution range of the data was established based on the resolution shell at which I/σ fell below 
2.3 provided that Rsym was also less than 0.50. Subsequent processing of crystallography datasets 
was done using the Phenix suite of programs.29 Molecular replacement30 was done in Phaser 
using PDB structure 2UWW as a model.31 Model refinement was performed using phenix.refine. 
Electron density maps were displayed using Coot.32    
 
 
5.3  Preliminary diffusion-based platforms for mesophase formulation 
In the course of developing an X-ray transparent lipidic mixer (Chapter 3), we established 
that even though this design was previously used for crystalizing membrane proteins on-chip,22 it 
was not optimal for high-throughput crystallization efforts and for X-ray transparency. Many of 
the problems associated with the mixer stemmed from the active mixing approach, which 
required normally open valves and permanent bonding between all layers of the device. 
Normally open valves require high actuation pressures for isolating tall channels,33 ultimately 
limiting the height of the sample compartments and, consequently, the maximal vertical 
dimension of protein crystals that can be grown on-chip. This parameter is extremely important 
because crystal size correlates with the quality of crystal X-ray diffraction data.21,34 The 
requirement for permanent bonding between all device layers led to an extremely laborious 
fabrication procedure with a relatively low success rate compared to the traditional multilayer 
soft lithography24-26 and the fabrication methods for X-ray transparent devices that use passive 
mixing.21 Most importantly, we found that true cubic phases could not be manipulated once 
formed, and the cooling procedure used to overcome this problem in the formulation of 
mesophases for phase behavior studies is unsuitable for protein-containing mesophases. 
Therefore, our subsequent efforts on developing X-ray transparent platforms for in meso 
crystallization focused on passive mixing strategies similar to the PLI6 and CIMP7 macroscale 
crystallization protocols (Chapter 1.2.4) and on sample formulation strategies that would not 
require mesophase routing on-chip. 
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Initially we attempted to optimize diffusion-based platforms for mesophase formulation 
based on the standard microfluidic architecture35,36 with compartments for lipid and aqueous 
solution fabricated in a fluid layer and connected through channels isolated with normally 
closed24,25 or normally open37-40 valves for metering. These approaches were found suboptimal 
for a variety of reasons as described in Chapters 5.3.1 and 5.3.2. The design finally used for in 
meso crystallization relied on multi-level sample compartments patterned in the fluid layer and in 
the substrate and is described in Chapter 5.4. 
 
5.3.1  Microfluidic devices with normally open valves 
To maximize the contact area between the lipid and the protein solution chambers and 
facilitate diffusion between the two materials, we tested a design where a single large chamber in 
the fluid layer was divided into compartments by actuating normally open valves24,25 spanning 
the entire width of the chamber (Figure 5.1). Here we used thick PDMS devices with 25 µm-tall 
control layer features and 14 µm-tall rounded fluid layer features as prototypes. The PDMS 
assembly was permanently bonded to a glass slide. The valves were kept closed during the 
chamber filling step and released for mixing. The mixing tests were carried out with monoolein 
and solutions of 5-20% OG in 25 mM NaH2PO4. Although some degree of mixing between the 
two materials could be achieved (Figure 5.1C), we established that the size of the valves made 
reliable actuation and compartment isolation difficult even when using small chamber heights 
(14 µm). We decided to not pursue this approach any further, in lieu of the alternative 
approaches described below. 
 
5.3.2  Microfluidic devices with normally closed valves 
Next we tested a design with the lipid and solution compartments connected via multiple 
channels isolated with normally closed valves37-40 (Figure 5.2) to avoid positive pressure 
actuation. As prototypes, we used thick PDMS devices permanently bonded to a glass slide with 
25 µm-tall control layer features and 50 µm-tall fluid layer features with vertical walls. The tests 
were carried out with monoolein and solutions of 10% OG in 25 mM NaH2PO4 or with 
detergent-free 25 mM NaH2PO4. Although the fluid layer compartments could be filled with the 
respective materials, the mixing step was unsuccessful. Application of vacuum for opening of the  
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Figure 5.1. (A) Schematic cross-section of a normally open pneumatic valve fabricated in PDMS. Open and closed states are 
shown. (B) Schematic design of a diffusion-based mixer with normally open valves with superimposed control (brown) and fluid 
(black) layer features and (C, D) optical micrographs of the mixing process between monoolein and a solution of 5% βOG in 25 
mM NaH2PO4, pH 5.5. For clarity, the boundary of the combined sample chamber in optical micrographs is indicated with a red 
or yellow line. (B) During device filling, valve line 2 is actuated to separate the large sample chamber into compartments for lipid 
(center) and aqueous solution (sides). Valve lines 1 and 3 are open in the filling step, and are closed once filling is complete. The 
control layer design is simplified to show only the lines used in the sample filling step. (C) Partially (C1) and fully (C2) cross-
polarized micrographs of the filled device immediately after opening of valve line 2. Formation of the lamellar phase, appearing 
bright under cross-polarized light, is immediately visible at the original lipid/solution/boundary due to the fast diffusion of water 
into lipid. (D) After 1 hr of incubation time the sample in the central part of the chamber has converted into a non-birefringent 
phase, whereas the sides of the chamber that initially contained OG solution remain birefringent. We speculate that the 
difference in diffusion rates of water and detergent leads to the formation of a water-rich cubic phase (dark) in the central part of 
the chamber, and a detergent-rich lamellar phase (bright) at edges. Overall, the appearance of the uniformly mixed sample 
obtained after 1 hour of diffusion is different from the appearance in the lipidic mixer at the identical sample composition 
(Chapter 3.3.4, Figure 3.3).  
mixing valve resulted in withdrawal of water from the fluid layer through the thin PDMS 
membrane in the valve seat area due to permeability of PDMS. Evaporation of water from the 
sample was faster than diffusion of water into the mesophase, rendering this approach unsuitable 
for the formulation of protein-loaded mesophases. This mixing strategy was successfully 
employed for aqueous solutions in soluble protein crystallization,21 highlighting the difficulties 
of applying the methods developed for low-viscosity solutions of small solutes to in meso 
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crystallization. 
 
Figure 5.2. (A) Schematic cross-section of a normally closed pneumatic valve fabricated in PDMS. Open and closed states are 
shown. (B) Schematic design of a diffusion-based mixer with normally closed valves with superimposed control (brown) and 
fluid (black) layer features. Valves 1 and 3 at chamber inlets are open by applying negative pressure (vacuum) to respective 
control lines and are closed once lipid and aqueous solution fill dedicated chambers. For mixing, valve 2 separating the two fluid 
layer compartments is opened by applying negative pressure to the line.  
 
5.4  X-ray transparent array chip for in meso protein crystallization 
The successful strategy developed for in meso crystallization on-chip combined the 
metering and fluid routing capabilities of multilayer PDMS devices with the architecture of the 
SlipChip41-43 (Chapter 4). The microfluidic platform described here is under 210 µm in thickness 
and implements the PLI method6 described in Chapter 1.2.5: the protein-loaded mesophase is 
prepared by incubating the protein solution with monoolein for several hours, followed by the 
addition of precipitant to induce protein crystallization. The platform contains 12 crystallization 
wells. The amount of monoolein per well was kept constant at 25 nL, whereas the amount of 
protein solution and precipitant varied between 40-65 and 215-300 nL, respectively, depending 
on the compartment height of the crystallization layer (Figure 5.4B). Thus, the total amount of 
material needed was reduced at least 6-fold compared to the macroscopic PLI approach.6 The 
device architecture (Figure 5.4-C1) maximizes the contact area between the monoolein and the 
protein solution for the formulation of the protein-loaded mesophases. The approach outlined 
below relies on the favorable combination of thermodynamic properties of the lipid and the 
dynamic properties of lipidic mesophases and eliminates the need for prolonged valve actuation 
during sample formulation. 
 
5.4.1  Sample formulation strategy 
The formulation strategy relied on two distinct fluid-routing assemblies (Figures 5.3 and 
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5.4), one of which was less than 200 µm thick (Figure 5.4) as required for X-ray 
transparency.16,21 The first auxiliary PDMS assembly (Figure 5.3) was used to fill molten 
monoolein into the respective 25 µm-deep chambers of the COC substrate (Figure 5.3C). 
Monoolein was then frozen using dry ice and the auxiliary PDMS assembly was removed. 
Because monoolein is solid at room temperature, the lipid-filled substrates could be easily 
manipulated in subsequent steps, unlike volatile and mobile aqueous solutions that require 
special precautions.44 
 
Figure 5.3. Device architecture and the sequence of operations in the lipid filling step. (A) Superimposed patterns in the hot-
embossed COC substrate (green) and in the auxiliary thick PDMS layer (red) of the 12-well microfluidic platform for in meso 
crystallization. (B) A magnified top view of a single well and the cross-section schematic of the PDMS assembly aligned with the 
patterned COC layer. Features in the top PDMS layer correspond to lines 1 and 2. (C1-C4) The sequence of steps for the lipid-
filling protocol. (C1) The part of the thin PDMS membrane corresponding to the circular end of line 1 in (A) is removed. (C2) 
The PDMS layer is placed on the COC substrate and upon application of negative pressure (vacuum) to line 2 air is withdrawn 
from line 1 due to air permeability of PDMS. This draws molten lipid into the chamber through line 1, (C3) eventually filling the 
entire chamber. (C4) After filling, the lipid is frozen and remains solid at room temperature. The auxiliary PDMS layer is 
removed. The lipid-filled COC layer is ready for the crystallization step (Figure 5.4). 
The auxiliary PDMS layer for lipid filling contained two sets of channels patterned in the 
thick PDMS layers and was sealed by bonding a thin PDMS layer to the thick layer (Figure 
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5.3B). One set was used as a fluidic line and consisted of branched channels that terminated 
above the patterned chambers in the COC substrate (Figure 5.3A). The thin PDMS membranes 
were selectively removed at the ends of the channels to form a continuous fluidic path between 
the inlet port and the chambers patterned in COC (Figure 5.3-C1 and C2). The other set of 
channels passed over the patterned chambers and was connected to the vacuum source. Although 
the control line was separated from the chambers with the thin PDMS membrane, a pressure 
gradient between the chambers and the inlet port of the fluidic line arose due to the air 
permeability of PDMS, and monoolein was drawn into the chambers through the fluidic line 
(Figure 5.3-C2). This approach, while slightly sacrificing the accuracy of monoolein metering in 
the chambers due to lipid protrusions above the chamber height upon removal of the PDMS layer 
(Figure 5.3-C4), ensured that monoolein only remained in the COC chambers once the PDMS 
layer was removed as the fluidic lines themselves were sealed from contact with the substrate. 
Lipid protrusions may be minimized by optimizing the PDMS membrane removal procedure to 
handle membranes of small lateral dimensions.  
In the second step, a hybrid COC/PDMS/PDMS assembly of 135-160 µm in thickness 
with patterned control and fluid layers was aligned over the 50 µm-thick monoolein-filled COC 
substrate (Figure 5.4). The normally closed monolithic microvalves of this assembly were used 
for fluid routing on-chip as usual.37-40 Protein solution was drawn through a dedicated fluidic line 
on top of the lipid by applying vacuum to respective control lines, and then incubated for several 
hours to form the mesophase (Figure 5.4-C2). Strategies for protein solution metering are 
discussed in Chapter 5.4.2. The geometry of the protein solution/lipid contact is similar to the 
SlipChip43 (Chapter 4) and is optimal for passive mixing due to the large contact area between 
the samples and the small length scale required for diffusion (Figure 5.4-C2). The mesophase 
formed in the incubation step remained immobile in the compartment due to is viscoelastic 
properties (Figure 5.4-C3), enabling the valve-less geometry of the combined 
mesophase/precipitant chamber (the crystallization well). Once the mesophase had formed, a 
precipitant solution was used to fill the mesophase/precipitant chamber to volume through a 
dedicated fluidic line (Figure 5.4-C4) and the device was incubated for crystal growth for up to 
several days. 
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Figure 5.4. Device architecture and the sequence of operations in the protein crystallization step. (A) Superimposed patterns of 
the control (orange) and fluid (black) layer of the 12-well microfluidic platform for in meso crystallization. (B) A magnified top 
view of a single crystallization well and the corresponding cross-section of the COC/PDMS/PDMS assembly for fluid routing. 
(C1-C5) The sequence of steps for the protein crystallization protocol. (C1) The hybrid COC/PDMS/PDMS assembly is placed 
on a patterned COC substrate previously filled with the lipid. (C2) Protein solution is drawn on top of the lipid through the 
corresponding fluid line by applying negative pressure (vacuum) to control lines 1 and 2. Line 2 serves to increase the rate of air 
withdrawal from the chamber. (C3) Protein-loaded mesophase forms spontaneously upon incubation.6,7 (C4) Precipitant is filled 
through the corresponding fluid line by applying negative pressure to lines 3 and 4. Line 3 serves to increase the rate of air 
withdrawal from the chamber. (C5) Protein crystals form in the mesophase after incubation.  
 
5.4.2  Protein metering strategies 
The valve-less architecture of the crystallization well is a highly desirable feature as it 
eliminates prolonged valve actuation that would otherwise be necessary either in the protein 
solution metering step or during incubation with the precipitant. However, this architecture 
presents challenges for protein solution metering because the volume of solution is not rigidly 
defined by the volume of the corresponding chamber, as typical for multilayer PDMS 
microfluidic devices. Therefore, several strategies and geometries of the protein/mesophase 
chamber were tested for protein solution metering (Figures 5.5. and 5.6). 
127 
 
One of the approaches to the protein solution metering involved filling of auxiliary 
metering chambers connected to the crystallization well via a channel isolated with normally 
closed valves (Figure 5.5A). After metering into the auxiliary chambers, the protein solution was 
transferred onto the lipid by opening the normally closed valve and briefly actuating the 
membrane on top of the chambers (Figure 5.5B). Several geometries of the channels connecting 
the metering chamber with the crystallization well were tested (Figure 5.5A). 
 
Figure 5.5.  Different approaches to protein solution metering with positive/negative pressure actuation. (A) Top view of 
crystallization wells with (A1-3) various types of channel geometries connecting the protein metering chamber and the 
crystallization well with superimposed patterns of the control (brown) and fluid (black) layers. The compartments patterned in 
PDMS (brown and black) are shown side-by-side with the (A4) compartments patterned in COC substrate (green), alignment of 
the patterns is shown with the dotted lines. (B) Cross-section of the crystallization wells corresponding to the dashed lines for all 
geometries in (A). (B1-B5) The sequence of steps in the protein metering protocol. (B1) Protein solution is drawn into the 
metering chamber through the corresponding fluid line by applying negative pressure (vacuum) to control lines 1 and 2. Line 2 
serves to increase the rate of air withdrawal from the chamber. (B2) The solution is transferred into the crystallization well by 
applying negative pressure to line 3 to open the valve, and positive pressure to line 2 to push the solution out. (B3) 
Positive/negative pressure actuation is stopped and (B4) protein loaded-mesophase forms after incubation.  
This approach ensured a well-defined protein solution volume in the metering step, but 
accurate solution transfer from the metering chamber into the crystallization well could not be 
achieved. A variable amount of solution stayed in the metering chambers after transfer, and 
back-flow from the crystallization wells into the metering chamber was observed once pressure 
was released from the membranes on top of the metering chambers. Valve-less metering 
strategies for the protein solution were also tested. In the crystallization trials of RC on-chip 
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described below we employed a modified device geometry with valve-less metering (Figure 5.6), 
achieved by offsetting the position of the hybrid COC/PDMS/PDMS crystallization layer (Figure  
5.4) relative to lipid chambers patterned in COC (Figure 5.3). This type of geometry provided a 
way of sampling various strategies of incorporating the protein solution into the mesophase in a 
single device and of creating samples with gradients of protein concentrations within the 
mesophase for testing a wider area of the crystallization phase space. 
 
Figure 5.6. Valve-less protein solution metering for mesophase formulation with offset crystallization layers and COC substrates. 
(A1, A2) Top view of crystallization wells in the two 6-well rows of a single 12-well device with superimposed patterns of the 
control (orange) and fluid (black) layers. The compartments patterned in PDMS (brown and black) are shown side-by-side with 
the (A4) compartments patterned in COC substrate (green), alignment of the patterns is shown with brown dotted lines. The 
COC/PDMS/PDMS layer is offset relative to the lipid-filled COC substrate to achieve different configurations of the wells on the 
two sides of the device. Control layer features with identical numbers belong to the same control line and operate simultaneously. 
Arrows indicate channel expansion points that acts as capillary valves for advancing protein solution. (B) Cross-section of the 
crystallization wells corresponding to the dashed lines in (A). (B1-B6) The sequence of steps for protein metering. The steps take 
place simultaneously on both sides of the device. (B1, B2) Protein solution is drawn into the metering chamber through the 
corresponding fluid line by applying negative pressure (vacuum) to control lines 1 and 2. Line 2 serves to increase the rate of air 
withdrawal from the chamber and draw the protein solution past the channel expansion area that serves as a capillary valve 
(indicated with arrows). (B3, B4) After drawing a desired volume of the protein solution into crystallization wells (B5, B6) 
protein loaded-mesophase forms after incubation.  
Work is currently in progress to further optimize protein solution metering strategies to 
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improve consistency of protein solution metering by incorporating capillary valves of different 
geometries45 in the device.  
 
5.4.3  Results: crystallization of photosynthetic reaction center on-chip and in well plates 
All protein solution metering strategies produced crystals on-chip after the incubation and 
precipitant addition step with a variety of protein and precipitant concentrations and incubation 
times allowed for mesophase formation. Figure 5.7 shows samples at different stages of the 
crystallization protocol. Examples of crystals grown on-chip are shown in Figure 5.8. 
 
Figure 5.7. Appearance of crystallization wells at different stages of the crystallization protocol. The design shown corresponds 
to panel A2 in Figure 5.6. A view of a crystallization well with: (A) dry monoolein prior to filling the protein solution in the 
chambers; (B) the protein solution prior to incubation to form (C) protein-loaded mesophase after 12 hrs of incubation; (D) 
protein crystals in the mesophase after 2 days of incubation with (E) the inset showing a magnified view of the section containing 
crystals. Some of the protein crystals are indicated with white arrows. The mesophase converts into a fluid sponge phase35,46,47 
and is pushed away from the original location of monoolein. Crystallization conditions: RC, 10 mg/mL in 10mM Tris pH 7.8, 
280 mM NaCl, 0.05% LDAO; precipitant: 1.15 M (NH4)2SO4, 14% Jeffamine, 1 M HEPES, pH 7.5. 
 
Figure 5.8. Examples of crystals of RC grown on-chip. Some of the crystals are indicated with white arrows. Crystallization 
conditions: RC, 10-24 mg/mL in 10mM Tris pH 7.8, 280 mM NaCl, 0.05% LDAO; precipitant: 1.15 M (NH4)2SO4, 14% 
Jeffamine, 1 M HEPES, pH 7.5. 
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A systematic study of RC crystallization on-chip was carried out to investigate the effects 
of the (i) incubation time for mesophase formulation (4, 8, and 12 hrs) and (ii) the protein 
concentration in solution (10, 15, 20, and 24 mg/mL). Two 12-well crystallization devices were 
set up for each combination of parameters. A single precipitant formulation that produced best 
results in prior wellplate trials was used (1M HEPES, 1.15 M (NH4)2SO4, pH 7.5, 14% w/v 
Jeffamine M-600). All chips were set up using valve-less metering with offset crystallization / 
lipid layers (Figure 5.6). For comparison, well-plate trials were also set up at the same time using 
the same batches of the protein solutions with incubation times identical to on-chip samples (4, 
8, and 12 hrs) for protein solutions with the concentrations of 15 and 24 mg/mL (4 wells per each 
incubation time/concentration combination). While many on-chip crystallization trials produced 
small crystals or showers of crystals with little dependence on the incubation time or protein 
concentration, a single device (12 hr incubation, RC 24 mg/mL) produced large, well-separated 
crystals in several wells that were used for crystal X-ray diffraction data collection. Similar 
results were obtained with crystallization trials in well plates, where well-separated crystals or 
showers of crystals formed in different wells set up for the same condition. 
Overall, these results suggest lack of reproducibility in the protein incorporation into the 
mesophase in the first incubation step both on-chip and off-chip. Efforts are underway to 
optimize the design of crystallization wells on-chip to improve consistency of protein 
incorporation into the mesophase. Here microfluidic chips provide an advantage over well plates, 
where precise control of mass transport may not be possible. 
 
5.4.4  Results: crystal X-ray diffraction and protein structure solution 
On-chip crystal X-ray diffraction data were collected on-chip at room temperature at 
beamlines 21-ID-F and 21-ID-D, of LS-CAT, Advanced Photon Source, Argonne National Lab. 
The microfluidic chips were fully compatible with existing beamline infrastructure and could be 
mounted directly on the goniometer using the standard magnetic base (Figure 5.9A). An XY-
positioner was used to move the chip in the X-ray beam to target different crystals within the 
chip, and exact beam position was monitored in an on-axis video microscope (Figure 5.9B). 
Compared to the standard cryogenic technique, the advantage of room-temperature data 
collection is a potentially higher quality of some metrics of diffraction data (for example, 
mosaicity), and the lack of ice formation on the protein crystals during data collection, which 
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Figure 5.9. (A) The 12-well chip mounted on the goniometer for crystal X-ray diffraction data collection at beamline 21-ID-F. 
(B) Section of a crystallization well as with several crystals of RC as seen in the on-axis video microscope during data collection. 
The red circle represents the footprint and the location of the X-ray beam. (C) A diffraction pattern of an RC crystal grown and 
analyzed on-chip. The green ring indicates the resolution of 1.98 Å. The inset shows the clearly resolved diffraction spots from 
the crystal on top of the background noise (dark rings) coming from the chip materials.  
  
Figure 5.10. Distribution of resolution of partial crystal X-ray 
diffraction datasets for RC crystals grown and analyzed on-
chip and used for structure solution (Table 5.1). 
Figure 5.11. A diffraction pattern of an RC crystal grown in 
a well plate, mounted in a crystal loop and analyzed under 
cryogenic conditions. The green ring indicates the resolution 
of 2.45 Å. The inset shows the mounted crystal as seen in the 
on-axis video microscope during data collection. The protein 
crystal is poorly visible in the mesophase and is within the 
red circle representing the footprint and the location of the 
X-ray beam. 
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contributes to the diffraction pattern and compromises resolution.48 However, because of 
radiation damage only an incomplete data set can be obtained from each crystal at room 
temperature. To overcome this problem, we used the previously established strategy of collecting 
small wedges of diffraction data from a number of crystals and then merging the datasets.21,34 
This approach is relatively straightforward in the on-chip data collection because multiple 
crystals can be grown and analyzed in a single chip and the cumbersome manual harvesting is 
not required for each crystal. Furthermore, locating the crystals in the chip during data collection 
is often easier than in standard loop mounts (Figures 5.9B and inset in Figure 5.11) due to the 
favorable optical properties of the chips. 
RC crystals grown on-chip diffracted to 1.98 Å (Figure 5.9C), which is a significant 
improvement compared to the previously reported diffraction limit of 2.5 Å reported for crystals 
of the same protein in a plug-based microfluidic system.23 Using the data collection strategy 
outlined above, we were able to obtain a complete dataset for RC crystals on-chip and solve the 
structure at the resolution of 3.33 Å (Table 5.1) using data from 14 best-diffracting crystals out 
of the 54 crystals that were probed. Space group type and lattice parameters were in agreement 
with previously published data for RC.27,47 Although the background scatter from device 
materials was clearly visible in the diffractograms as diffuse rings in the d-spacing ranges of 4.7-
5.7 and 6.9-8.7 Å (Figure 5.9C), it did not interfere with indexing of X-ray diffraction data. 
Figure 5.10 shows the distribution of resolution limits of diffraction data for on-chip crystals 
used for the final dataset as assessed visually from the X-ray diffraction data. The majority of 
crystals diffracted to ~3 Å, slightly better the final resolution of the structure. The resolution 
deteriorated consistently with each frame collected for a given crystal.  
Contrary to the findings for soluble protein structure determination,34 we were able to 
obtain higher-resolution data on-chip than for crystals grown and analyzed following the 
traditional cryogenic data collection protocol (Table 5.1). Nine RC crystals grown in well-plates 
were harvested, flash-frozen, and analyzed under cryogenic conditions. Although a complete 
dataset could be obtained from a single crystal, the crystals only diffracted to 3.3-3.8 Å and 
produced a structure with the resolution of 3.93 Å. These results are in agreement with the 3.6 Å 
resolution of diffraction data reported for the RC crystals grown previously in well plates using 
the PLI approach with dry monoolein.6 Additionally, background scattering similar in the 
intensity to that seen from the chip materials was observed in the 3.6-4.9Å range of d-spacings 
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(Figure 5.11), which may be attributed amorphous ice, a vitrified monoolein- or Jeffamine-
containing phase, or noise from the nylon loop. Data collected both on-chip and off-chip were of 
poorer quality than the highest-resolution structure of RC reported so far (solved to 2.2 Å).47  
 
Table 5.1 Summary of crystallographic data for RC crystals grown and analyzed on-chip and in the traditional 
cryogenic data collection for crystals grown in well-plates.  
Parameter On-chip Traditional (cryogenic) 
Crystal quality 
# of crystals probed 54 9 
# of indexable crystals 22 5 
# of crystals used for 
structure solution 
14 1 
# of frames for structure 
solution 85 120 
Crystallographic dataa,b 
Space group P42212 P42212 
Unit cell dimensions a, b =102.5 Å, c = 240.1 Å a, b =100 Å, c = 232.8 Å 
Resolution 24 - 3.33 Å 24 - 3.93 Å 
Rsym 0.5 0.5 
Mosaicity 0.16° 1.2° 
Redundancy 3 4.5 
Completeness 98% 99.9% 
I/σ 2 2 
Refinement 
R (Rfree) 0.2237 (0.2988) 0.2817 (0.3672) 
Ramachandran statisticsc 
Most favored 91.9% 83.8% 
Allowed 6.4% 12.0% 
Disallowed 1.7% 4.3% 
a On-chip structure solution: merging of small datasets from "multiple crystals" analyzed on-chip within a 
24-well device at room temperature.  bThe "traditional" sample was grown using the PLI technique6 in a 
well plate and mounted using a standard crystal mount for cryogenic data collection. cRamachandran 
statistics is reported without manual optimization. Reported values are for all hkls. R-factor = Σ(|Fobs|-
k|Fcalc|)/ Σ |Fobs| and Rfree is the R value for a test set of reflections consisting of a random 5% of the 
diffraction data not used in refinement.49  Rsym = Σ |Ii - <Ii> | / Σ Ii where Ii = intensity of the ith reflection 
and <Ii> = mean intensity.  
Anecdotal evidence suggests that several hundred crystals may be probed in order to find 
one that diffracts to high resolution, and the limited number of crystals tested here does not allow 
for rigorous statistical analysis. However, the quality of X-ray diffraction data for all crystals 
mounted in loops as assessed visually was relatively poor, with diffuse diffraction spots and 
significant background noise, although a larger fraction of well-plate crystals (~55%) produced 
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indexable diffraction data than in on-chip crystals (~40%). We speculate that the quality of the 
well-plate crystals may have been compromised due to manual harvesting and flash-freezing, 
highlighting the crucial nature of those steps and further suggesting that strategies that obviate 
those steps may provide a pathway to higher-resolution structure data for membrane proteins. 
  
5.5  Conclusions 
To our knowledge, the microfluidic chip described in this chapter the first example of an 
X-ray transparent microfluidic platform for in meso crystallization of membrane proteins. 
Successful crystallization of a membrane protein photosynthetic reaction center (R. Sphaeroides) 
followed by resolving its structure at a resolution of 3Å using crystal X-ray diffraction on-chip 
validates our approach.  
  The 12-well crystallization platform developed here reduces the amount of material for 
trial formulation at least 7-fold compared to comparable methods of protein crystallization in 
well plates. The X-ray transparency of the platform obviates the manual crystal harvesting and 
freezing steps that often compromise the quality of crystals and thus the resolution of diffraction 
data.  The X-ray transparent platform can be used for in situ crystal X-ray data collection without 
additional modifications to beamline infrastructure. Furthermore, it can be easily used to test 
different lipids as crystallization matrices. These features make it a highly valuable tool for the 
crystallization of scarcely available membrane proteins that typically form only small fragile 
crystals. 
The chip automates metering required for sample formulation and only requires a vacuum 
pump for the operation, in contrast to expensive and complex crystallization robots. Because the 
architecture of the chip is optimized for passive mixing between protein solution and solid lipid 
for the formulation of protein-loaded mesophases, the chip can be easily pre-filled with the lipid 
before supplying it to biochemists for protein crystallization. Elimination of lipid handling, 
which is perceived as difficult by the users, may facilitate the wider penetration of the method in 
the structural biology community.  
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Appendix A. 
Small-angle X-ray scattering analysis of lipidic mesophases 
The microstructure of lipidic mesophases is deduced from diffraction patterns obtained in 
small-angle X-ray scattering (SAXS) experiments. In direct analogy with atomic, ionic, or small-
molecule crystals, the ordered arrangement of bilayers is characterized by the lattice type and the 
lattice parameter, i.e., the dimensions of the smallest repeating unit. Mesophases produce 
diffraction patterns similar to those of powder crystalline samples, and their analysis relies on 
well-established crystallographic principles. Below the important aspects of crystallography 
relevant for SAXS analysis of the microstructure of lipidic mesophases are outlined. Detailed 
information on principles of crystal X-ray diffraction analysis, concepts used in the description 
of crystal symmetry and diffraction patterns (for example, hkl planes and Miller indices), and on 
types of crystal structures can be found in standard texts on X-ray crystallography.1 
Raw diffraction patterns of lipidic mesophases consist of sets of concentric rings, similar 
to those of powdered crystalline samples. Diffractograms of various types of lipidic mesophases 
are shown at the end of this section (Figures A1-A5). The small-angle range arises due to the 
values of lattice parameters of lipidic mesophases that typically lie in the range of 40-200 Å, 
significantly larger than those of atomic, ionic or small-molecule crystals. Large lattice 
parameters result in small scattering angles because of the inverse relationship between the two 
as postulated by Bragg’s law:1 
hklhkld  sin2         Equation A1 
where λ is the wavelength of the incident X-ray beam, dhkl is the lattice spacing of a family of 
periodically spaced crystal planes with Miller indices h, k, and l, and θhkl is the scattering angle 
corresponding to this family of planes. The values of dhkl are related to lattice parameters, as 
described below for relevant types of phases. 
Integration of diffraction patterns produces plots of intensity I vs. scattering angle 2θ with 
a series of peaks. (Care must be taken when processing data as the original SAXS patterns 
produce plots of I vs. 2θ, rather than I vs. θ, which must be taken into account in subsequent 
calculations based on Equation A1.) Each peak in the diffractogram corresponds to a family of 
periodically spaced hkl crystal planes. The symmetry of the unit cell determines the 
combinations of values of h, k, and l for reflections with non-zero intensities, and these 
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combinations have been summarized for all possible crystallographic unit cells in reference 
sources.2 For uniform representation of data obtained at different X-ray wavelengths, intensity 
may be plotted as a function of scattering vector q related to the scattering angle θ as 

 sin4q      Equation A2. 
Depending on the shape of the unit cell, up to three length parameters and three angles 
may be required for its description. The unit cells of cubic mesophases belong to cubic symmetry 
and require a single parameter (cell edge length) to fully characterize the unit cell. Hexagonal 
and lamellar mesophases differ from small molecule crystals because they are only periodic in 
one (lamellar) or two (hexagonal) dimensions. Conveniently, each of these phases can also be 
described with a single parameter, which is easily obtained from SAXS data. 
Below we describe phase assignment and lattice parameter calculation procedures for 
each type of mesophases. All procedures relied on the conversion of the positions of peaks 
(reflections) observed in the diffractogram into corresponding d-spacings via Bragg’s law 
(Equation A1), followed by the calculation of ratios between inverse d-spacings, i.e., d-1, to 
establish the mesophase type. Lattice parameters were calculated based on the d-spacing 
corresponding to the highest-intensity reflection of a given mesophase type as indicated in 
respective subsections. 
Lamellar phases. The lamellar Lα phase is comprised of stacks of flat lipid bilayers 
separated with layers of water (Chapter 1, Figure 1.10). This phase has a single periodic repeat 
distance, that between midplanes of bilayers, and possible hkl indices of h00. In diffractograms it 
appears as a set of rings with the ratio of inverse d-spacings 1:2:3:etc. (Figure A1). The highest- 
 
intensity reflection of the Lα phase is 100, and the lattice parameter of a lamellar phase reported 
in Chapters 2-4 is simply 
aLα = d100     Equation A3 
which is obtained directly from SAXS data via Bragg’s law (Equation A1). 
Hexagonal phases. The inverse hexagonal lipidic mesophase (HII) consists of infinitely 
long cylindrical inverse micelles packed on a hexagonal lattice (Chapter 1, Figure 1.10). This 
arrangement can be thought of as the P6 phase (space group 168) with one of the dimensions of 
the unit cell being infinitely long. Because of symmetry, a single parameter corresponding to the 
distance between the centers of the cylinders is sufficient to unequivocally describe the HII 
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phase. For small-molecule hexagonal crystals with finite unit cell dimensions the equation 
relating hkl spacings and the lattice parameters in the hexagonal phase is  
2
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where a and c are, respectively, the center-to-center distance between the cylinders and the 
length of the cylinders. The length of the cylinder for HII mesophases is infinitely large (c = ∞), 
resulting in the only allowed value of l = 0. Hence, Equation A4 reduces to 
  2122
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a
d hk    Equation A5. 
Equation A5 indicates that the HII phase produces patterns with the ratios of inverse d-spacings 
of .,2:3:1 etc  corresponding to the hkl reflections 100/010, 210/120, 220, etc. The highest-
intensity reflection of the HII mesophase is d100/d010, and, consequently, the lattice parameter of 
the HII mesophase in Chapter 2 was calculated as 
2
3)( 100dHa II      Equation A6. 
Cubic phases. Conveniently, IPMS of G, P, and D types correspond to crystallographic 
cubic space groups Ia3d (Q230), Im3m (Q229), and Pn3m (Q224). The unit cell of any cubic phase 
is a cube and requires a single lattice parameter a (the length of the edge of the cube) to fully 
describe its dimensions, which is related to d-spacings simply as  
222 lkhda hklcubic     Equation A7. 
Due to the high symmetry of cubic phases, only certain combinations of hkl values produce 
reflections with non-zero intensity,2 as listed below along with corresponding ratios of dhkl for the 
first several peaks of each cubic mesophase: 
Phase type Allowed hkl combinations Ratios of inverse d-spacings 
Pn3m 110, 111, 200, 211, 220, 221, 310, 
311, 222, 321, 322 
17:14:12:11:10:9:8:6:4:3:2
Ia3d 211, 220, 321, 400, 042/332, 422, 431, 
440 
26:22:20:16:14:8:6  
Im3m 110, 200, 211, 220, 310, 222, 321 12:10:8:6:4:3:2  
Cubic mesophases tend to produce low-intensity reflections starting at the peak corresponding to 
the third- or fourth-highest value of d (Figures A2 and A3). Depending on the sample 
composition and the X-ray source, only a few reflections of cubic phases may be visible in the 
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diffractogram, appearing in the low range of q values (Figure A4). Im3m phases are not typical 
for monoolein systems and have not been observed in this work. Lattice parameters of Pn3m and 
Ia3d phases in Chapters 2-4 were calculated based on respective highest-intensity reflections, 
d110 and d211, respectively, and Equation A7. 
Differences between cubic and lamellar phases. Cubic and lamellar mesophases often 
produce diffraction patterns with marked differences in the appearance of the rings (Figures A4 
and A5), which may be helpful in the preliminary assessment of diffractograms of samples with 
coexisting mesophases. Diffraction patterns of cubic phases may appear as spotty rings, owing to 
the tendency of cubic phases to form relatively large (up to 50 µm) monocrystalline domains3 
(Figure A4). On the contrary, lamellar phases typically produce uniform diffraction rings 
(Figures A1 and A4) or rings with smooth variations in intensity along the radial direction of the 
ring (Figure A5). Here intensity variations are caused by the preferred orientation of lamellar 
sheets in the sample. 
 
Figure A1. Raw diffractogram of a lamellar Lα phase with the lattice parameter of 50.5 Å (right) and a corresponding integrated 
diffractogram (left) with hkl peak assignments. Sample composition: 50 wt% of monoolein, 50 wt% of solution of 10% w/v -
octylclucosige in 25 mM NaH2PO4, pH 5.5. 
 
Figure A2. Raw diffractogram of a cubic Ia3d phase with the lattice parameter of 123 Å (right) and a corresponding integrated 
diffractogram (left) with hkl peak assignments. Sample composition: 30 wt% of aqueous solution of 1.0M KH2PO4, pH 5.5, 70 
wt% of mixture of monoolein and -octylglucoside (-octylglucoside/monoolein ratio of 0.066 w/w). 
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Figure A3. Raw diffractogram of a cubic Pn3m phase with the lattice parameter of 102 Å (right) and a corresponding integrated 
diffractogram (left) with hkl peak assignments. Sample composition: 30 wt% of aqueous solution of 1.0M KH2PO4, pH 5.5, and 
70 wt% of mixture of monoolein and -octylglucoside (-octylglucoside/monoolein ratio of 0.066 w/w). 
 
 
Figure A4. Raw diffractogram (right) of a mixture of a cubic Pn3m mesophase with a lamellar Lα phase. Reflections 
corresponding to the Lα phase are indicated with red arrows and have a smooth texture, unlike the spotty rings corresponding to 
the cubic Pn3m phase. Corresponding integrated diffractogram (left) with hkl assignments for Pn3m and Lα phases shown in 
respectively in black and red. Because of the low content of the Pn3m phase in the sample, only reflections up to 220 are visible. 
Sample composition: 55 wt% of monoolein, 45 wt% of solution of 10% w/v -octylclucosige in 25 mM NaH2PO4, pH 5.5. 
Lattice parameters: Pn3m, 175 Å, Lα, 50.1 Å. 
 
Figure A5. Raw diffractogram (right) of a mixture of a cubic Ia3d mesophase with a lamellar Lα phase. The intensity of the 100 
reflection of the Lα phase (indicated with a yellow arrow) varies smoothly in the radial direction. Corresponding integrated 
diffractogram (left) with hkl assignments for Ia3d and Lα phases shown in respectively in black and red. The 321 reflection of the 
Ia3d phase overlaps with the 100 reflection of the Lα phase. Sample composition: 56 wt% of monoolein, 44 wt% of solution of 
5% w/v -octylclucosige in 25 mM NaH2PO4, pH 5.5. Lattice parameters: Ia3d, 178 Å, Lα, 48.7 Å. 
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Appendix B. 
Effect of phosphate salts and -octylglucoside on lattice 
parameters of lipidic mesophases 
Quantitative effects of detergent -octylglucoside (OG) and phosphate salts on the 
lattice parameter of fully hydrated quaternary mesophases of lipid monoolein (MO) reported in 
Chapter 2 were estimated as described below.  
MO/OG/ salt solution samples with KH2PO4. Various datasets used for the 
calculations of regression coefficients in samples prepared with KH2PO4 and resulting values of 
regression coefficients are shown in Table B1. 
Table B1. Lattice parameters and regression coefficients for MO/βOG/salt solution mixtures prepared with 
KH2PO4. 
aPn3m, Å 
RβOG/MO csalt, M Set A* Set B* Set C* Set D* 
0.033 0.7 112.1 112.1 115.1 115.1 
0.066 0.7 131.7 131.7 138.9 131.7 
0.099 0.7 156.1 156.1 162.4 156.1 
0.033 1.0 102.4 97.8 102.4 106.0 
0.066 1.0 122.0 122.0 128.5 128.5 
0.099 1.0 141.4 141.4 154.4 141.4 
0.033 1.3 96.2 93.7 96.2 99.2 
0.066 1.3 114.6 114.6 118.0 118.0 
0.099 1.3 134.6 134.6 137.7 134.6 
                                                            Regression coefficients** 
 Set A Set B Set C Set D 
Intercept, Å 113 ± 8 112 ± 9 117 ± 9 117 ± 10 
∂aPn3m/ ∂RβOG/MO 6.1 ± 0.6 6.5 ± 0.7 7.1 ± 0.7 5.6 ±0.8 
∂aPn3m/ ∂csalt -3.0 ± 0.7 -3.2 ± 0.8 -3.6 ± 0.7 -2.8 ± 0.8 
*Set A: at each RβOG/MO and csalt, lattice parameter at lowest waq resulting in excess aqueous phase formation. 
*Set B: at each RβOG/MO and csalt, lattice parameter at lowest waq producing the Pn3m mesophase without other 
mesophase types present (may be above or below the hydration boundary depending on the sample). 
*Set C: at each RβOG/MO and csalt, lattice parameter at second-lowest waq producing the Pn3m mesophase without 
other mesophase types present (i.e., waq is 10% larger for each sample than in set B). 
*Set D: lattice parameters at waq = 60 wt% for all values of RβOG/MO and csalt. 
**Values for the 95% confidence interval are shown. 
 
For each set of data shown in Table B1 coefficients were calculated in Matlab (R2012a, v. 
7.14.0.739, The MathWorks Inc., Natick, MA) via multilinear regression and scaled to 
correspond to the unit of 0.01 for OG/MO ratio and to the unit of 0.1M for the salt 
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concentration, respectively, for ease of numerical comparison between the two additives. For 
example, the projected lattice parameter of the Pn3m phase aPn3m at ROG/MO = 0.033 and 
KH2PO4 concentration of 0.7 M based on the coefficients for Set A in Table B1 is calculated as 
aPn3m = 113.2  +  6.13 · 3.3  +  (-3.0) · 7. 
 
Mixtures with NaH2PO4. Perusal of data for samples prepared with NaH2PO4 revealed 
that under otherwise identical conditions the change in the lattice parameters upon transition 
from RβOG/MO = 0.033 to RβOG/MO = 0.066 was noticeably smaller than upon transition from 0.066 
to 0.099 in fully hydrated Pn3m mesophase. This disparity led to very large standard deviations 
if a single set of parameters was used in the regression. In contrast, in mixtures with KH2PO4 the 
lattice parameters changed uniformly in the entire range of conditions studied in this work. 
Because of those differences, a modified protocol was adopted for the calculations in mixtures 
with NaH2PO4. Lattice parameters of Pn3m phases did not vary appreciably above the hydration 
boundary in samples with NaH2PO4, and all data points where Pn3m-only mesophase was 
observed at both NaH2PO4 concentrations at a given waq were used in the regression (Table B2). 
Regression coefficients were calculated separately for the RβOG/MO range 0.033 - 0.066 (data in 
rows 1-20 in Table B2) and 0.066 - 0.099 (data in rows 11-28 in Table B2). Regression 
coefficients reported in Table B2 have been scaled in the same way as those in Table B1 to 
correspond to the unit of 0.01 for OG/MO ratio and to the unit of 0.1M for the salt 
concentration. 
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Table B2. Lattice parameters and regression coefficients for 
MO/βOG/salt solution mixtures prepared with NaH2PO4. 
Row # RβOG/MO waq, wt% csalt, M aPn3m, Å 
1 0.033 40.1 1.3 94.2 
2 0.033 50.1 1.3 96.5 
3 0.033 59.9 1.3 97.9 
4 0.033 69.8 1.3 99.0 
5 0.033 80.0 1.3 100.4 
6 0.033 39.9 2.0 76.1 
7 0.033 49.8 2.0 80.7 
8 0.033 59.9 2.0 82.7 
9 0.033 70.0 2.0 81.9 
10 0.033 79.9 2.0 86.4 
11 0.066 40.0 1.3 98.1 
12 0.066 50.0 1.3 105.8 
13 0.066 59.9 1.3 104.9 
14 0.066 69.9 1.3 111.6 
15 0.066 80.0 1.3 113.3 
16 0.066 40.1 2.0 88.2 
17 0.066 49.9 2.0 93.2 
18 0.066 60.0 2.0 96.5 
19 0.066 70.0 2.0 96.6 
20 0.066 79.9 2.0 98.2 
21 0.099 50.0 1.3 118.8 
22 0.099 59.8 1.3 132.1 
23 0.099 69.9 1.3 133.2 
24 0.099 80.1 1.3 131.9 
25 0.099 50.0 2.0 103.8 
26 0.099 59.9 2.0 105.1 
27 0.099 69.9 2.0 108.5 
28 0.099 80.0 2.0 109.8 
Regression coefficients, *  RβOG/MO = 0.033 - 0.066,  rows 1 - 20 
Intercept, Å 111.8 ± 11.3 
∂aPn3m/ ∂RβOG/MO 3.4 ± 1.2 
∂aPn3m/ ∂csalt -2.0 ± 0.6 
Regression coefficients, *   RβOG/MO = 0.066 - 0.099,   rows 11 - 28 
Intercept, Å 105.4 ± 19.6 
∂aPn3m/ ∂RβOG/MO 5.2 ± 1.7 
∂aPn3m/ ∂csalt -2.4 ± 0.8 
*Values for the 95% confidence interval are shown. 
 
 
 
 
